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ABSTRACT 
ASYMMETRIC SYNTHESIS OF ALL-CARBON α-ARYL QUATERNARY 
CARBONYL COMPOUNDS BY PALLADIUM-CATALYZED ASYMMETRIC 
ALLYLIC ALKYLATION (PA-AAA) AND THEIR APPLICATION TO THE 
SYNTHESIS OF BIOLOGICALLY IMPORTANT 3,3′-DISUBSTITUTED OXINDOLE 
AND α-DISUBSTITUTED QUATERNARY β-LACTONE FRAMEWORKS 
 
by 
Md. Sharif A. Asad 
 
The University of Wisconsin-Milwaukee, 2015 
Under the Supervision of Professor M. Mahmun Hossain. 
 
 
The development of catalytic, enantioselective methods for the construction of all-carbon 
quaternary stereocenters is an outstanding achievement in the recent history of organic 
chemistry. The palladium-catalyzed asymmetric allylic alkylation (Pd-AAA) reaction has 
played a key role in creating such stereocenters and has allowed researchers to synthesize 
a vast number of biologically potent natural products. However, synthetic methodologies 
to access compounds containing α-aryl groups to the quaternary carbon stereocenters are 
still rare. The increasing appearance of these all-carbon α-aryl quaternary stereocenters in 
a growing number of biologically active natural products and pharmaceutical agents 
creates a pressing need for the ability to construct this important motif enantioselectively. 
In this endeavor, a set of acyclic all-carbon α-aryl quaternary stereocenter has been 
synthesized via intermolecular Palladium catalyzed Asymmetric Allylic Alkylation (Pd-
AAA). Here hydroxyacrylate was used as an unprecedented nucleophilic counterpart 
instead of the widely used ketonic substrate. This produced a very rare all-carbon 
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quaternary aldehydes with good to excellent yields (75–99%) and enantioselectivities 
ranges between 75–94%. This methodology is not only limited to produce aldehydes, as 
an analogous ketone with a quaternary α-carbon center has also been synthesized 
successfully. 
 
Using this methodology, chiral 3,3′-disubstituted oxindole moiety was produced with 
high yield (80%) and enantioselectivity (82%) from o-nitrophenylhydroxyacrylate in 
three simple steps. The oxindole framework bearing a tetrasubstituted carbon stereocenter 
at 3-position is a privileged heterocyclic motif that constructs the core of a large family of 
bioactive natural products and a series of pharmaceutically active compounds. An 
intensive research has been conducted to synthesize 3,3′-disubstituted oxindole which 
resulted in a fair amount of methods to produce such an important moiety. However, to 
the best of our knowledge, all of the reported methodologies so far have used pre-formed 
oxindole ring itself or a highly specialized compound as a prochiral starting material to 
produce asymmetry. Another application of this method includes the synthesis of chiral 
α-disubstituted quaternary β-lactone from the parent phenylhydroxyacrylate in high yield 
(87%) and enantioselectivity (94%). β-lactones have recently emerged as important 
synthetic targets due to their occurrence in a variety of natural products, their utility as 
versatile synthetic intermediates, and their use as monomers for the preparation of 
biodegradable polymers. 
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CHAPTER 1: ORGANOCATALYTIC FORMATION OF ALL-CARBON 
QUATERNARY STEREOCENTERS 
 
1.1. Introduction 
 
1.1.1. Importance of quaternary stereocenters and asymmetric catalysis 
 
“The construction of chiral tetrasubstituted carbon stereocenters, especially quaternary 
stereocenters, is one of the most important and difficult tasks in asymmetric catalysis.”1 
 
-Dr. Masakatsu Shibasaki  
 
All-carbon quaternary stereocenters is extremely difficult to synthesize due to the 
inherent steric repulsion associated with the presence of four different carbon substituents 
on the same carbon atom (quaternary carbon) in the formation of these stereocenters. 
Owing to steric hindrance, relatively harsh reaction conditions are required and only 
limited combinations of nucleophiles and electrophiles can be employed. Despite 
extensive research in this area, the number of methods available for the construction of 
all carbon quaternary stereocenters is still limited and demand further investigation. 
Recent reviews have highlighted important contributions in this area of research.
2,3,4,5,6
 
Moreover, the development of methodologies for the asymmetric synthesis of quaternary 
stereocenters has attracted a huge attention to the scientific community, much of which is 
due to their ubiquitous presence in a series of bioactive natural products and 
pharmaceutically active compounds (Figure 1).
7,8,9 
2 
 
 
 
Figure 1. Natural products bearing chiral quaternary carbons. 
 
 
 
Two enantiomers of a molecule can have drastically different biochemical effects in 
biological systems, and even in some cases, while one enantiomer has therapeutic 
properties, the opposite enantiomer can be highly toxic. Therefore there is an obvious 
interest to synthesize one enantiomer over other, i.e., chiral molecules, via an asymmetric 
route. As a result, remarkable progress has been achieved in the area of asymmetric 
catalysis, especially in last thirty years. Among the various techniques for creating 
quaternary stereocenters in an enantioselective fashion, employing catalyst as chiral 
inducing agent is the method of choice for several reasons: 1) it avoids the use of chiral 
auxiliaries which need to be added in stoichiometric amount and thereby costly; 2) high 
3 
 
 
 
amounts of enantioselectivity can often be achieved with very little amount of catalyst; 3) 
milder reaction conditions are attainable by the introduction of correct catalyst; and 4) the 
substrate scope is often much greater in compare with enzyme catalysis, and both 
enantiomers of a molecule can be created merely by switching the chirality of the catalyst 
being employed.  
 
1.1.2. General considerations in the formation of quaternary stereocenters via 
asymmetric catalysis 
 
Without employing a catalyst, conditions of a reaction to form quaternary stereocenters 
are usually quite harsh involving high temperatures and long reaction times. This is costly 
for an industrial-scale production. Moreover, increased reaction temperatures usually 
adversely affect the stereoselectivity of a reaction. Catalysts, either organo or metal 
complexes, can overcome these difficulties by allowing much milder reaction conditions, 
such as low temperature, which has the added benefit of often improving the 
stereoselectivity of a reaction significantly.  
 
All reactions have certain limitations in their substrate scope. As an example, an SN2 
reaction with a prochiral tertiary carbon nucleophile is possible with a carbon 
electrophile, only if there is a primary carbon at the electrophilic position. The same 
reaction could not take place with an electrophile having a tertiary carbon. In the case of 
asymmetric synthesis, these limitations in substrate scope are particularly evident. Minor 
changes in the structure of a substrate can lead to profound changes in stereoselectivity, 
4 
 
 
 
the worst case being the loss of stereocontrol. These limitations are common to almost all 
catalytic asymmetric reactions. For example
10
 (Scheme 1) nearly complete loss of 
stereoinduction was observed for α,β-unsaturated products when small modifications 
were made in asymmetric Michael reaction substrates. When the alkyl group of the 
Michael donor is changed from phenethyl to phenyl, the ee changes from 94% to 18% in 
the case of the (E) stereoisomer and from 84% to 0% in the case of the (Z)-stereoisomer 
of the Michael product. Unfortunately, often authors fail to report reasons of these 
limitations in the scope of substrates. Striking changes in stereoselectivity can also be 
observed by subtle changes in the catalyst structure. Choices of solvents as well as 
temperature of the reaction also have significant impact on the stereoselectivity. 
Considering these factors, a thorough screening of reaction conditions has to be carried 
out to optimize stereoselectivity and yield. Usually asymmetric catalysis leads to 
satisfactory results for only a few substrates and other conditions may need to be 
screened for other analogs for the same reaction. 
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Scheme 1: Striking effect in stereocontrol with subtle changes in structure. 
 
1.1.3. General reaction classes to construct quaternary stereocenters 
 
Catalytic asymmetric methods for the synthesis of quaternary stereocenters can be 
devided into three main categories: organocatalysis (the use of organic molecules as 
catalysts), chiral metal-Lewis acid catalysis and transition-metal catalysis. Lewis acid 
catalyzed asymmetric construction of quaternary stereocenters has been successfully 
achieved for the following reaction classes: Diels-Alder reactions, 1,3-dipolar [3+2] 
cycloadditions, the synthesis of β-lactams via overall [2+2] cycloadditions, 
cyclopropanations, 1,4 conjugate additions (Michael additions), the alkylation of tributyl 
tin enolates, Michael additions with hard nucleophiles, copper catalyzed SN2
′
 allylation, 
reactions with carbonyl and imine electrophiles, metal catalyzed diene and enyne 
cyclizations, and Claisen rearrangements. Transition-metal catalyzed reactions that take 
place via oxidative addition-reductive elimination processes include, but is not limited to 
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α-arylation and vinylation reactions of ketones and lactones, intramolecular Heck 
reactions, C-H insertions and allylation via palladium π-allyl intermediates.  
 
A thorough literature survey reveals that the majority of methods involving the 
construction of quaternary stereocenters used cyclic substrates. As an example, in the 
review by Marco Bella
4
 on the organocatalytic formation of quaternary stereocenters, 
only six out of a total of twenty-eight examples of Michael adducts bearing quaternary 
stereocenters are with acyclic substrates. For other reaction classes
3,11
 (such as the 
asymmetric allylic alkylation), the use of acyclic substrates is, in some cases, non-
existent. The challenge of attaining expected enantiodiscrimination associated with an 
increased numbers of degrees of freedom in regards to acyclic substrates is attributed to 
this finding.
5
  
 
1.1.4. General mechanisms of activation for formation of quaternary stereocenters via 
organocatalysis 
 
A general classification of the reaction classes used in organocatalysis shows that two 
general approaches are feasible: nucleophilic activation (Scheme 2; i-iii) and electrophilic 
activation (Scheme 3; iv and v).  
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Scheme 2. Organocatalytic nucleophilic activation. 
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Scheme 3. Organocatalytic electrophilic activation. 
 
Activation of the nucleophile can occur in various ways: 
 
(i) Tertiary amines 
 
Tertiary amines are able to deprotonate nucleophiles with a pKa < 10-11 exceptionally 
well. Upon deprotonation, a tight ion pair is formed between the conjugate base of the 
acid (typically an enolate) and the quaternary ammonium cation. In case a chiral tertiary 
amine, usually based on an alkaloid scaffold
12
 is used, the formed nucleophile, usually an 
ion-paired salt, can attack the electrophile from the less hindered face (Scheme 4).
13,14,15
 
A number of catalysts employed recently involve transformations mostly at C-9 or C-6′ 
positions (Figure 2). The hydrogen bonding to a carbonyl group plays a crucial role to 
position and activate the electrophile by demethylating C-6′ position of the catalyst. 
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Figure 2. Cinchona alkaloid based catalysts. 
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Scheme 4. Organocatalytic Michael additions using cinchona alkaloid catalysts. 
 
(ii) Inorganic bases and quaternary ammonium salts16 
 
Nucleophiles with pKa
 
values < 22 can be deprotonated by inorganic bases (either 
aqueous solutions or in solid form). Once a base deprotonates the nucleophile, an ion 
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exchange takes place between the counter ion of the inorganic base and the chiral 
quaternary ammonium ion and thus, this chiral ion becomes the counterion of the 
activated nucleophile, leading to the nucleophile having much greater solubility in 
organic solvents and instills chiral induction to the product. Similar to approach (i), the 
nucleophile forms a tight ion pair with the chiral counterion, thus allowing for one face of 
the nucleophile to be blocked from attack by the electrophile (Scheme 5).
17,18,19
 The 
quaternary ammonium salts employed are usually obtained from cinchona alkaloids or 
from axially chiral quaternary ammonium salts (Figure 3).
20
 This approach has been used 
successfully for the asymmetric alkylation of cyclic ketones
21
 (Scheme 6) and cyclic β-
keto esters
22
 (Scheme 7).  
 
Figure 3. Chiral phase transfer catalysts. 
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Scheme 5. Organocatalytic reactions with chiral phase transfer catalysts. 
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Scheme 6. Alkylation of indanones catalyzed by chiral phase transfer catalysts. 
 
 
 
Scheme 7. Alkylation of β-keto esters by C2 symmetric chiral phase transfer catalyst. 
 
(iii) Enamine activation of aldehydes with primary or secondary amines 
 
Aldehydes are usually activated by the formation of enamines from analogous pyrrolidine 
or proline catalysts or from primary amines (Scheme 8
23,24,25
,Figure 4). Enamines derived 
from ketones are comparatively weaker nucleophiles and have not been used so far for 
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the asymmetric formation of quaternary stereocenters. Aldehydes with doubly 
substitution at the terminal position of the enamine are weak nucleophiles as well and 
require very strong electrophiles for the reaction. 
 
Figure 4. Proline based catalysts. 
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Scheme 8. Organocatalytic Michael addition of aldehydes via enamine catalysis. 
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The most common methods for electrophilic activation are discussed below (Scheme 3):  
 
(iv) Formation of iminium ions of α,β-unsaturated carbonyl compounds 
 
By employing a secondary amine (occasionally primary amines are also used), an α,β-
unsaturated carbonyl compound can be converted to an iminium ion and thereby, 
activated for nucleophilc attack. In an iminium ion of an α,β-unsaturated carbonyl 
compound, the β-position is more electron deficient and therefore more susceptible to 
nucleophilic attack. So far, no examples have been reported in the literature for this 
approach. However, a dienophile has been successfully activated by a secondary amine 
catalyst for the Diels-Alder reaction, and various examples were found in the literature 
involving this approach.
26
 
 
(v) Activation by Brønsted acids 
 
Even though limited, axially chiral phosphoric acid has been used successfully as a 
catalyst to activate a ketone or an imine for nucleophilic attack. This approach is less 
reported in the literature in comparison to approaches i-iv due to the somewhat limited 
scope of substrates that have been proven to be successful thus far. However, the 
quaternary centers formed with ketones or imines by this approach provided 
comparatively high yields and satisfactory enantiomeric excesses. 
27
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(vi) Activation via N-heterocyclic carbenes (NHC) 
 
An NHC can act as a nucleophilic catalyst and activates a ketone or aldehyde by 
attacking the carbonyl carbon. The Stetter reaction has often been used in this approach 
(Scheme 9).
28
 
 
 
 
Scheme 9. Catalytic intramolecular Stetter reaction. 
 
(vii) Mixed activation 
 
A dual organocatalytic system has recently been employed successfully to counter 
reduced reactivity in some substrates, such as the reaction of di-substituted α-aryl 
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aldehydes to enones. It was found that the proline by itself did not catalyze the reaction. 
However, when a quinine based catalyst was introduced along with a proline catalyst to 
deprotonate the carboxylic acid proton in proline, the reactivity was dramatically 
enhanced.
29
 
 
1.2. 3-Hydroxy aryl acrylates 10 and their potential utilities in synthetic 
transformations 
 
The Hossain group, in 1998, reported the formation of 3-hydroxy aryl acrylates 10 via an 
unprecedented [1,2]-aryl shift, when aromatic aldehydes and EDA (ethyl diazoacetate) 
was allowed to react in the presence of an iron Lewis acid catalyst, [η5-
(C5H5)Fe(CO)2(THF)]BF4 9 (Scheme 10). As a side reaction, it also produced very little 
or sometimes none of the β-keto esters 11 via a [1,2]-hydride shift.30 The yield of 3-
hydroxy acrylates 10 diminished with a resultant increase in the undesired β-keto ester 11 
with electron poor aldehydes due to the increased difficulty of achieving the necessary 
[1,2]-aryl shift. 
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Scheme 10. Reaction and mechanism of arylaldehydes with EDA in the presence of 
catalyst 9. 
 
The same group, in 2004, reported that Brønsted acids such as HBF4·OEt2 are also able to 
effectively catalyze the same reaction with aromatic aldehydes as well as ketones 
(Scheme 11).
31
 Again it was proved that the use of electron deficient aromatic aldehydes 
has a detrimental effect on the yield of the desired 3-hydroxy aryl acrylates formation. 
 
20 
 
 
 
 
 
Scheme 11. HBF4 catalyzed reaction of aromatic aldehydes or ketones with EDA. 
 
As a continuation, synthesis of 3-ethoxycarbonylbenzofuran analogs from 2-
hydroxybenzaldehyde derivatives and ethyl diazoacetate was reported.
32
 The final 
benzofuran product was isolated after the acid dehydration of the intermediate hemiacetal 
formed in situ (Scheme 12). 
 
 
 
Scheme 12. Formation of benzofurans via an in situ formed hemiacetal. 
 
The versatility of the 3-hydroxyaryl acrylates to make heterocyclic aromatic compounds 
was further demonstrated by the same group in the synthesis of indoles employing 
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substituted O-nitroarylaldehydes to the HBF4 catalyzed reaction and the subsequent 
reduction closes the ring to form the desired indole products (Scheme 13).
33
 
 
 
 
Scheme 13. Formation of indoles via a one pot reductive ring closing. 
 
It has become quite clear in this point that the usefulness of 3-hydroxy aryl acrylates can 
be extended further due to the presence of prochiral α-carbon with double substitution 
which makes it a suitable candidate to construct all-carbon quaternary stereocenter. Due 
to the previously mentioned importance of quaternary stereocenters in various bioactive 
natural products and pharmaceutically active compounds, and the enormous current 
attention for their synthesis via asymmetric catalytic routes, 3-hydroxy aryl acrylates 
became an obvious substrate choice to pursue this goal. The reaction of 3-hydroxy aryl 
acrylates with an appropriate electrophile would yield one of possible stereoisomers with 
all carbon quaternary stereocenters, depending on whether the electrophile approaches 
from the Re or Si faces. Therefore, the reaction should be more favorable towards one 
over the other two prochiral faces due to effectively blocking the unreactive face by the 
chiral catalyst (Figure 5). 
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Figure 5. Formation of quaternary stereocenters via 3-hydroxy aryl acrylates. 
 
 
 
An aldehyde bearing a quaternary carbon center will be generated from such reaction of 
3-hydroxy aryl acrylate with an electrophile, which is far less common in the literature 
than the corresponding ketones bearing α-quaternary carbon centers.  
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1.2.1. Development of a convenient work-up method of the synthesis of 3-hydroxy aryl 
acrylates 10 
 
Due to the reversible nature of the reaction, there is always unreacted arylaldehydes left 
in the reaction mixture along with the desired 3-hydroxy acrylates 10 and undesired β-
keto esters 11. This mixture of compounds in the crude reaction mixture makes the 
separation of the desired product difficult by column chromatography, especially due to 
fact that the Rf values of 10 and starting arylaldehydes are almost identical. Thus, both of 
these compounds elute together in most cases, even when 100% hexane is employed. An 
alternate methodology to isolate the desired acrylates was needed. 
 
By being acidic due to the extended conjugation in 3-hydroxy acrylates 10, it can be 
easily converted to salts employing simple bases, i.e. Et3N, by stirring the acrylate with 
Et3N in DCM for 5 mins. When the pH indicating paper shows that the solution is basic, 
it was passed through a thick pad of silica gel. The salt of acrylate stays at the top of 
silica gel and is easy to see due to the distinct brown color. After passing enough DCM 
through the silica plug to elute out excess arylaldehydes and undesired β-keto esters, the 
salt can be scraped out along with silica, stir to produce thick slurry in DCM and then 
treat with acid followed by extraction with DCM provides desired 3-hydroxy acrylates in 
pure form. 
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1.3. 3-Hydroxy aryl acrylates 10 as prochiral nucleophiles for organocatalytic 
asymmetric alkylation 
 
1.3.1. Phase transfer catalysis (PTC): general concepts and mechanisms of action  
 
The alkylation of aldehydes in α-carbon by organocatalysis is a fairly under explored area 
of research and none of the research has been reported to achieve a methodology that 
would be broadly applicable to a wide range of electrophiles. Currently employed 
methodologies to achieve this goal are: the amino-catalytic concept exploited by 
MacMillan et al. based on radical intermediates, using a combination of photoredox 
catalysis and amine catalysis and the use of electrophiles with highly stabilized 
carbenium ions such as: 3-substituted indoles or the use of benzylic carbocations, 
stabilized isolable carbenium ions.
 34
 A methodology with a much broader substrate 
scopes is highly desirable. Hence, we were interested to see whether the phase-transfer 
catalyzed alkylation is achievable to overcome these challeges. Theoretically, such a 
methodology should allow a much broader scope of electrophiles, and thereby might able 
to be deemed as a truly versatile method for the α-alkylation of aldehydes. 
 
In order to achieve the successful alkylation of 3-hydroxy aryl acrylates 10, a basic 
understanding of the processes underlying the phase transfer catalyzed reaction is 
required.  
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The first clear-cut example of a phase transfer catalyzed reaction was reported on the 
alkylation of a sodium carboxylate salt in 1946. Benzyltriethylammonium chloride, the 
phase transfer catalyst employed, is formed in situ by the reaction of triethylamine with 
benzyl chloride (Scheme 14).
35
 
 
 
 
 
Scheme 14. First report of a true example of phase transfer catalysis. 
 
However, the term phase transfer catalysis was first coined by Starks in 1971
36
 where he 
described the dramatic increase in the rate of reaction between an organic solution of an 
alkyl halide and an inorganic solution of sodium cyanide when tetralkyammonium or 
tetralkylphosphonium was employed as catalyst (Scheme 15). 
 
 
 
Scheme 15. Examples reported by Starks of phase transfer catalyzed reactions. 
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Figure 6. Mechanism for halide displacement by cyanide ion catalyzed by PTC. 
 
 
 
Due to the insolubility of NaCN in the organic phase, the reaction is unable to proceed 
without the help from a phase transfer catalyst. Therefore, the phase transfer catalyst acts 
as a vehicle to carry the nucleophilic cyanide ion from aqueous phase to organic phase 
through ion exchange with the phase transfer catalyst at the interface. From there, the 
new ion pair (Q
+
CN
-
) which contains nucleophilic CN
− 
travels to the organic phase to 
react with the electrophile (Figure 6). If the reaction in organic phase is rate determining 
(in the above example the reaction between cyanide and octyl bromide), the mechanism 
is known as the extraction mechanism. If the transfer of the nucleophile from aqueous 
phase to organic phase via the aid of the phase transfer catalyst (the transfer step) is rate 
determining, the mechanism is known as the interfacial mechanism.  
 
Factors affecting the rate of transfer of ions into the organic phase from aquous phase 
include: 
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a) Interfacial tension: An increase in the interfacial tension results in a decrease of 
the interfacial area, which, in turns, lowers the rate at which ions can be shuttled 
from the aqueous into the organic phases. Highly concentrated solutions and non-
polar solvents result in a decrease of the interfacial area due to an increased 
interfacial tension. 
 
b) Stirring: The formation of tiny droplets resulting from high stirring speeds can 
greatly increase the interfacial area leading to enhanced reaction rates. 
 
c) Nature of the counter anion of the phase transfer catalyst: Large anions that are 
weakly hydrated such as perchlorate and iodide allow easier access to the 
interface from the organic phase. The contrary holds true for small anions that are 
hydrated with much greater ease, such as fluoride or hydroxide. 
 
d) The bulkiness of the counter cation in the PTC: Due to the low effective 
concentration of the larger cation in the interface, it decreases the rate of transfer. 
On the other hand, unsymmetrical cations allow closer approach of the cation to 
the interface, enhancing the transfer step. 
 
Overall, a phase transfer catalyzed reaction is affected by following variables: 
 
a) Quantity of water (concentration): Even though the use of more concentrated 
solutions leads to an increased interfacial tension and decreased transfer rate, 
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the transfer of anions into the organic phase is promoted with increased 
concentration, as long as this is not the limiting factor.  
b) Catalyst: This is the most important variable. The shape and size of the 
catalyst may influence factors such as: the surfactant properties of the catalyst, 
its ability to promote the transfer of the substrate nucleophilic anion into the 
organic phase, transfer rates (as seen above bulkier cations lead to decreased 
rates). Furthermore, the catalyst could also play a role to activate the anionic 
nucleophile in the organic phase. Many phase transfer catalysts are able to 
undergo a Hoffmann elimination under base mediated reaction conditions, 
which is commonly employed in phase transfer catalysis. 
 
c) Solvent: Solvent should be able to dissolve ionic phase transfer compounds. 
Dichloromethane is frequently used due to its ability to dissolve most phase 
transfer catalysts readily. Choice of solvents is important as it can affect both 
the rate of the reaction itself as well as the interfacial tension. 
 
d) Temperature: The phase transfer catalyst might decompose at high 
temperature in the presence of base. Therefore, a temperature should be 
chosen considering these factors. 
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The use of phase transfer catalysis has several practical advantages: 
 
1) Inorganic bases (such as NaOH, KOH, K2CO3) are cheaper and easy to handle 
compare to organic bases such as MHMDS bases, NaH, t-BuOK etc. The use of 
inorganic bases also makes the condition of the reaction easily attainable such as 
no requirement of inert atmosphere and also leads to a simplified work-up 
procedure. 
 
2) High yields and purity are often reported for many reactions. 
 
3) The reactions are often susceptible to scale-up which is advantageous for 
industrial production. 
 
4) Cost effective and minimum industrial wastes. 
 
Just a few of the reactions that have successfully found application in asymmetric 
catalysis via phase transfer catalysis include: alkylations, Michael additions, aldol 
reactions, Darzens reactions, cyclopropanations, epoxidations, aziridinations and 
oxidations.
16a
 The asymmetric alkylation of t-butyl glycinate esters will best serve to 
elucidate the mechanism of the asymmetric version of this reaction (Figure 7). 
 
 
 
30 
 
 
 
Figure 7. Mechanism for phase transfer catalyzed alkylation of Schiff bases. 
 
 
 
In the mechanism, as soon as the glycinate Schiff base comes in the interface of the 
organic and aqueous faces, it meets with the water soluble base which pulls up the acidic 
proton from the Schiff base forming the corresponding enolate. At this point, it is crucial 
for the phase transfer catalyst to quickly exchange its chiral positive ion with the counter 
ion of enolate anion (in this case K
+
). Otherwise, the enolate will directly react with the 
electrophile at the interface, leading to racemic product. Once the enolate exchanges ions 
with the phase transfer catalyst, it comes to the organic phase due to the high solubility of 
this new ion pair in organic solvent and reacts with the electrophile in a stereoselective 
manner by virtue of the tight ion pair formed between the prochiral enolate and the chiral 
quaternary ammonium ion. 
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1.3.2. General consideration on C- vs O-alkylation of carbonyl compounds 
 
An alkylation reaction of a carbonyl compound usually consists of two steps. The first 
step is the deprotonation of the α-proton by a base to form stabilized enolate anion. The 
second step is a substitution reaction with an electrophile, e.g., alkyl halides. All the 
factors controlling SN1 and SN2 reactions are applicable in this step (Scheme 16).
37
 
 
 
Scheme 16. Reaction mechanism of alkylation of carbonyl compounds. 
 
Choosing a base for the deprotonation step of the carbonyl compound depend on several 
important factors: 
 
a) If a strong base is employed, there will be complete conversion of the carbonyl to 
the corresponding enolate. 
 
b) Alternatively, a weaker base can be used, in which case, there will be an 
equilibrium established between the enolate and unreacted carbonyl compound, 
instead of the quantitative conversion of the starting carbonyl substrate. However, 
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more of the enolate will immediately be formed in the course of the reaction as it 
is consumed by the electrophile. 
 
The first approach requires separate addition of base and nucleophile and usually prior to 
the addition of electrophile and as a result, can be tedious. However, it has advantages of 
its own as it requires no prior caution of whether the base and electrophiles are 
compatible to each other. On the other hand, the second approach is more practical in a 
sense that it allows mixing of the carbonyl compound, base and electrophile altogether. 
However, the base and electrophile must be compatible, or at least not react to any 
significant extent for this approach to work. Excess of base and electrophile can be 
introduced to overcome this problem in some extent. 
 
The alkylation of carbonyl compounds requires consideration of another very important 
factor: enolates are ambident nucleophiles that consists an electron rich of both carbon 
and oxygen atoms, and either of these two can act as a nuclophile. Therefore, there is the 
question of whether alkylation will take place at the nuclephilic carbon atome or oxygen 
atom (Scheme 17). 
 
 
Scheme 17. O- vs C-alkylation of enolates. 
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There are various factors that determine whether C- or O-alkylation will occur: 
 
a) When an inorganic base is employed, it depends on whether the metal counter-ion 
will be dissociated or clustered (depends on the metal and solvent). O-alkylation 
is favored when the enolate is dissociated and it is naked, i.e., the oxygen is 
unhindered for the attack to the electrophile. C-alkylation is prevalent where 
metal clustering occurs. Examples of ion clustering using lithium, sodium and 
potassium enolates of pinacolone were described by Williard et al.
38
 and Seeback 
et al.
39
 Using lithium and sodium enolates, tetrameric clusters were obtained, 
while the use of potassium enolates resulted in the formation of hexameric 
clusters (Figure 8). In polar aprotic solvents the metal counter-ion tends to be 
solvated by a lone pair of electrons from the solvent leading to a slight 
dissociation of the metal ion from the enolate oxygen ion and thereby, the enolate 
oxygen atom is exposed for the electrophile. In addition, metal chelators can be 
added to the mixture to promote O-alkylation by creating naked enolate. On the 
contrary, C-alkylation is favored when harder, smaller counter-ions are present 
which makes a tighter coordination bonds with enolate oxygen, hence effectively 
blocking the oxygen from electrophilic attack. Protic solvent also favors C-
alkylation. These solvents can form H-bond with the enolate oxygen atom and 
thereby, block it in a fashion similar to that of using harder counterions. Apolar 
solvents also tend to favor C-alkylation.  
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Figure 8. Clustering of enolates with different metal ions and THF. 
 
 
 
The following is an appropriate example (Scheme 18, Table 1), which shows that 
the percentage of O-alkylation dramatically increases as dissociation of metal 
clusters is favored. THF promotes ion clustering of the potassium enolate, leading 
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to an increased amount of C-alkylation. Being able to form H-bonding with the 
enolate anion, t-BuOH also favors C-alkylation.
40
 
 
 
Scheme 18. Reaction of enol with electrophile leading to O- and/or C-alkylation. 
 
Table 1. Ratios of O- vs C-alkyltion with different solvents. 
Solvent A B C 
HMPA 15% 2% 83% 
t-BuOH 94% 6% 0% 
THF 94% 6% 0% 
 
b) Charge vs. orbital control (Figure 9): Considering charge control, reaction occurs 
at the atoms carrying the highest total electron density.
41
 This approach dominates 
when electrophiles contain hard leaving groups, or with charged electrophiles 
(e.g. H
+
). In case of enolate nucleophiles, charge control provides O-alkylation 
since oxygen atom is harder compared to carbon atom and hard-hard interaction 
of electrophile and nucleophile prevails in this mode. Charge control is favored by 
an early transition state when charge distribution is the most important factor, as 
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well as by conditions that favor dissociated enolate clusters. In orbital control, 
reaction takes place at the atom that has the highest frontier electron density, and 
is favored by neutral electrophiles with soft leaving groups that possesses 
relatively low-lying LUMO. For orbital control, the HOMO of nucleophile and 
LUMO of electrophile must be sufficiently close to permit effective overlap. In 
this case a later transition state is favorable. The C-alkylated product is the 
thermodynamic product, since the total bond energies for the C-alkylated product 
(C=O: 745 kJ mol
-1
 + C-C bond: 347 kJ mol
-1
 = 1097 kJ mol
-1
) are greater than 
the total bond energies for the O-alkylated product (C=C: 614 kJ mol
-1
 + C-O: 
358 kJ mol
-1
 = 972 kJ mol
-1
).
42, 37
  
 
Figure 9. Molecular orbital theory to illustrate charge vs orbital control. 
 
 
 
c) Hard-soft compatibility: According to the hard-soft theory of acid (electrophiles) 
and bases (nucleophiles), hard acids will combine with hard bases, and similarly 
soft acids – soft bases interaction predominates. The hardness of the leaving 
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group of the electrophile is the determining factor on whether the electrophile will 
attach with oxygen (hard) or with carbon (soft) of the carbonyl nucleophile. The 
reaction of potassium enolate of ethyl 3-oxobutanoate with electrophiles with 
leaving groups of varying hardness serves to demonstrate the remarkable 
influence of this theory on the prediction of O- vs C-alkylation of enolates 
(Scheme 19,Table 2).
43
 From the results, it becomes evident that harder leaving 
groups favor O-alkylation and softer leaving groups favor C-alkylation. 
 
 
Scheme 19. Reaction of enolate with electrophile leading to O- and/or C-alkylation. 
 
Table 2. Ratios of O- vs C-alkyltion with different solvents. 
X A B C 
OTs 11% 1% 88% 
Cl 32% 8% 60% 
Br 38% 23% 39% 
I 71% 16% 13% 
 
d) Stereoelectronics: Alkylation will take place at the nucleophilic site that allows 
maximal orbital overlap (Scheme 20).
44
 In an enolate, oxygen and carbon atom 
have different hybridizations (sp
3
 and sp
2
 respectively). As a result, their orbitals 
point in different directions and thereby, will have varying degrees of overlap 
38 
 
 
 
with the C-X σ* orbital. The orbital of the atoms in enolate that is able to achieve 
maximum overlap with electrophile’s LUMO (σ*) will be the one to ultimately 
produce the product via an SN2 displacement reaction. 
 
 
 
 Scheme 20. Effect of stereoelectronics in C- vs O-alkylation. 
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1.4. Results and discussions 
 
Due to the presence of aryl bound tertiary prochiral carbon centers in 3-hydroxyaryl 
acrylates 10a, these compounds should allow us to synthesize chiral all-carbon α-aryl 
quaternary stereocenters. To prove this hypothesis, we first attempted allyltion of these 
substrates in phase transfer catalytic (PTC) conditions using achiral Bu4NI, Bu4NBr, or 
chinchonidium bromide as PTC catalyst with various allylic electrophiles. Allylation with 
bases such as solid or aqueous KOH and NaOH gives exclusive O-allylation product 12a 
(Scheme 21), whilst the attempted allylation with solid or aqueous KHCO3, K2CO3, 
NaHCO3, and Na2CO3 gave only a small amount of C-allylated product 13a (ca 20% 
with allyl iodide and allyl tosylate). NMR studies (NOESY experiment) showed E-
stereochemistry of the double bond of O-allylated product, presumably due to steric 
hindrance between the oxygen of the allyl vinyl ether and the carbonyl oxygen of the 
ester. We believe that O-allylation is much more favored since the high degree of 
conjugation present in the acrylates 10a, preserved in O-allylation, is disrupted in C-
allylation. We have screened various electrophiles (allyl chloride, allyl bromide, allyl 
iodide, allyl tosylate, and allyl phosphate) and solvents (toluene, dichloromethane, THF); 
all reactions with KOH under any conditions provided exclusively O-allylated product. 
An electrophile with a softer leaving group (allyl iodide and allyl tosylate) resulted only a 
small amount (20%) of C-allylated products. As a continuation of the previously reported 
data,
45
 some of the new allyl electrophiles have been employed during the course of this 
study. 
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Scheme 21. Phase transfer catalyzed allylic alkylation of 3-hydroxy aryl acrylates 10a. 
 
Disappointed by the findings, we turned our attention to the simpler organocatalytic 
reaction conditions instead of PTC conditions (Scheme 22, Table 3). This time we chose 
to use allyl tosylate and allyl phosphate as allyl electrophiles because of their softer 
nature, mainly due to the fact that it provided as much as 20% C-allylated product 13a in 
PTC conditions while employing this class of electrophiles (allyl iodide, and allyl 
tosylate). Simple non-nucleophilic amine base, quinine and H-bond donor, guanidine 
have been employed as catalyst. H-bonding catalyst guanidine did not proceed to react 
with either of the electrophiles. On the other hand, while quinine did not allow the 
reaction with allyl phosphate, much to our delight, it provided solely desired C-allylated 
product 13a with allyl tosylate. Even though the conversion was only 20%, this 
observation was crucial in the progress of the research. This was the first time we 
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observed exclusively C-allylated product. Not even a trace amount of O-allylated product 
12a was found, which was omnipresent in PTC condition.  
 
 
 
Scheme 22. Organocatalytic allylic alkylation of 3-hydroxy aryl acrylates 10a. 
 
Table 3. Organocatalytic allylic alkylation of 3-hydroxy aryl acrylates 10a. 
Starting material Catalyst Electrophile Alkylation (C/O) 
[%] 
Acrylate Guanidinium Allyl phosphate No Rxn. 
Acrylate Guanidinium Allyl tosylate No Rxn. 
Acrylate Quinine Allyl phosphate No Rxn. 
Acrylate Quinine Allyl tosylate 20% C, No O 
 
We attributed to the softer nature of allyl tosylate as electrophile to this encouraging 
finding and decided to use palladium-allyl complex due to its even softer electrophilic 
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properties (Scheme 23). We have used in situ prepared palladium allyl complex 14
46
 as 
electrophile for this purpose using existing procedure. As anticipated, the reaction 
provided quantitative conversion of the desired C-allylated product 13a when Et3N was 
employed as base. Not even a trace amount of O-allylated 12a was observed. Without 
base, only 10% conversion of the desired product was observed and there was no O-
allylated product found in the crude. 
 
 
 
Scheme 23. Palladium allyl complex 14 allyl electrophile for the allylic alkylation of 3-
hydroxy aryl acrylates 10a. 
 
1.5. General methods and experimental 
 
General considerations 
All starting materials and reagents were obtained from commercial sources and used as 
received unless otherwise noted. All solvents used were freshly distilled prior to use. 
1
H 
and 
13
C spectra were recorded on a Bruker DRX 300 operating at 300 MHz and 75 MHz, 
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and referenced to the solvent used (7.27 and 77.00 ppm for CDCl3). Analytical thin layer 
chromatography was performed using EMD Chemicals TLC Glass plates, Silica Gel 60 
F254. Flash column chromatography was performed using Biosolve 60 Å (0.032–0.063 
mm) silica gel. 
 
1.5.1. Synthesis of 3-hydroxy phenyl acrylate 10a 
 
Benzaldehyde (0.77 ml, 7.6 mmol) was dissolved in DCM (19 mL), followed by addition 
of HBF4·OEt2 (52 μL, 0.381 mmol, 10 mol%). The mixture was allowed to cool down to 
-78 °C, at which point EDA (0.434 g, 3.81 mmol) was added dropwise over a period of 5 
minutes. After complete consumption of EDA was identified by TLC analysis, the 
reaction mixture was allowed to slowly warm up to 0 °C, at which point the reaction 
mixture was passed through silica plug, and excess Et3N was introduced followed by 
stirring for 5 minutes. When the pH indicating paper showed that the solution was basic, 
it has been passed through a thick pad of silica gel. The salt of acrylate is not able to pass 
through silica and stays on the top. The light to dark brown color of the silica gel 
indicated the salt of phenyl acrylate. Enough DCM was passed through to elute out all 
unreacted arylaldehydes and β-keto esters. The region of silica indicating brown was then 
scraped out in a beaker with an appropriate (usually long that compliments the beaker) 
stir bar. DCM was added and stirred vigorously until it became slurry and distribution of 
solid silica particles was uniform. Then 6N HCl was added. Enough acid was added with 
continued stirring until the pH paper showed the solution acidic. The solution was then 
transferred to a separatory funnel along with solid silica and extracted with DCM three 
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times. The silica usually stays at the interface of the bottom organic (DCM) and top 
aqueous phase. the combined organic layers were washed with brine, dried over 
anhydrous Na2SO4, and evaporated in vacuo to afford the desired 3-hydroxy phenyl 
acrylates 10a (0.44 g, 60% yield) as a light yellow oil.  
 
1.5.2. Alkylation reactions 
 
Reactions of 3-hydroxy phenyl acrylate 10a with electrophiles under phase transfer 
catalysis (PTC) 
 
As an example of a typical reaction, 3-hydroxy phenyl acrylate 10a (50 mg, 0.26 mmol) 
was allowed to dissolve in DCM (2.6 ml) followed by the addition of n-Bu4NI (33 mg, 
0.051 mmol, 20 mol%). Next, solid Na2CO3 (276 mg, 2.6 mmol, 10 eq.) was slowly 
added with vigorous stirring and allowed to stir for 5 minutes. At this point, allyl iodide 
(48 μL, 0.52 mmol) was slowly added via syringe. After a few minutes, the color of the 
reaction mixture changed from light yellow/brown to an almost colorless cloudy mixture. 
The reaction was allowed to stir overnight under N2, at which point TLC analysis 
confirmed the completion of the reaction. The reaction was quenched with sat. NH4Cl 
and allowed to stir for a few minutes, the layers were separated and the aqueous layer 
was then extracted with DCM. The combined organic extracts were dried over Na2SO4 
and passed through a 1 cm high Celite pad in a 4 cm diameter fritted funnel (medium 
porosity) to remove small amounts of residual precipitates. The resulting yellow solution 
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was then concentrated under vacuum, leaving dark yellow oil. The crude mixture was 
then analyzed by 
1
H NMR for the % conversion of 12a and 13a.  
 
Reactions of 3-hydroxy phenyl acrylate 10a with electrophiles employing 
organocatalysts (Et3N, quinine, or guanidine) 
 
As a typical example, palladium allyl complex 14 was prepared in situ in an evacuated, 
Argon-purged, and sealed round bottom flask following existing procedure. Meanwhile, 
in another evacuated, Argon-purged, and sealed round bottom flask 3-hydroxy phenyl 
acrylate 10a (50 mg, 0.26 mmol) was allowed to dissolve in dry and degassed DCM (2.6 
ml) followed by the addition of Et3N (43.5 µL, 0.312 mmol, 1.2 eq). The mixture was 
stirred for few minutes to allow the formation of enolate. At this point, the enolate 
solution was transferred to the other round bottom flask containing palladium allyl 
complex 14 via cannula. The reaction was allowed to stir for 2 h, at which point TLC 
analysis confirmed the completion of the reaction. Then the mixture passed through a 
thick pad of silica gel, and concentrated under vacuum. Purified products 13a was 
obtained as light yellow oil (60.0 mg, >99% yield) by column chromatography of the 
crude mixture on silica gel eluted with EtOAc in Hexane.  
 
1
H NMR (300 MHz, CDCl3): δ 9.92 (s, 1H), 7.44–7.23 (m, 5H), 5.76 (m, 1H), 5.13 (d, J 
= 18.3 Hz, 1H), 5.08 (d, J = 9.6 Hz, 1H), 4.30 (q, J = 7.1 Hz, 2H), 3.14 (dd, J = 6.3, 13.8 
Hz, 1H), 2.88 (dd, J = 8.1, 13.8 Hz, 1H), 1.30 (t, J = 7.1 Hz, 3H).  
Analytical data matched previously reported data.
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CHAPTER 2: ASYMMETRIC SYNTHESIS OF ALL-CARBON α-ARYL 
QUATERNARY CARBONYL COMPOUNDS INCLUDING BOTH ALDEHYDE 
AND KETONE BY PALLADIUM-CATALYZED ASYMMETRIC ALLYLIC 
ALKYLATION (Pd-AAA) 
 
2.1. Introduction 
 
2.1.1. Palladium 
 
“You would be forgiven if you thought the most important element in an organic 
transformation was carbon. Matthew Hartings argues that, for just over half a century in 
many of chemistry’s most renowned organic reactions, it has actually been palladium.”47 
-Matthew R. Hartings 
Even though the versatility of palladium was well known to industrial and chemical 
communities for long time, it truly reached far beyond in 2010 when Richard Heck, Ei-
ichi Negishi, and Akira Suzuki received the Nobel Prize in recognition of their work on 
the development of palladium-catalyzed carbon-carbon bond formation. It’s omnipotence 
is vividly evident in its ability to perform numerous reaction classes that includes, but not 
limited to, hydroarylation/alkenylation of bicycles, carbopalladation−addition/cyclization 
of allenes, enyne cycloisomerizations, carbonylation and cyclocarbonylation reactions, 
various kinds of cycloaddition reactions, addition of carbon nucleophiles to carbon-
oxygen, carbon-nitrogen, and activated carbon-carbon double bonds, various cross-
coupling reactions, allylation/arylation of ketone enolates, hydrosilylations, 
hydroamination of 1,3-dienes, fluorination of β-ketoesters, and hydrogenation of 
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imines.
48
 In addition, palladium has been employed as a catalyst in the Wacker process – 
regarded as the first industrially applied organometallic reaction. One of the important 
reasons behind this remarkable utility of palladium in organic transformation, as Dr. 
Hartings argues,
47
 is the ability of palladium (II) to adopt square-planar geometries – 
which, conveniently, have two empty axial coordination sites necessary for oxidative 
addition. More importantly, to run reactions which involve activation of olefinic double 
bonds, a metal catalyst must be able to coordinate with the double bond first. Even 
though nickel, palladium, and platinum all have the proper orbital energies to do just that, 
palladium provided best activation. Platinum turned out to be a poor catalyst due to the 
slow coordination of the metal to olefin and only a few nickel complexes show catalytic 
activity towards olefin. Moreover, palladium has some exceptionally special 
characteristics. It is the only transition metal that possesses a completely filled d orbital 
along with an empty frontier s orbital, due to having ground-state electronic configuration 
4d
10
5s
0
. This, in combination with its low percentages of hybridization from the 5s and 
5p orbitals due to the larger energy transition from lowest d to p makes palladium ‘just 
right’ as catalyst. 
 
2.2. Palladium as transition metal catalyst 
 
In 1962, Smidt reported the transformation of olefin to carbonyl by Palladium (II) 
chloride (eq 1).
49
 In this publication, it was resolved that the activation of olefin is 
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accomplished by coordination of palladium to its double bond, which makes it 
electrophilic in nature and thereby, labile for the nucleophilic attack by hydroxide anion 
(Scheme 24).  
 
 
 
Scheme 24. Mechanism of the oxidation of olefin to carbonyl by PdCl2. 
 
He also succeeded in producing carbon dioxide from carbon monoxide using this 
methodology (eq 2).  
 
 
 
Note that the above is a stoichiometric reaction. The resulting Pd (0) cannot be reoxidized 
to Pd (II) in the reaction, which is essential for it to act as a catalyst. Hence, a catalytic 
version of the reaction was developed later which is called Wacker-Tsuji Oxidation,
50
 
where additional copper (II) chloride and atmospheric oxygen were employed (Scheme 
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25). Copper (II) chloride serves as redox cocatalyst which regenerates Pd (II) catalyst by 
oxidizing the resulting Pd (0) in the reaction and in turns, Copper (II) becomes copper (I) 
chloride. Air, pure oxygen, or a number of other oxidizers can then oxidize the 
resultant copper (I) back to copper (II), hence allowing the cycle to continue.  
 
 
 
Scheme 25. Catalytic oxidation of olefin by palladium (II) chloride. 
 
This newly found process to oxidize olefin to carbonyl by Palladium (II) provided very 
important insight to the scientific community and was picked up brilliantly by Tsuji. He 
hypothesized that this type of olefinic activation could also be employed to create new 
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carbon-carbon bond. The evidence to prove his hypothesis was published in 1965.
51
 The 
group successfully produced a carbon-carbon bond by reacting a dimeric allylpalladium 
chloride complex with sodium salt of diethyl malonate, forming a mixture of both mono- 
and di-alkylated product (Scheme 26).  
 
 
 
Scheme 26. First carbon-carbon bond formation using Palladium. 
 
The next big breakthrough came in 1973, when Trost reported the necessity of at least 4 
equivalent of triphenylphosphine for the alkylation to proceed with hindered allyl 
counterpart.
52
 During the research on synthesizing acyclic sesquiterpenes to generate 
juvenile hormone derivatives, he was unable to alkylate malonate anion with alkyl-
substituted allyl group. However, the problem was overcome with the addition of 
triphenylphosphine, which provided surprisingly quick reaction to products (Scheme 27).  
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Scheme 27. Introduction of triphenylphosphine as a ligand for palladium. 
 
He suggested the formation of a more reactive intermediate complex where both 
triphenylphosphine and allyl group are bound to palladium metal. This discovery soon 
initiated the research of employing chiral version of triphenylphosphine as ligand for 
palladium to investigate asymmetric version of the reaction. 
 
2.3. Chiral induction by organo-cocatalyst in palladium catalyzed reaction 
 
Enantioselective two-component catalytic system is fairly common in organic synthesis. 
In this kind of reaction, one component is usually transition metal catalyst and the other is 
organic co-catalyst. Well-designed, two-component activation systems with Pd that 
combine the metal catalyst with catalytic amounts of an organic catalyst have been 
successfully employed in allylic alkylation reactions as well.
53
 One of the important 
advantages of this kind of reaction where organocatalyst is used as chiral inducing agent 
instead of chiral ligand lies in the easily accessible and cheap organocatalysts. 
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In 2006, Cordova and co-workers
54
 reported the asymmetric allylic alkylation where 
enantiodiscrimination was achieved by organocatalytic chiral amine bases, which 
provided as much as 88% ee (Scheme 28). 
 
 
 
Scheme 28. Chiral induction by prolin based organocatalyst in Pd-catalyzed reaction. 
 
In another research, Takemoto and co-workers
55
 have used chiral phase-transfer catalyst 
for the first time as chiral inducing agent, along with palladium catalyst in asymmetric 
allylation of tert-butyl glycinate-benzophenone Schiff base with allyl acetate. This 
provided allylated products with good yields and enantioselectivity without using any 
chiral ligands for palladium (Scheme 29).  
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Scheme 29. PTC as chiral inducing agent in Pd-catalyzed reaction. 
 
Very recently, List and co-workers
56
 have shown a remarkable use of axially chiral binol-
phosphoric acid as chiral inducing agent in Pd-catalyzed asymmetric allylic alkylation of 
α-enolizable aldehydes, where allyl alcohol has been employed as allylic counterpart 
instead of widely used allylic halides, esters, or carbonates. Use of allyl alcohols was 
widely commended due to its environment friendly nature as well as its wide synthetic 
reliability and step economy.
57
 However, alcohols are not good of a leaving group. This 
problem was overcome by using catalytic amount of chiral phosphoric acid, where this  
facilitates the oxidative addition of Pd to allylic alcohols and controls the stereochemistry 
as well (Scheme 30). 
 
54 
 
 
 
 
Scheme 30. Chiral phosphoric acid as chiral inducing agent in Pd-catalyzed reaction. 
 
In 2013, Gong and co-workers
58
 used both of the catalytic components as chiral to enable 
Pd-AAA with high ee (Scheme 31). A chiral phosphoramidite ligand for the palladium 
complex and a chiral phosphoric acid were used for AAA of pyrazol-5-ones with allyl 
alcohols, which afforded multiply functionalized heterocyclic products in high yields 
with excellent enantioselectivity. Further investigation provided the clue about the 
important intermediate where conjugate base of chiral phosphoric acid acts as a 
counterion of the π-allylpalladium (II) complex and also participates in a hydrogen-
bonding interaction with enolized substrate pyrazol-5-one (Scheme 31). In that way, both 
the chiral palladium complex and chiral phosphate counterion work cooperatively to keep 
the substrate in close proximity to the chiral environment and control the stereochemistry 
of the AAA reaction, affording the product with very high enantioselectivity. 
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Scheme 31. Both chiral Pd and chiral phosphoric acid in Pd-AAA. 
 
2.4. Asymmetric transformations catalyzed by palladium 
 
The importance of Pd in organic synthesis is clearly visible from the huge number of 
reaction methodologies developed in connection with this field. Except Palladium 
catalyzed Asymmetric Allylic Alkylation (Pd-AAA) which will be discussed in details 
later, a few of the important Pd-catalyzed enantioselective transformations will be briefly 
presented in this section.  
 
2.4.1. Heck reaction 
 
After the discovery of this reaction in the late 1980s, it has been used as an important 
synthetic tool in organic chemistry since then. Between both inter- and intra-molecular 
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versions of this reaction, intramolecular Heck reaction, first reported by Shibasaki
59
 and 
Overman,
60
 has been proved to be the most powerful method for the enantioselective 
synthesis of both tertiary and quaternary stereogenic centers and has been used to 
synthesize an enormous number of natural products and their precursors. As an example, 
Overman and co-workers have reported the first example of an all-carbon quaternary 
stereocenters employing this method.
61
 Subsequently, they have successfully created a 
series of 3,3′-disubstituted oxindoles employing the methodology (Scheme 32).62 
 
 
 
Scheme 32. An example of asymmetric Heck reaction. 
 
2.4.2. Hydroarylation/Alkenylation of [2.2.1] bycycles 
 
Just like the Heck reaction, hydroarylation/alkenylation of alkene involves the oxidative 
addition of arylhalides followed by alkene insertion to palladium. However, unlike the 
Heck reaction, reductive elimination of the palladium complex takes place instead of β-
hydride elimination. Therefore, the generation of stereogenic center is more likely in this 
reaction compare to Heck type methods since β-hydride elimination often provides 
olefinic compounds. The reaction was discovered in 1991 by Brunner and Kramler
63
 to 
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produce exo-2-arylnorbornanes with a maximum of 41% ee, which has been later 
improved by Achiwa and coworkers
64
 to up to 74% (Scheme 33). 
 
 
Scheme 33. An example of asymmetric hydroarylation/alkenylation reaction of [2.2.1] 
bycycles. 
 
2.4.3. Carbopalladation - addition/cyclization of alenes 
 
This reaction proceeds with the formation of intermediate β-aryl π-allylpalladium 
complex by asymmetric carbopalladation of allenes, followed by nucleophilic attack of 
the intermediate. It is a powerful synthetic tool for the synthesis of enantioenriched 
hetero- and carbocycles as well as α,β-functionalized olefins. As an example, Hiroi and 
co-workers recently have reported palladium-catalyzed asymmetric α,β-functionalization 
of allene with high yield and enantioselectivity (Scheme 34).
65
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Scheme 34. An example of asymmetric Carbopalladation - addition/cyclization of alenes. 
 
2.4.4. Enyne cycloisomerizations 
 
Enyne cycloisomerizations, originally developed by Trost and co-workers,
66
 is a very 
useful method to create cyclic and polycyclic compounds asymmetrically. Recently, 
Mikami and co-workers
67
 have reported a highly efficient palladium catalyzed reaction of 
this class where enantiopure five-membered fural ring with a quaternary chiral center has 
been synthesized with >99% ee. Further investigation provided an innovative use of 
Pd(OCOCF3)2 as palladium source instead of Pd(OAc)2 or Pd2(dba)3, which was deemed 
as the reason behind this surprisingly high enantioselectivity (Scheme 35). 
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Scheme 35. An example of asymmetric enyne cycloisomerizations. 
 
2.4.5. Carbonylation and cyclocarbonylation reactions 
 
Palladium catalyzed carbonylation is one of the most efficient tool for homologation, and 
the corresponding asymmetric hydroformylation, hydrocarboxylation, and 
hydroesterification of prochiral olefins. One of the important aspects of this reaction is 
the use of carbon monoxide. This method provided very efficient enantioselective 
synthesis of most widely used anti-inflammatory agents, (S)-ibuprofen and (S)-naproxen. 
These drugs have been produced with very high yield and ee using 4-(isobutyl)-styrene 
and 2-vinyl-6methoxynaphthalene respectively as starting material, under exceptionally 
mild conditions (Scheme 36).
68
 The reaction emerges as one of the most lucrative 
synthesis in this field.  
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Scheme 36. An example of asymmetric carbonylation and cyclocarbonylation reactions. 
 
2.4.6. Cycloaddition reactions 
 
The asymmetric cycloaddition reactions are one of the most powerful and versatile in 
organic chemistry. The ability to form new ring systems, especially heterocyclic rings 
made this reaction as such. Chiral Lewis acids have been used to induce 
enantioselectivity in this reaction class which extended the scope and utility of this 
reaction significantly.
69
 However, there was always a need to find new methodology to 
increase the efficiency of the reaction. Palladium has been successful employed in 
different kinds of cycloaddition reaction, including but not limited to, Diels-Alder 
reactions,
70
 hetero Diels-Alder reactions,
71
 [3+2] dipolar cycloaddition reaction.
72
 
 
2.4.7. Nucleophilic addition to C=O bonds 
 
The catalytic asymmetric aldol reaction has been an excellent tool to access a huge 
number of natural products and pharmaceutical intermediates. In 1997, Shibashaki and 
co-workers
73
 have reported the preparation of the air- and moisture-stable crystalline 
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diaqua-Pd(II) complex. This remarkable catalyst, which itself was a great achievement, 
was subsequently used to synthesize aldol product with high yield and ee (Scheme 37). 
 
 
 
Scheme 37. Enantioselective aldol condensation by palladium catalyst. 
 
2.4.8. Nucleophilic addition to C=N bonds 
 
The first reported Pd (II) catalyzed asymmetric addition of silylenol ethers to imine was 
by Sodeoka and co-workers
74
 in 1998, where an innovative use of novel binuclear Pd (II) 
complex as catalyst provided excellent yield and enantionselectivity with a series of 
silylenol ethers (Scheme 38). 
 
 
 
Scheme 38. Asymmetric Mannich reaction by palladium catalyst. 
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2.4.9. Nucleophilic addition to C=C bonds by Michael addition 
 
In 2002, Sodeoka and co-workers
75
 have reported a mechanistically interesting and 
highly efficient Michael addition of 1,3-dicarbonyl compounds with α,β-unsaturated 
ketones where, once again, the diaqua palladium complex was used as catalyst 
effectively. Treatment of the diketone with the diaqua complex showed the formation of a 
stable palladium diketonato complex which did not react at all with the Michael acceptor 
methyl vinyl ketone. However, when TfOH was added, the reaction was found to go to 
completion with high enantioselectivity (Scheme 39). 
 
 
 
Scheme 39. Asymmetric Michael addition. 
 
2.4.10. Cross-coupling reactions 
 
Most probably, transition metal catalyzed cross-coupling is the most frequently used 
reaction in organometallic chemistry. It represents one of the most straight-forward 
methods for aryl C-C bond formation. This reaction class has been studied most 
intensively which produces a number of name reactions. Among those, Kumada cross 
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coupling is one demands discussion. Hayashi’s defining work has shown that the axially 
chiral biaryls can be synthesized by Pd-catalyzed asymmetric Kumada coupling reaction 
with high yield and enantioselectivity using chiral phosphine ligands.  It’s important to 
note that the addition of lithium bromide was found to be essential for high 
enantioselectivity as well as for high catalytic activity (Scheme 40).
76
 The product was 
found to be useful as a building block for the synthesis of chiral phosphine ligands. 
 
 
 
 Scheme 40. Kumada cross coupling reaction. 
 
Another important types of cross-coupling reaction needs to be discussed is Suzuki-type 
cross coupling reaction. Along with Richard Heck and Ei-ichi Negishi, Suzuki received 
the prestigious Nobel prize in 2010 for discovering this reaction class. One of the notable 
achievement as an application of this reaction is the ability to synthesize axially chiral 
biaryl compounds. In 2000, both Cammidge
77
 and Buchwald
78
 simultaneously reported 
the first example of the synthesis of axially chiral biaryls by Suzuki cross coupling 
reaction. Cammidge and co-workers
25
 obtained binaphthyl product with a maximum ee of 
85% (Scheme 41, eq 1). Buchwald
26
 synthesized chiral biaryls with phosphonate moiety 
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which was shown to be suitable for their further functionalization and has been used to 
produce new chiral ligands (Scheme 41, eq 2). 
 
 
Scheme 41. Suzuki cross-coupling reactions.  
 
2.5. Palladium-catalyzed asymmetric allylic alkylation (Pd-AAA) 
 
The Pd-AAA
79
 (Tsuji-Trost reaction) reaction has emerged as a powerful tool for the 
creation of quaternary stereocenters with high chemo-, regio-, and stereoselectivity.
80
 The 
term “Tsuji-Trost reaction” is a generic term used to describe two reaction classes. The 
first class, called Pd-AAA, utilizes a nucleophile that is coupled intermolecularly with a 
Pd π-allyl complex, typically generated from allyl acetate or allyl carbonate (Scheme 42, 
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eq 1). In the second class an allyl enol carbonate or silyl enol ether forms an in situ 
generated enolate nucleophile via decarboxylation (hence called Pd-catalyzed 
decarboxylative asymmetric allylic alkylation, Pd-DAA) that reacts intramolecularly with 
the corresponding in situ generated Pd π-allyl complex (Scheme 42, eq 2). “Soft” 
nucleophiles such as malonates (pKa < 20) are often used for attack on the π-allyl 
palladium intermediate in the intermolecular version of the reaction. 
 
 
 
Scheme 42. Kinds of palladium catalyzed asymmetric allylic alkylation.  
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The basic mechanism (Scheme 43)
81
 of intermolecular Pd-AAA reaction involves 
complexation of Pd metal to the olefinic double of the allyl complex, followed by 
ionization where Pd by being electron rich attacks the electron deficient carbon on allyl 
electrophile by SN2 fashion and forms π-allylpalladium complex in situ. Subsequent SN2 
attack of nucleophile on allyl group in π-allylpalladium and decomplexation provides the 
desired product. In both intermolecular (Pd-AAA) and intramolecular (Pd-DAAA) 
reactions, a common electrophilic π-allylpalladium complex is formed, which can be 
reacted with a variety of nucleophiles.
82, 79e
 Quaternary stereocenters can be formed either 
on a prochiral nucleophilic partner or, more commonly, on the electrophilic partner. 
 
 
 
Scheme 43. Mechanism of Pd-AAA. 
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 One of the inherent difficulties to get better enantioselectivity, which is evident in this 
mechanism, is the fact that both bond breaking (ionization) and making (nucleophilic 
substitution) events occur outside of the coordination sphere of the metal, i.e., on the face 
of the π-allyl unit opposite to the palladium and its chiral inducing ligands. Thus, both the 
leaving group and nucleophile are segregated from the chiral environment of the ligand 
by π-allyl moiety. For this very reason, it took a notable amount of time to harness the 
enantiodiscriminative potential of this reaction with a wide range of substrates in a 
predictable manner. Only recently these reactions have developed into processes with a 
variety of substrates, even though the first report of the enantioselective variant of this 
reaction was in 1977. This lag time may be due to the fact that the chiral ligand must 
somehow reach across the plane of the ally fragment in order to transfer their chirality to 
the electrophile or nucleophile. Also, it is much harder to induce chirality to nucleophile 
compare to electrophile, since nucleophile is only approaching towards the π-allyl moiety 
from outside and is further from the chiral environment of the metal.  
 
With all these difficulties, still Pd-AAA has become an extremely powerful method for 
asymmetric synthesis and provided extremely high ee with chiral centers on both 
nucleophiles and electrophiles. This reaction differentiates itself from other catalytic 
methods in its ability to form multiple types of bonds such as C−C, C−O, C−S, C−N, and 
C−H. Moreover, the conditions of this reaction are mild and it is tolerant to most 
functional groups. Furthermore, this Pd-AAA reaction is unique in a sense that it has 
multiple mechanisms for enantiodiscrimination (which will be discussed later in this 
chapter) compare to most other metal-catalyzed asymmetric reactions where 
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enantioselectivity is derived only from differentiation of the enantiotopic π-faces of an 
unsaturated system. 
Besides, the allylic moiety which is attached to the nucleophilic carbon by this reaction 
possesses great synthetic utility (Scheme 44), and is one of the main reasons for the great 
success of this Pd-AAA reaction. 
 
 
Scheme 44. Possible synthetic transformations of the allyl group. 
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2.5.1. Mechanisms for enantiodiscrimination 
 
Each step in the mechanism (Scheme 43) of Pd-AAA reaction offers an opportunity for 
enantiodiscrimination. Therefore, several ways to achieve enantioselection are available. 
The potential sources of enantiodiscrimination in Pd-AAA are (a) metal-olefin 
complexation, (b) ionization, (c) enantioface discrimination of the π-allyl complex, (d) 
nucleophilic attack at enantiotopic termini, and (e) enantioface discrimination in the 
nucleophile.
83
 
 
(a) Enantiofacial complexation 
 
Metal-olefin complexation is a potential source of stereoinduction. Pd must distinguish 
between different faces of the olefin, if it is not symmetrically C2h disubstituted. During 
this step, if one diastereomer of the complexes ionizes faster compare to other 
diastereomer and the capture of the π-allyl complex formed from that diastereomer by 
nucleophile is faster in relation to π-σ-π equilibration, then the complexation of the 
enantiotopic faces of olefin becomes enantiodetermining step. 
 
(b) Enantiotopic ionization of leaving groups 
 
In Pd-AAA reaction, stereoinduction is greatly influenced by ionization of the leaving 
group. With meso-allyl or achiral gem-disubstituted allyl electrophiles, the selective 
ionization of one of the two enantiotopic leaving groups becomes enantiodetermining 
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step. As an example, the meso-cyclopentene-1,4-diol can selectively form one enantiomer 
over other with a pyrrole nucleophile (Scheme 45). 
 
 
Scheme 45. Enantiodiscrimination via enantioselective ionization. 
 
(c) Enantiofacial exchange of the η3–allyl complex 
 
In an unsymmetrical acyclic allylic system, enantioselection is determined by which face 
of the allylic fragment palladium metal presents to the nucleophile. When the initial 
olefinic complexation is rapid and reversible, or when π-σ-π equilibration is significantly 
faster than nucleophilic capture, two diastereomeric π-allylic palladium complexes can 
form via Pd-σ-allylic complex (Scheme 46). However, these two π-allylic palladium 
complexes can equilibrate through π-σ-π equilibration. For this very reason, both of the 
enantiomers can be formed if the rate of nucleophilic capture for both complexes is 
similar. However, if the rate of attack by nucleophile is significantly faster with one 
complex compare to another, high enantioselectivity should be observed. 
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Scheme 46. Enantioselection by discrimination of the π-allyl intermediates. 
 
(d) Differentiation of the enantiotopic allyl termini 
 
When the η3-allyl moiety has C2h symmetry, i.e., when the starting allylic system is a 
chiral racemic mixture but the ionization leads to a meso-π-allyl ligand, nucleophilic 
attack to either one of the enantiotopic termini becomes enantiodetermining step and 
provides a chiral product. 
 
As an example (Scheme 47), 1,3-diphenylallyl acetate in Pd-AAA reaction forms the 
intermediate π-allylpalladium complex where π-allyl ligand is now meso. If a chiral 
ligand is introduced with palladium, one terminus of this π-allyl ligand will be 
preferentially attacked by the nucleophile to furnish one enantiomer of the product. In 
this particular example, benzylamine has been used as the nucleophile which yielded an 
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allylic amine product in excellent ee.
84
 Even though the chiral ligand resides opposite to 
the π-allyl moiety on the palladium metal, yet it provided remarkable 
enantiodiscriminative control (98% ee). 
 
 
 
Scheme 47. Deracemization through desymmetrization of an intermediate meso- π-allyl 
ligand. 
 
(e) Enantiofaces of prochiral nucleophile 
 
Enantioselectivity can be achieved on nucleophiles as well, by reacting π-allylpalladium 
complex with prochiral nucleophiles. This occurs by enantioface discrimination of the 
nucleophile. Prochiral nucleophiles, such as 3-hydroxy-2-aryl-acrylic acid ethyl ester can 
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lead to enantioselective alkylation with symmetrically substituted or unsubstituted allylic 
moieties (Scheme 48).
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Scheme 48. Enantioselection by discrimination of enantiofaces of prochiral nucleophile. 
 
Another mechanism of action comes from equilibrating mixture of enantiomers of 
racemic nucleophiles where one enantiomer is favored for nucleophilic attack over other. 
If the allyl unit is also prochiral, a potential double enantioselectivity provides 
diastereoselectivity. 
 
2.5.2. General considerations and rationale of ligand design 
 
The mechanism (Scheme 43) of Pd-AAA clearly shows that both bond breaking and 
bond making events occur outside of the coordination sphere of the metal, opposite to the 
chirality control element and thereby, distal to the chiral environment. This difficulty 
created a big challenge to design a suitable ligand that would be able to induce chirality 
by overcoming the drawbacks, and as a result, it has stimulated a great deal of work.  
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Three concepts have gained ground: 
 
(a) Attaching a substituent to the ligand via a tether long enough to reach the other 
side of the π-allyl moiety to intereact with any incoming nucleophile. The 
ferrocenyl ligands family represents this class of ligands.
86
 
 
(b) Employing electronic desymmetrization to the ligand due to which the bond 
length between Pd and carbon on one allyl termini will be different than other 
allyl termini and thus creating a biasness of nucleophile to attack towards one 
terminus over other. Oxazolines are an example of this class of ligands.
87
 
 
(c) Creating a chiral space for the substrate to immerse wherein the 
enantiodiscriminative step can occur in that chiral space. This can be generated by 
the conformational bias for edge-face interactions of the phenyl groups of the 
diarylphosphino moieties induced by the stereogenic centers. Trost ligands solely 
represent this class. 
 
Even though, both ferrocenyl and oxazoline ligands have shown success in various cases, 
Trost ligands
88
 have proven to be the most general in inducing chirality in Pd-AAA to 
date.
89
  
 
The concept of creating a chiral space in Trost ligand class has been inspired by 
enzymatic catalysis. Enzymes, depending on the substrate, create chiral spaces by 
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conformational change, and induce asymmetry by keeping the substrate and making the 
reaction happens inside the chiral space. Similarly, a chiral space was envisioned in 
ligands that envelops the ally substrate situated on the other side of the metal (Figure 10, 
image I). To do so, a chiral scaffold, similar to folding in enzyme, was needed (Figure 10, 
image II) that will produce primary chirality. This chiral scaffold would, in turns, induce 
conformational chirality of the diarylphosphino moieties and a linker, i.e., amide in this 
case, can create the chiral space for the substrate to reside (Figure 10, image III), just like 
the catalytically active site in enzyme. 
 
Figure 10. Cartoon model for ligand design. 
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Figure 11 shows a few examples of the Trost ligands that have been developed depending 
on the cartoon image II, Figure 10. All of These ligands have proven to be successful in 
producing enantiopure compounds with one substrate classes or other. 
 
Figure 11. Typical Trost ligands for Pd-AAA. 
 
 
 
Recent structural and mechanistic studies consolidated the analogy to an active site of an 
enzyme by the fact that the H-bonding interactions between the N-H of the linker amides 
with either the leaving group when the ionization is enantiodetermining or the 
nucleophile when nucleophilic capture is enantiodetermining are vital for the chiral 
recognition (Figure 12).
90
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Figure 12. Cartoon models for kinetic resolution (I) and asymmetric induction (II) in Pd-
AAA with Trost ligand showing the ability of the ligand to act as both H-bond donor and 
acceptor. 
 
 
 
When it provided very high enantio- and stereo-selectivity on electrophilic allylic moiety, 
the Trost ligand class has shown a significant enantioselective control on nuclephiles as 
well, which is very challenging due to the fact that the nucleophile is rather approaching 
towards the electrophilic allyl group from outside of the power-sphere of the chiral 
ligand. So, for a successful reaction, the chiral ligands must influence the trajectory of the 
approach and impart a facial bias to the incoming nucleophile. Clearly, this idea was 
proven possible by Trost ligands since various stabilized and unstabilized enolates are 
allylated asymmetrically with high ee.
89, 91
  
 
As an example, for the Pd-AAA of tetralone, it produces allylated product with 99% yield 
and 88% ee (Scheme 49).
92
 There are several approaches that may be considered for the 
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nucleophile to approach the π-allylpalladium complex (Scheme 49, Approach I, II, and 
III). Approach I is eliminated due to the assumption that the preferred transition state 
will place the sterically bulky aryl ring under the flap rather than under the allyl moiety. 
Approaches II and III can be differentiated by the same steric reason between the 
substrate and ligand. In approach II, there’s a steric interaction of both ring systems with 
the back wall of the ligand since enolate anion which actuall works as nucleophile is 
other side of these rings in regards to electrophilic allylic moiety. However, these steric 
interactions are minimized in approach III. According to this analysis, the predicted 
stereochemistry is (S) as was determined experimentally.  
 
 
 
 
 
Scheme 49. Chirality at the nucleophile in Pd-AAA. 
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2.5.3. Pd-AAA employing acyclic nucleophile 
 
Even though the asymmetric synthesis of compounds containing chiral centers on 
nucleophiles is difficult to achieve compare to that on electrophilic allyl moieties, 
numerous amount of work has been carried out to accomplish it. This produces a large 
number of accounts in various peer reviewed journals all over the world. However, most 
of these works have been carried out with cyclic substrates, using mainly cyclic enolates 
as starting material. It is even more challenging to achieve desired stereoinduction on the 
nucleophile when acyclic enolates are employed. The reason is that the conformationally 
non-rigid acyclic substrates possess more degrees of freedom. However, high 
enantioselection requires proper matching of the substrate in the chiral pocket of the Pd-
π-allyl complex and thereby less randomness. This factor decreases the probability of 
achieving high degree of stereoselctivity when acyclic substrates are employed, since it 
contains greater number of rotatable bonds, which in turns increases the entropy and 
probability of mismatching.  
 
While the first example of an enantioselective Pd-AAA reaction was reported in 1977,
93
 
it’s only in 2005 when the first account of asymmetric induction on acyclic nucleophile 
was published, although by decarboxylative (Pd-DAAA) version of the reaction (Scheme 
50).
94
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Scheme 50. First example of using acyclic substrate in palladium catalyzed reaction. 
 
Recently in 2014, Guo and co-workers
95
 have synthesized a series of α-fluorinated 
quaternary ketones by Pd-AAA reaction using tBuPHOX as chiral ligand (Scheme 51). 
Fluorinated compounds are potentially useful molecules for the development of drugs, 
agrochemical, and functional materials. Before this account, few accounts
96
 have been 
reported to synthesize similar compounds containing fluorine in α-position, but with less 
success in regards to enantioselectivity. 
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Scheme 51. Acyclic α-fluorinated quaternary ketones by Pd-AAA. 
 
An outstanding finding has been reported by Hossain and co-workers
39
 in 2014 where a 
set of acyclic all-carbon α-aryl quaternary stereocenter has been synthesized via Pd-AAA 
using hydroxyacrylate as unprecedented nucleophilic counterpart instead of the widely 
used ketonic substrates. This produced a very rare all-carbon quaternary aldehydes with 
high yield and ee (Scheme 52).  
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Scheme 52. Acyclic all-carbon α-aryl quaternary aldehydes by Pd-AAA. 
 
This group argues that the above reaction methodology possesses significant advantage 
over other Pd-AAA reaction due to its unprecedented use of hydroxyacrylate as 
nucleophile, while most researches reported so far was with ketones. However, one of the 
obvious problems of ketones as starting material is their tendency to form multiple 
products in presence of bases
8
 (Scheme 53, Eq. 1). To avoid this structural difficulty, 
allyl enol carbonates
97
 and silyl enol ethers
98
 have been introduced successfully (Scheme 
53, Eq. 2). However, it requires one more extra step to make these substrates. Substrates 
either lacking an α- proton or containing an α-electron withdrawing groups on one site, or 
a combination of both, have also been successfully employed (Scheme 53, Eq. 3),
99
 even 
though the substrate is now biased towards certain functionalities. These above 
mentioned problems associated with ketones as starting material can be avoided in this 
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protocol. Moreover, aldehydes are more reactive than ketones which might increase the 
scope of further research. 
 
 
 
Scheme 53. Formation of mixed products while ketonic substrates used as nucleophile in 
Pd-AAA and approaches investigated to curb this phenomenon. 
 
Another remarkable research has been published in early 2012 by Ooi and co-workers, 
where a novel ion-paired chiral ligand has been developed for Pd-AAA of α-
nitrocarboxylates. This novel ligand consists of an achiral cationic ammonium-phosphine 
hybrid ligand coupled with a chiral binaphtholate anion. This ion-paired chiral ligand 
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provided remarkable stereocontrolling ability to its palladium complex, affording 91-97% 
ee with a series of substituted α-nitrocarboxylates (Scheme 54). 
 
 
 
Scheme 54. Ion-paired ligand in Pd-AAA of acyclic α-nitrocarboxylates. 
 
In 1996, Ito and co-workers
100
 reported the synthesis of similar acyclic α-nitrocarboxylate 
comounds with good yield and enantioselectivity. This time, another innovative design of 
a novel ligand containing crown-ether moiety was instrumental for this success. Use of 
additive was also a key component in this reaction, which is a fairly common practice in 
Pd-AAA reaction (Scheme 55). 
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Scheme 55. Chiral crown-ether phosphine ligand in Pd-AAA reaction of acyclic 
substrate. 
 
Other transition-metal catalysts instead of palladium, e.g., molybdenum, Irridium, etc., 
have also been successfully employed. Recently, Trost and co-workers
101
 have reported a 
number of highly functionalized branched acyclic cyanoesters containing a quaternary 
carbon stereocenter with a vicinal tertiary stereocenter by a prudent use of Molybdenum 
as a transition-metal catalyst. Surprisingly, the reaction was highly enantio- and 
diastereoselective (Scheme 56). 
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Scheme 56. Enantioselective synthesis of acyclic compounds by Mo-AAA. 
 
Another important transition metal frequently used for the synthesis of acyclic quaternary 
all-carbon or tertiary stereocenters by AAA reaction is iridium.
102
 As an example, the 
first regio-, diastereo-, and regioselective Ir-AAA reaction of acyclic β-ketoesters to form 
vicinal tertiary and all-carbon quaternary stereocenters was reported recently by Stoltz 
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and coworkers (Scheme 57).
103
 This iridium catalyzed asymmetric allylic alkylation 
reaction showed broad functional group tolerance at the keto-, ester-, and α-position of β-
ketoester.  
 
 
 
Scheme 57. Enantioselective synthesis of linear quaternary compounds by Ir-AAA. 
 
In order to demonstrate the utility of this method, Aldol condensation, Pauson-Khand 
cyclization and ring closing metathesis reactions were carried out with the alkylation 
product to synthesize biologically important building blocks (Scheme 58). 
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Scheme 58. Derivatization of β-ketoester products. 
 
Previously, it has also proved to be a powerful transition metal catalyst in accessing 
vicinal all-carbon quaternary and tertiary stereocenters by the regio-, diastereo-, and 
enantioselective asymmetric allylic alkylation of cyclic substratess.
104
 
 
2.6. Results and discussions: Pd-AAA of 3-hydroxy aryl acrylates 10 for the synthesis 
of all-carbon α-aryl quaternary carbonyl compounds 
 
The development of catalytic, enantioselective methods for the construction of all-carbon 
quaternary stereocenters
2,3,4,5,6
 is an outstanding achievement in the recent history of 
organic chemistry. The Pd-AAA reaction has played a key role in creating such 
stereocenter and allowed researchers to synthesize a vast number of biologically potent 
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natural products.
7,8,9
 However, synthetic methodologies to access compounds containing 
α-aryl groups to the quaternary carbon stereocenters are still rare. The increasing 
appearance of these all-carbon α-aryl quaternary stereocenters105 in a growing number of 
biologically active natural products and pharmaceutical agents
106
 creates a pressing need 
for the ability to construct this important motif enantioselectively. 
 
We envisioned the possibility of constructing this vitally important all-carbon α-aryl 
quaternary stereocenters employing 3-hydroxy aryl acrylates 10 as substrates, since it 
features aryl-bound tertiary prochiral α-carbon which should be easily converted to 
quaternary carbon. We chose allyl group to be attached to this tertiary carbon due to it 
versatile synthetic utility (Scheme 59, to see versatility of allyl group Scheme 44). 
 
 
 
Scheme 59. Rationale for 3-hydroxy aryl acrylate as a suitable candidate for the 
construction of all-carbon α-aryl quaternary stereocenters. 
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Since we have already achieved quantitative conversion of the desired C-allylated 
product 13a from 3-hydroxy phenyl acrylate 10a employing stoichiometric amount of π-
allylpalladium complex 14 (Scheme 23, section 1.4), our next goal was to obtain catalytic 
version of this reaction. Pd(PPh3)4 has been employed as a catalyst and allyl acetate as 
allyl electrophile. We knew that base is essential for the reaction to proceed, which has 
been proved earlier (see scheme 43). This time we wanted to check whether it would 
need in catalytic or stoichiometric amounts. Thus, two sets of reactions was investigated 
at this point; one with stoichiometric and other with catalytic amount of base Et3N. Both 
of these reactions provided quantitative conversion of desired all-carbon α-aryl 
quaternary stereocenter 13a from 3-hydroxy phenyl acrylate 10a using only 5 mol% of 
catalyst Pd(PPh3)4 (Scheme 60). 
 
 
Scheme 60. Catalytic allylic alkylation of 3-hydroxy phenyl acrylate 10a. 
 
From the above observation, we concluded that the reaction is going through using base 
as a co-catalyst whereas Pd (0) is the catalyst. Thus we proposed the following 
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mechanism (Scheme 61): Pd (0) is first complexed with the olefinic double-bond of allyl 
group, and then in the ionization step, π-allylpalladium complex 14 is formed. 
Meanwhile, 3-hydroxy aryl acrylates 10 are deprotonated to reactive enolate by the action 
of the base. This enolate now attacks the electrophilic allyl terminus of the π-
allylpalladium complex 14 by SN2 fashion. In this step, co-catalytic base is regenerated 
along with byproduct acetic acid. In the final step, Pd (0) is regenerated by 
decomplexation from the allylic double-bond of the product 13.  
 
 
Scheme 61. Mechanism of catalytic allylic alkylation showing Pd(0) as catalyst and Et3N 
as co-catalyst. 
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This, in turn, means that there are two ways to achieve enantioselectivity: by (i) chiral 
base, or (2) chiral ligand. 
 
2.6.1. Chiral induction by chiral amine bases 
 
Our first approach was to achieve enantiodiscrimination by employing chiral bases. We 
have selected both quinine- and proline-based amines for the purpose. Two quinine based 
amines 15 and 16 as well as two proline-based amines 17 and 18 were employed for the 
reaction of 10a in DCM at rt with the presence of Pd(PPh3)4 as catalyst. Unexpectedly, ee 
values for 13a never exceeded more than 10%, even though conversion to 13a was 
always quantitative. More surprisingly, the ee for even the stoichiometric amount of 15 
was similarly unusually low (Scheme 62, Table 4). 
 
 
 
Scheme 62. Chiral induction by chiral bases. 
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Table 4. Optimization studies for chiral induction by chiral bases. 
Entry Chiral Base 
[Eq] 
Conv. 
[%] 
ee 
[%] 
1 15 (1.1 eq) Quantitative 10 
2 15 (10 mol%) Quantitative 10 
3 16 (10 mol%) Quantitative 10 
4 17 (10 mol%) Quantitative Racemic 
5 18 (10 mol%) Quantitative 5 
 
Puzzled by the outcome of this investigation, we questioned ourselves whether the base 
was even participating in the reaction (Scheme 63). Hence, we carried out a reaction 
without the introduction of any base and used allyl acetate as electrophile. To our 
surprise, complete conversion was detected by 
1
H NMR analysis (Scheme 63, eq 1). That 
means, the counterion of π-allylpalladium complex or the leaving group of the allyl 
electrophile, acetate anion, was basic enough to remove a proton from the starting 
acrylate 10a. Furthermore, we questioned if allyl tosylate or allyl phosphate can be 
employed instead of allyl acetate. As expected, both allyl tosylate and allyl phosphate did 
not give any reaction (Scheme 63, eq 2). However, when base Et3N was employed, they 
too reacted quickly and yielded the desired product 13a quantitatively (Scheme 63, eq 3). 
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Scheme 63. Pd-AA employing allyl acetate, allyl tosylate, and allyl phosphate as allyl 
electrophiles; reaction with allyl tosylate or allyl phosphate require base to proceed. 
 
Now that we found that allyl tosylate and allyl phosphate did not react without 
introduction of bases, we optimize the reaction again for the chiral induction employing 
various chiral bases. This time, we investigated quinine-based amines 15 and 16 and one 
proline-base amine 17 in DCM at rt (Scheme 64, Table 5). This time too, similar 
disappointing results were obtained in terms of ee. A slightly better ee was observed with 
16 for both allyl tosylate (25%, entry 8) and allyl phosphate (18%, entry 11), even though 
95 
 
 
 
only when stoichiometric amount of 16 was employed. However, this investigation 
assured the participation of the bases in the course of the reaction, since most of the 
reaction showed almost identical conversion to the equivalence of bases employed. When 
stoichiometric amount of bases were introduced, the conversions were quantitative (entry 
1, 4, 8, and 11). The conversions were also increased linearly with the amou nt of bases 
used (entry 2, 3, 5, 6, 7, and 10). 
 
 
 
Scheme 64. Investigation of chiral induction when ally tosylate and allyl phosphate were 
allyl electrophiles. 
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Table 5. Optimization studies for the chiral induction of the reaction between 10 and 
allyl tosylate or allyl phosphate. 
 
2.6.1.1. NMR investigation
107
 
 
The above results raised a well-deserved question: why was desired chiral induction not 
achieved by a chiral base even though it completely participated in the progress of the 
reaction? To find out the answer, we will have to know what is occurring mechanistically 
in the reaction and how the substrate 3-hydroxy aryl acrylates and the chiral amine 
Entry Electrophile Chiral Base 
[equiv] 
Conv. 
[%]  
ee 
[%] 
1 Allyl tosylate 15 (1.2 eq.) Quantitative 7 
2 Allyl tosylate 15 (5 mol%) 5 - 
3 Allyl tosylate 15 (10 mol%) 10 - 
4 Allyl tosylate 17 (1.2 eq.) Quantitative 10 
5 Allyl tosylate 17 (10 mol%) 10 5 
6 Allyl tosylate 16 (10 mol%) 10 - 
7 Allyl tosylate 15 (10 mol%) & Cs2CO3 10% C, rest O - 
8 Allyl tosylate 16 (1.2 eq.) Quantitative 25 
9 Allyl phosphate - - - 
10 Allyl phosphate 15 (10 mol%) 18 9 
11 Allyl phosphate 16 (1.2 eq.) Quantitative 18 
12 Allyl phosphate 17 (1.2 eq.) 9 - 
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catalysts binding and is it a favorable process. Thus, we went on to study the interaction 
of chiral base 15 with nucleophile 10a by NMR. 
 
In chloroform or methylene chloride, the acrylate 10a assumes the Z configuration 10a-Z 
(Figure 13), with only small amount of the tautomeric aldehyde form 10a-Ald (Figure 
13) present. Upon mixing 10a-Z with the quinine base 15 in a 1:1 ratio in chloroform or 
methylene chloride, the proton spectra showed two major sets of signals that can be 
assigned to an acrylate species, a minor set of signals attributed to the aldehyde tautomer 
10a-Ald and one set of signal from quinine 15 (Figure 13).  Of the two acrylate species, 
one set of signals is virtually identical with the initial Z-acrylate, with the exception of the 
signal from the OH hydrogen, which is not visible at room temperature, and a significant 
broadening observed for the H-1 signal.  The second set of acrylate signals exhibits a 
signal for H-1 that is shifted downfield to 8.51 ppm compared to 7.38 ppm observed for 
the equivalent proton in 10a-Z (Figure 14). 
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Figure 13. NMR assigned positions. 
 
 
 
Two dimensional 
1
H{
13
C} HSQC- and HMBC spectra are consistent with both 10a-Z and 
10a-E present in the mixture (Figure 14), with carbon chemical shifts 163.5 ppm and 
163.0 respectively for C-1 and 108.6 and 107.8 ppm for C-2 in the two species.  A 
NOESY spectrum at room temperature showed strong positive cross peaks arising from 
exchange between the two acrylate species (Figure 14).  In addition, exchange peaks 
between the acrylate forms and the minor aldehyde form were observed.
108
  These data 
indicate that in the presence of quinine 15 the intramolecular hydrogen bond stabilizing 
the Z-form gets weakened, resulting in a lowering of the barrier of acrylate to aldehyde 
tautomerization, and a loss in thermodynamic preference for the Z configuration. 
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Figure 14. Expanded NOESY spectrum regions of a 1:1 mixture of 10a and 15 in DCM 
at 273 K. Displayed are correlations of the 10a H1 protons to aromatic/olefinic protons. 
Positive cross peaks due to exchange are shown in blue, negative cross peaks arising 
from NOE are shown in red. Exchange between E and Z isomer is observed both for the 
H-1 protons and the H-2′ protons of 10a. 
 
 
 
More interestingly, NOESY spectra exhibited negative NOE cross peaks between 10a-E 
and quinine 15, mainly between H-1 and H-2′ with hydrogens near the OH group in 15 
and with its aromatic ring.
108
 On the other hand, not a single cross peak between 10a-Z 
and quinine 15 was observed, indicating that only 10a-E is binding to 15 (Figures 14 and 
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15).  A closer analysis of the relative signal integrals shows that the ratio of 10a-E: 15 is 
non-stoichiometric, but only the sum (10a-Z + 10a-E): 15 as expected from the ratio at 
which the two components were mixed.  Further experiments using either an excess of 
10a or 15 displayed a similar picture with only one set of signal present for 15 but two 
sets of signals for 10a.  
 
Figure 15. Expanded 10a-H-1 to aliphatic crosspeaks of the NOESY spectrum of a 1:1 
mixture of 10a and 15 in DCM at 273 K.  Negative NOE cross peaks are shown in red. 
Intermolecular NOEs between 10a and 15 are only observed for the 10a-E but not for 
10a-Z. 
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Chemical shifts of protons in 10a-E and 15 exhibited a much larger dependence on 
concentration that did the ones in 10a-Z, and studies at different temperatures (263 – 
308K) showed a remarkable temperature dependence of the proton shifts for 10a-Z and 
15 compared to 10a-Z.  From those data it appears that 10a-E is in fast exchange between 
a 10a/15 complex and the free 10a-E. 
 
The NOESY data indicate that Z- to E-isomerization of the acrylate 10a takes place 
through the tautomeric aldehyde form 10a-Ald.  In the absence of quinine 15 this 
tautomer is present in small quantities, but no exchange between the two species is 
observed on the NMR time scale.  Most likely the acrylate form of 10a-Z is stabilized by 
the intramolecular OH∙∙∙O=C hydrogen bond.  In the presence of a base like quinine the 
breakage of this hydrogen bond is catalyzed as evidenced by the disappearance of the OH 
proton signal in 10a-Z after the addition of quinine 15 and the presence of exchange 
between10a- Z and 10a-Ald peaks in the mixture.  Free rotation about the C1-C2 single 
bond in 10a-Ald then results in formation of the 10a-E in equilibrium with 10a-Z and 
10a-Ald (Scheme 65). 
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Scheme 65. Interaction of 3-hydroxy phenyl acrylate 10a with quinine 15. 
 
In conclusion, NMR investigation suggested that quinine 15 acts as regular base when 
comes in contact with the 3-hydroxy aryl acrylate and there is rapid inter-conversion of E 
and Z isomers which is preventing us from obtaining high asymmetric induction. 
 
2.6.2. Chiral induction by chiral ligands 
 
Since NMR analysis showed that enantiodiscrimination is unlikely employing chiral 
bases, we have to find a way to effectively blocking one form between E and Z of 3-
hydroxy aryl acrylates over the other. Therefore, we moved on to employing chiral 
ligands instead for the asymmetric variant of this Pd-catalyzed allylic alkylation reaction. 
To optimize the reaction conditions for high asymmetric induction, we first started 
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investigating the effects of systematic variations in the solvent, ligand, and temperature 
on enantiodiscrimination. Both C2-symmetric Trost modular ligands 
(diphenylphosphino)benzoic Acid (DPPBA) as well as mixed P/N-type 
phosphinooxazoline (PHOX) ligands were selected for the investigation (Figure 16). 
 
Figure 16. Chiral ligands used for optimization. 
 
 
 
It should be noted, however, that the DPPBA ligands class, such as (R,R)-L2, (R,R)-L3, 
and (R,R)-L4 showed greater levels of enantioselectivity compared to PHOX ligands, S-
L1 (Table 6, entry 1-5) yielding α-tetrasubstituted aldehyde 13a quantitatively at room 
temperature with around 30% ee for both (R,R)-L3, and (R,R)-L4 in DCM (entry 3 and 
4). Increasing the polarity of the solvent did not have much effect on enantioselectivity 
for (R,R)-L3 (entry 7). Even though a significant increase from 30 to 49% in ee was 
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observed for ligand (R,R)-L4 in THF (entry 8), it showed little or no further improvement 
on chiral recognition towards variation of solvents and temperatures. In summary, we 
only found a slight increase in enantioselectivity by changing solvents to toluene and 
hexane:toluene (1:1) at rt with this ligand (entry 13 and 20). Lowering the temperature 
too from rt to −20˚C via −10˚C showed a minimal effect (entry 14, 15, and 21). On the 
other hand, ligand (R,R)-L3 demonstrated a high level of enatiodiscriminative sensitivity 
towards polarity of solvents and temperature changes of the reaction. As the solvent 
system became more non-polar, from toluene to a 1:1 mixture of hexane:toluene, a sharp 
increase in ee was observed at rt from 30% to 79% (entry 9 and 18). The use of 
hexane:toluene solvent mixtures has been reported earlier by Stoltz
109
 and it is thought 
that this very low polarity system increases stereoinduction by helping to form tight ion 
pairs via the formation of “solvent cages”. We thus reasoned that the combined effect of 
the formation of “solvent cages” by using low-polarity hexane:toluene (1:1) solvent and 
tightening the ligand pocket by switching to naphtholinker, (R,R)-L3, from the phenyl 
linker, (R,R)-L4, was instrumental in this dramatic increase in enantioselectivity. 
However, a noticeable decrease in conversion (64%) was observed with hexane:toluene 
(1:1) as solvent at rt. Unlike ligand (R,R)-L4, ligand (R,R)-L3 is also extremely sensitive 
to temperature. At rt the ee of the reaction using (R,R)-L3 was 30% in toluene, and it 
increased substantially (up to 72%) by decreasing the temperature to −10˚C with 80% 
conversion (entry 9 and 10). Interestingly, it failed to show further improvement in 
enantioselectivity beyond −10˚C in toluene (entry 11). However, when hexane:toluene 
(1:1) was employed as solvent at −20˚C, a remarkable increase in ee (94%) was observed 
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even though with a significant decrease in conversion (entry 19). No reaction was 
observed below −20˚C (entry 12 and 16). 
 
Table 6. Selected optimization studies.
a
 
 
a
All reactions were performed with 0.26 mmol of 10a and 0.30 mmol of allyl acetate in 
solvent (5.0 mL). 
b
Optimized temperature for the best ee value and conversion. 
c
Determined by 
1
H NMR analysis of the reaction mixture. 
d
Determined by HPLC analysis using a chiral stationary phase. 
Entry Ligand Solvent T 
[˚C]b 
Conv. 
[%]
c
 
ee 
[%]
d
 
1 S-L1 DCM rt > 99 5 
2 (R,R)-L2 DCM rt > 99 10 
3 (R,R)-L3 DCM rt > 99 29 
4 (R,R)-L4 DCM rt > 99 30 
5 S-L1 THF rt > 99 4 
6 (R,R)-L2 THF rt > 99 10 
7 (R,R)-L3 THF rt > 99 27 
8 (R,R)-L4 THF rt > 99 49 
9 (R,R)-L3 Toluene rt > 99 30 
10 (R,R)-L3 Toluene −10 80 72 
11 (R,R)-L3 Toluene −20 45 70 
12 (R,R)-L3 Toluene −41 0 - 
13 (R,R)-L4 Toluene rt > 99 55 
14 (R,R)-L4 Toluene −10 54 55 
15 (R,R)-L4 Toluene −20 70 62 
16 (R,R)-L4 Toluene −41 0 - 
17 (R,R)-L2 Hex:Tol rt 58 57 
18 (R,R)-L3 Hex:Tol rt 64 79 
19 (R,R)-L3 Hex:Tol −20 33 94 
20 (R,R)-L4 Hex:Tol rt 66 55 
21 (R,R)-L4 Hex:Tol −20 34 51 
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Having identified a set of reaction conditions that provided 94% ee, we then directed our 
focus to increasing the conversion while keeping the enantioselectivity unaffected. We 
did this by adjusting the equivalence of reactants, or by introducing exogenous bases 
(Table 7). While addition of excess allyl acetate showed no effect (entry 1), excess 
nucleophilic counterpart demonstrated an almost linear increase in conversion (entry 1-4) 
along with enantioselective fidelity unaffected, reaching >99% with 4.0 equivalent of 
acrylate nucleophile 10a (entry 4). This phenomena is explained by the fact that anionic 
acetate ion, which is the counterion of the Pd-allyl complex, is nucleophilic itself and can 
compete with the desired acrylate nucleophile, thereby reducing the percent yield. This 
can thus be improved by increasing the presence of the substrate to outweigh the 
concentration of competing acetate ion in the system. However, we hypothesized that 
there must be an ideal base which would enable the reaction to proceed without using an 
excessive amount of expensive nucleophile by forming more reactive enolate. Thus, we 
examined KOtBu, Et3N, and DIPEA as bases (entry 5-11).  Both Et3N and KOtBu proved 
to be damaging to the enantioselective fidelity (entry 5 and 6). However, when DIPEA 
was employed, a significant increase in percent conversion was observed without 
lowering the percent ee (entry 7-11). Eventually, 2.0 equivalent of DIPEA was found to 
be optimal affording 98% conversion (95% isolated yield) and 94% ee (entry 10). 
Therefore, the optimum condition is to use (R,R)-DACH-naphthyl Trost ligand L3 (6.0 
mol%) in hexane:toluene (1:1) as solvent along with [Pd2(dba)3.CHCl3] (2.5 mol%) in the 
presence of DIPEA (2.0 eq) as base. It should be noted, however, that the use of base is 
not absolutely necessary as the substrate is acidic enough to proceed on its own with a 
similar level of selectivity if excess is introduced. 
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Table 7. Key results from further optimization studies on additional bases and reactants 
loading.
a
 
a
All reactions were performed on a 0.26 mmol scale in 1:1 mixture of hexane:toluene (5.0 
mL). 
b
Determined by 
1
H NMR analysis of the reaction mixture. 
c
Determined by HPLC analysis using a chiral stationary phase. 
 
 
With the optimized reaction conditions in hand, we then investigated the scope of the 
reaction by subjecting a variety of substituted aryls and a heteroaryl analogs to the Pd-
AAA process (Scheme 66). In general, good to excellent yields (75-99%) and 
enantioselectivities (75-94%) were obtained. Interestingly, unsubstituted one 13a 
exceeded any other examined analogs in terms of enantiodiscriminative selectivity. Both 
electron withdrawing (13e-g) and electron donating (13b-d) substituents on the aromatic 
Entry 10a 
[Equiv] 
Allyl 
acetate 
[Equiv] 
Base 
[Equiv] 
Time 
[h] 
Conv. 
[%]
b
 
ee 
[%]
c
 
1 1.0 4.0 - 120 33 92 
2 2.0 1.0 - 120 56 92 
3 3.0 1.0 - 120 63 92 
4 4.0 1.0 - 120 > 99 94 
5 1.0 1.2 Et3N [1.0] 48 > 99 52 
6 1.0 1.2 KOtBu [1.0] 24 74 33 
7 1.0 1.2 DIPEA [1.0] 72 84 91 
8 1.0 1.2 DIPEA [1.2] 12 84 90 
9 1.0 1.2 DIPEA [1.5] 72 98 91 
10 1.0 1.2 DIPEA [2.0] 12 98 94 
11 1.0 1.2 DIPEA [2.2] 12 96 87 
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ring were tested by this process. Surprisingly, either of the analog classes functioned 
well, yielding ee ranges from 81% for the para-methoxy substrate 13d to as much as 90% 
for the para-nitro substituted substrate 13g. Bulky tert-Butyl analog 13c provided better 
ee (89%) than any other electron donating substituents. The heteroaryl substituted analog 
13i also shared similar impressive reactivity (99% yield), but with a little less 
enantioselectivity (75%). The sterically bulky, and hence, theoretically more challenging 
naphthyl analog 13h provided a high yield (99%) and enantioselectivity (83% ee) as well. 
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Scheme 66. Scope of the Pd-AAA of 3-hydroxy-2-arylacrylates 10a-i. All reactions were 
performed on 0.16-0.26 mmol scale in solvent (5.0 mL). The yields shown are of isolated 
products and the ee values were determined by HPLC analysis using a chiral stationary 
phase. 
a
Reactions run for 72 h.  
b
Reactions run without DIPEA. 
 
c
ee value of fural analog reported is for alcohol reduced from quaternary aldehyde. 
 
110 
 
 
 
To the best of our knowledge, this Pd-AAA methodology is the very first example of 
intermolecular transition metal-catalyzed AAA of a hydroxyacrylate. In addition, this 
method allowed access to chiral quaternary aldehydes, which is still surprisingly limited. 
List and coworkers recently have reported the only example of a synthesis of quaternary 
α-allylated all-carbon aldehyde, which, however, requires the presence of additional 
chemical entities in the system.
56
 Besides this above mentioned account, only ketonic 
compounds with a quaternary α-stereogenic center have been synthesized asymmetrically 
to date by Pd-AAA. 
 
One of the potentially inevitable problems in producing chiral ketonic compounds by 
AAA from α-substituted ketones is the formation of multiple isomeric enolates in base-
mediated reaction conditions and the consequent formation of mixed products (Scheme 
67a, Eq. 1).
8
 To overcome this structural difficulty inherent to ketones, allyl enol 
carbonates
97
 and silyl enol ethers
98
 have been introduced to impart position control of the 
enolate (Scheme 67a, Eq. 2). Substrates either lacking an α- proton or containing an α-
electron withdrawing groups on one site, or a combination of both, have also been 
successfully employed (Scheme 67a, Eq. 3).
99
 However, these strategies require either 
one extra step to create selective enolate nucleophiles or a biasness of the substrate 
towards certain functionalities. We believe that the above mentioned problems associated 
with ketonic substrates can be avoided in this protocol while maintaining the step 
economy intact and the substrate unbiased (Scheme 67b). Moreover, aldehydes are more 
reactive than ketones which might increase the scope of further research. 
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Scheme 67. Pd-AAA reaction; a) Formation of mixed products while ketonic substrates 
used as nucleophile and approaches investigated to curb this phenomenon. b)  A new 
approach to avoid above mentioned problem by using prochiral hydroxyacrylates as 
nucleophile. 
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In order to consolidate our claim, we have produced an all-carbon α-aryl quaternary 
ketonic compound (20) with high yield and moderate enantioselectivity using Ethyl 3-
hydroxy-2-phenylbut-2-enoate (19) as starting material (Table 8). We did not observe 
mixture of compounds even though the product has another unblocked α-carbon and an 
excess of both allyl acetate and base have been employed. This substrate proved to be 
less reactive and did not allow the reaction to happen when previously optimized 
condition was employed (entry 2). However, a slight decrease in temperature from −20˚C 
to −10˚C afforded a descent yield (39%) of product with 44% ee (entry 3). Using base is 
essential as no reaction was observed when not applied (entry 1 and 4). Introduction of 
strong bases is proved to be vital in terms of yield as LiHMDS and KOtBu provided 
better yield (entry 6,7,9, and 12) compare to DIPEA (entry 2,3,5,8,10, and 11). Once 
again, 1:1 mixture of hexane:toluene solvent delivered best in regards to both yield and 
enantioselectivity, eventually providing desired product 20 with 97% yield and 52% ee  
at −10˚C temperature with KOtBu as base (entry 7). Even though both toluene (entry 9) 
and THF (entry 12) came near, these never exceeded  hexane:toluene (1:1) as solvents in 
terms of enantioselectivity. 
 
 
 
113 
 
 
 
Table 8. Selected optimization studies of Pd-AAA of Ethyl 3-hydroxy-2-phenylbut-2-
enoate 19.
a
 
a
All reactions were performed on a 0.12 mmol scale in 5.0 mL of solvent. 
b
1.2 equivalent. 
c
Determined by 
1
H NMR analysis of the reaction mixture. 
d
Determined by HPLC analysis using a chiral stationary phase. 
e
Isolated yield. 
 
In conclusion, we have developed a new intermolecular Pd-AAA reaction where, 3-
hydroxyl aryl acrylates 10 have been used as nucleophiles for the first time to produce 
acyclic all-carbon α-aryl quaternary carbonyl compounds including both aldehyde and 
ketone. Hydroxyarylacrylates with a variety of substitution patterns were used as 
nucleophiles which yielded desired products with high yields and enantioselectivities. 
Entry Solvent T 
[˚C] 
Baseb Conv. 
[%]c 
ee 
[%]d 
1 Hex:Tol −20 - 0 - 
2 Hex:Tol −20 DIPEA Trace - 
3 Hex:Tol −10 DIPEA 39 44 
4 Hex:Tol rt - Trace - 
5 Hex:Tol rt DIPEA 67 22 
6 Hex:Tol −10 LiHMDS 93 25 
7 Hex:Tol −10 KOtBu 97e 52 
8 Tol −10 DIPEA 53 44 
9 Tol −20 KOtBu 83 41 
10 THF rt DIPEA 90 30 
11 THF 0 DIPEA 82 34 
12 THF −10 KOtBu 99 37 
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2.7. General methods and experimental 
 
General considerations 
 
All reactions were performed under argon atmosphere in oven-dried glassware with 
magnetic stirring. Air and moisture-sensitive liquids and solutions were transferred via 
oven-dried, stainless steel syringe and were introduced into the reaction vessel through 
rubber septa. CH2Cl2 was distilled from calcium hydride.  Other solvents used were 
distilled from sodium-benzophenone. Freshly distilled solvents were then degassed for 
Pd-catalyzed reactions by freeze-pump-thaw techniques under vaccum. Previously 
reported compounds were identified by 
1
H NMR (nuclear magnetic resonance) spectrum.  
All new compounds were characterized by additional
 13
C NMR and high resolution mass 
spectroscopy. Analytic thin layer chromatography (TLC) was performed on silica gel 
plates (Merck 60F254) visualized either with a UV lamp (254 nm) or by using iodine 
chamber. Flash chromatography was performed using 40-60 µm silica gel (Silicycle). 
The eluent employed for flash chromatography is reported as volume/volume ratios. 
Organic extracts were dried over anhydrous Na2SO4. 
1
H and 
13
C NMR spectra were 
performed on a Bruker NMR at 300 and 75 MHz, or 500 and 125 MHz respectively. 
1
H 
NMR data are reported as follows: chemical shift (δ) in parts per million (ppm) from 
tetramethylsilane as an internal standard (CDCl3 δ7.26 ppm), multiplicity (s = singlet, d 
= doublet, t = triplet, q = quartet, m = multiplet), integration. 
13
C data were reported as 
follows: chemical shifts (δ) are reported in parts per million (ppm) from tetramethylsilane 
with the solvent as an internal indicator (CDCl3 δ77.16 ppm). Chiral HPCL analysis was 
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performed using Waters 1500 Series HPLC equipped with Regis Technologies Pirkle 
Covalent chiral stationary phase column. HPLC retention times of enantiomers were 
determined by comparison to racemic materials. Optical rotations were measured by 
Jasco DIP-370 digital polarimeter using 1 cm glass cells with a sodium 589 nm filter and 
are reported as [α]D
27 
, concentration (mol/L) and solvent.  High-resolution mass spectra 
were acquired by the University of Wisconsin Biotechnology Center Mass Spectrometry 
laboratory (E-Mail: mass spec@biotech.wisc.edu) or the Mass Spectroscopy facility, 
department of Chemistry & Biochemistry, University of Wisconsin –Milwaukee. 
 
2.7.1. Preparation of 3-hydroxy aryl acrylates 10 for Palladium-Catalyzed Asymmetric 
Allylic Alkylation (Pd-AAA) 
 
Hydroxyarylacrylates 10a,
30
 10b,
30
 10c,
110
  10d,
30
 10e,
111
 10f,
111
 10g,
30
 10i,
31
 and 19
31
 
were prepared according to previously existing procedures. Work-up procedure described 
in sections 1.2.1 and 1.5.1 was followed. 
 
Ethyl 3-hydroxy-2-(naphthalen-2-yl)acrylate (10h) 
 
2-naphthaldehyde (1.56 g, 10.0 mmol) was dissolved in freshly distilled dichloromethane 
(50 mL) under nitrogen. HBF4.OEt2 (0.14 mL, 1.0 mmol) was added followed by another 
portion of dichloromethane (50 mL) and then the reaction mixture was stirred at -78
0
C 
for at least 15 minutes. Ethyl diazoacetate (1.45 mL, 12.0 mmol) contains 87% by wt. 
was diluted in freshly distilled dichloromethane (25 mL) and drawn into a gas-tight 
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syringe. The diluted Ethyl diazoacetate was then added to the aldehyde over a period of 
5-6 h with the help of a syringe pump. The reaction mixture was allowed to stir for an 
additional 12 h. The reaction was quenched by adding THF (10 mL), to remove any 
product that might be bound to catalyst. Then it was filtered through a silica plug and the 
solvent removed in vacuo. At this point, the crude was then dissolved in enough DCM 
and excess Et3N was introduced followed by stirring for 5 minutes. When the pH 
indicating paper showed that the solution was basic, it has been passed through a thick 
pad of silica gel. The salt of acrylate is not able to pass through silica and stays on the 
top. The light to dark brown color of the silica gel indicated the salt of 10h. Enough 
DCM was passed through to elute out all unreacted 2-naphthaldehyde and β-keto esters. 
The region of silica indicating brown was then scraped out in a beaker with an 
appropriate (usually long that compliments the beaker) stir bar. DCM was added and 
stirred vigorously until it became slurry and distribution of solid silica particles was 
uniform. Then 6N HCl was added. Enough acid was added with continued stirring until 
the pH paper showed acidity of the solution. The solution was transferred to a separatory 
funnel along with solid silica and extracted with DCM three times. The silica usually 
stays at the interface of the bottom organic (DCM) and top aqueous phase. the combined 
organic layers were washed with brine, dried over anhydrous Na2SO4, and evaporated in 
vacuo to afforded the desired 10h (1.48g, 61% yield) as yellowish solid.  
 
1
H NMR (CDCl3, 300 MHz): δ 12.30 (d, j = 12.6 Hz, 1H), 7.89 (m, 3H), 7.75 (s, 1H), 
7.54 (m, 4H), 4.38 (q, j = 7.2 Hz, 2H), 1.35 (t, j = 7.2 Hz, 3H). 
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13
C NMR (75 MHz, CDCl3): δ 171.8, 163.7, 133.5, 132.4, 131.8, 128.1, 127.9, 127.7, 
127.6, 127.5, 126.2, 126.0, 108.8, 61.1, 14.2. 
HRMS (ESI): Calculated (m/z) for C15H15O3 (M+H)
+
 : 243.1021, Found 243.1017.  
 
2.7.2. General procedures for palladium-catalyzed allylic alkylation reactions 
 
Method 1: General Procedure for Pd-AAA Reaction Optimization Studies (13a, Table 6 
& 7) 
 
In an oven dried and desiccator-cooled sealable test tube was added Pd2(dba)3∙CHCl3 (6.7 
mg, 0.0065 mmol, 0.025 equivalent) and chiral ligand (L1-L4, 0.0156 mmol, 0.06 
equivalent). The test tube was then evacuated and backfilled with Ar three times. 
Previously degassed solvent (5 mL) was added to the test tube and the mixture was 
stirred for 15 min until it was homogeneous and an orange color persisted. Then allyl 
acetate (33.7 µL, 0.3122 mmol, 1.2 equivalent) was introduced into the system and the 
solution was stirred at room temperature for an additional 5 min. (Then the test tube was 
introduced into the appropriate cooling bath if conditions required and stirred for another 
15 min). At this point, the catalyst solution was charged with ethyl 3-hydroxy-2-
phenylacrylate 10a (50.0 mg, 44.3 µL, 0.2601 mmol, 1.0 equivalent) followed by the 
appropriate base (Et3N/KOtBu/DIPEA, 0.2601-0.5722 mmol, 1.0-2.2 equivalent), if 
mentioned. The reaction was then stirred for 12 h, unless otherwise mentioned. The 
reaction mixture was then passed through a thick pad of silica plug and the solvent was 
evaporated under reduced pressure. The resulting crude residue was then analyzed by 
1
H 
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NMR to calculate % conversion. Purification by flush column chromatography with 95:5 
hexane:EtOAc provided analytical samples of 13a for chiral HPLC analysis.  
 
Method 2: General Procedure for Pd-AAA Reaction Optimization Studies (20, Table 8) 
 
In an oven dried and desiccator-cooled sealable test tube was added Pd2(dba)3∙CHCl3 (3.1 
mg, 0.0030 mmol, 0.025 equivalent) and chiral ligand (R,R)-L3 (5.7 mg, 0.0073 mmol, 
0.06 equivalent). The test tube was then evacuated and backfilled with Ar three times. 
Previously degassed solvent (2 mL) was added to the test tube and the mixture was 
stirred for 15 min until it was homogeneous and an orange color persisted. Then allyl 
acetate (15.7 µL, 0.1454 mmol, 1.2 equivalent) was introduced into the system and the 
solution was stirred at room temperature for an additional 5 min. (Then the test tube was 
introduced into the appropriate cooling bath if conditions required and stirred for another 
15 min). At this point, the catalyst solution was charged with ethyl 3-hydroxy-2-
phenylbut-2-enoate 19 (25.0 mg, 0.1212 mmol, 1.0 equivalent) followed by the 
appropriate base (LiHMDS/KOtBu/DIPEA, 0.1454 mmol, 1.2 equivalent), if mentioned. 
The reaction was then stirred for 12 h. The reaction mixture was then passed through a 
thick pad of silica plug and the solvent was evaporated under reduced pressure. The 
resulting crude residue was then analyzed by 
1
H NMR. Purification by flush column 
chromatography with EtOAc in Hexane provided analytical samples for chiral HPLC 
analysis. Purified products 20 were obtained as a light yellow oil (29.0 mg, 97% Yield) 
by column chromatography of the crude mixture on silica gel eluted with 95:5 
hexane:EtOAc (Table 4, entry 7).  
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Method 3: General Procedure for Pd-AAA Reaction (13a-i, Scheme 66) 
 
In an oven dried and desiccator-cooled sealable test tube was added Pd2(dba)3 CHCl3 
(4.7-7.0 mg, 0.0045-0.00675 mmol, 0.025 equivalent) and (R,R)-L3 (8.5-12.8 mg, 
0.0108-0.0162 mmol, 0.06 equivalent). The test tube was then evacuated and backfilled 
with Ar three times. Previously degassed (1:1) Hex:Tol (3 mL) was added to the flask 
and the mixture was stirred for 15 min until it was homogeneous and an orange color 
persisted. Then allyl acetate (23.9-35.6 µL, 0.2213-0.3294 mmol, 1.2 equivalent) was 
introduced into the system and the solution was stirred at room temperature for an 
additional 5 min. In the meantime, another test tube was charged with 
hydroxyarylacrylates 10a-i (50.0 mg, 0.1844-0.2745 mmol, 1.0 equivalent), evacuated 
and backfilled with Ar, and then degassed solvent (1:1) Hex:Tol (2 mL) was introduced 
followed by DIPEA (64.2-95.6 µL, 0.3688-0.5490 mmol, 2.0 equivalent), unless 
otherwise mentioned and was stirred the mixture to dissolve. Both of the test tubes were 
then put into -20
0
C cooling bath and stir for another 15 min before transferring the 
substrate solution into the catalyst mixture via a cannula. The reaction was stirred for 12 
h, unless otherwise mentioned. The reaction mixture was then passed through a thick pad 
of silica plug and the solvent was removed in vacuo. Purified products 13a-i were 
obtained (55 − >99% Yield) by column chromatography of the crude mixture on silica 
gel eluted with EtOAc in Hexane. 
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Method 4: General Procedure for Racemic Pd-Catalyzed Allylic Alkylation Reaction 
(compounds 13a-i, 20) 
 
An oven dried, evacuated, and Ar flushed two-neck round-bottomed flask (RBF) was 
charged with a stir bar and Pd(PPh3)4 (21.3-31.8 mg, 0.0184-0.0275 mmol, 0.1 
equivalent) against the flow of Ar.  Previously degassed dichloromethane (5 mL) was 
added to the flask and the mixture was stirred for 15 min. Then allyl acetate (23.9-35.6 
µL, 0.2213-0.3294 mmol, 1.2 equivalent) was introduced into the system and the solution 
was stirred for an additional 5 min. At this point, the catalyst solution was charged with 
substrates 10a-i, and 19 (50.0 mg, 0.1844-0.2745 mmol, 1.0 equivalent) against Ar flow, 
followed by the addition of KOtBu (32.6 mg, 0.2908 mmol, 1.2 equivalent), only when 
substrate 19 was employed. Then, the reaction was stirred at room temperature for 2-5 h. 
The reaction mixture was then passed through a thick pad of silica plug and the solvent 
was evaporated under reduced pressure to afford a crude residue. Purified products (95-
99% Yield) were obtained by column chromatography of the crude mixture on silica gel 
eluted with EtOAc in Hexane. 
 
Ethyl 2-formyl-2-phenylpent-4-enoate (13a) 
 
Racemic: General procedure for racemic Pd-catalyzed allylic alkylation reaction 
(Method 4) using hydroxyarylacrylate 10a (50.0 mg, 0.2601 mmol, 1.0 eq), Pd(PPh3)4 
(30.0 mg, 0.0260 mmol, 0.1 eq), and allyl acetate (33.7 µL, 0.3121 mmol, 1.2 eq) in 
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dichloromethane (5 mL) at rt for 5h to provide the above mentioned compound as a light 
yellow oil (60.0 mg, >99% yield).  
Chiral: General procedure for Pd-AAA reaction (Method 3) using hydroxyarylacrylate 
10a (50.0 mg, 44.3 µL, 0.2601 mmol, 1.0 eq), Pd2(dba)3CHCl3 (6.7 mg, 0.0065 mmol, 
0.025 eq), (R,R)-L3 (12.3 mg, 0.0156 mmol, 0.06 eq), allyl acetate (33.7 µL, 0.3121 
mmol, 1.2 eq) and DIPEA (90.6 µL, 0.5202 mmol, 2.0 eq) at -20
0
C to provide the above 
mentioned compound as a light yellow oil (57.4 mg, 95% yield). 
1
H NMR (300 MHz, CDCl3): δ 9.92 (s, 1H), 7.44–7.23 (m, 5H), 5.76 (m, 1H), 5.13 (d, J 
= 18.3 Hz, 1H), 5.08 (d, J = 9.6 Hz, 1H), 4.30 (q, J = 7.1 Hz, 2H), 3.14 (dd, J = 6.3, 13.8 
Hz, 1H), 2.88 (dd, J = 8.1, 13.8 Hz, 1H), 1.30 (t, J = 7.1 Hz, 3H).  
Chiral HPLC: 94% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 98:02 hexane/ethanol, 0.8 mL/min, 220 nm, 12.35 min (minor), 15.52 min 
(major). 
[α]D
27
: = + 73.5
0
 (c = 0.082, EtOAc). 
Analytical data matched previously reported data.
45
 
 
Ethyl 2-formyl-2-p-tolylpent-4-enoate (13b) 
 
Racemic: General procedure for racemic Pd-catalyzed allylic alkylation reaction 
(Method 4) using hydroxyarylacrylate 10b (50.0 mg, 0.2424 mmol, 1.0 eq), Pd(PPh3)4 
(27.9 mg, 0.0242 mmol, 0.1 eq), and allyl acetate (31.4 µL, 0.2909 mmol, 1.2 eq) in 
dichloromethane (5 mL) at rt for 5h to provide the above mentioned compound as a 
yellow oil (59.5 mg, >99% yield).  
122 
 
 
 
Chiral: General procedure for Pd-AAA reaction (Method 3) using hydroxyarylacrylate 
10b (50.0 mg, 0.2424 mmol, 1.0 eq), Pd2(dba)3CHCl3 (6.2 mg, 0.0061 mmol, 0.025 eq), 
(R,R)-L3 (11.5 mg, 0.0145 mmol, 0.06 eq), allyl acetate (31.4 µL, 0.2909 mmol, 1.2 eq), 
and DIPEA (84.4 µL, 0.4848 mmol, 2.0 eq) at -20
0
C to provide the above mentioned 
compound as a yellow oil (44.8 mg, 75% yield). 
1
H NMR (300 MHz, CDCl3): δ 9.89 (s, 1H), 7.28–7.11 (m, 4H), 5.75 (m, 1H), 5.16 (d, J 
= 16.8 Hz, 1H), 5.07 (d, J = 10.2 Hz, 1H), 4.28 (q, J = 7.2 Hz, 2H), 3.12 (dd, J = 6.3, 13.8 
Hz, 1H), 2.88 (dd, J = 8.1, 13.8 Hz, 1H), 2.37 (s, 3H), 1.29 (t, J = 7.2 Hz, 3H). 
Chiral HPLC: 83% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 98:02 hexane/ethanol, 0.5 mL/min, 220 nm, 13.54 min (minor), 14.66 min 
(major). 
[α]D
27
: = + 42.5
0
 (c = 0.081, EtOAc). 
Analytical data matched previously reported data.
45 
 
Ethyl 2-(4-(tert-butyl)phenyl)-2-formylpent-4-enoate (13c) 
 
Racemic: General procedure for racemic Pd-catalyzed allylic alkylation reaction 
(Method 4) using hydroxyarylacrylate 10c (50.0 mg, 0.2014 mmol, 1.0 eq), Pd(PPh3)4 
(23.2 mg, 0.0201 mmol, 0.1 eq), and allyl acetate (26.1 µL, 0.2417 mmol, 1.2 eq) in 
dichloromethane (5 mL) at rt for 2h to provide the above mentioned compound as a 
yellow oil (52.9 mg, 91% yield).  
Chiral: General procedure for Pd-AAA reaction (Method 3) using hydroxyarylacrylate 
10c (50.0 mg, 0.2014 mmol , 1.0 eq), Pd2(dba)3CHCl3 (5.2 mg, 0.0050 mmol, 0.025 eq), 
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(R,R)-L3 (9.6 mg, 0.0121 mmol, 0.06 eq), allyl acetate (26.1 µL, 0.2417 mmol, 1.2 eq) 
and DIPEA (70.1 µL, 0.4028 mmol, 2.0 eq) at -20
0
C to provide the above mentioned 
compound as a yellow oil (47.0 mg, 81% yield). 
1
H NMR (300 MHz, CDCl3): δ 9.89 (s, 1H), 7.42 (d, J = 8.4 Hz, 2H), 7.17  (d, J = 8.4 
Hz, 2H), 5.90 (m, 1H), 5.15 (d, J = 18.9 Hz, 1H), 5.10 (d, J = 12.3 Hz, 1H), 4.30 (q, J = 
7.1 Hz, 2H), 3.15 (dd, J = 6.3, 14.1 Hz, 1H), 2.86 (dd, J = 8.1, 13.8 Hz, 1H), 1.33 (s, 9H), 
1.33 (t, J = 7.1 Hz, 3H). 
Chiral HPLC: 89% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 99:01 hexane/ethanol, 1.0 mL/min, 220 nm, 6.86 min (minor), 7.46 min (major). 
[α]D
27
: = + 83.0
0
 (c = 0.035, EtOAc). 
Analytical data matched previously reported data.
45
 
 
Ethyl 2-formyl-2-(4-methoxyphenyl)pent-4-enoate (13d) 
 
Racemic: General procedure for racemic Pd-catalyzed allylic alkylation reaction 
(Method 4) using hydroxyarylacrylate 10d (50.0 mg, 0.2250 mmol, 1.0 eq), Pd(PPh3)4 
(26.0 mg, 0.0225 mmol, 0.1 eq), and allyl acetate (29.2 µL, 0.2700 mmol, 1.2 eq) in 
dichloromethane (5 mL) at rt for 5h to provide the above mentioned compound as a 
yellow oil (58.5 mg, >99% yield).  
Chiral: General procedure for Pd-AAA reaction (Method 3) using hydroxyarylacrylate 
10d (50.0 mg, 0.2250 mmol, 1.0 eq, 1.0 eq), Pd2(dba)3CHCl3 (5.8 mg, 0.0056 mmol, 
0.025 eq), (R,R)-L3 (10.6 mg, 0.0135 mmol, 0.06 eq), allyl acetate (29.2 µL, 0.2700 
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mmol, 1.2 eq) and DIPEA (78.4 µL, 0.4500 mmol, 2.0 eq) at -20
0
C to provide the above 
mentioned compound as a yellow oil (47.2 mg, 80% yield). 
1
H NMR (300 MHz, CDCl3): δ 9.87 (s, 1H), 7.16 (d, j = 8.7, 2H), 6.93 (d, j = 8.7, 2H), 
5.76 (m, 1H), 5.16 (d, J = 18.6 Hz, 1H), 5.08 (d, J = 10.2 Hz, 1H), 4.30 (q, J = 7.1 Hz, 
2H ), 3.83 (s, 3H), 3.08 (dd, J = 6.3, 13.8 Hz, 1H), 2.85 (dd, J = 7.8, 13.8 Hz, 1H), 1.28 
(t, J = 7.1 Hz, 3H).  
Chiral HPLC: 81% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 96:04 hexane/ethanol, 0.5 mL/min, 220 nm, 18.2 min (minor), 20.5 min (major). 
[α]D
27
: = + 36.5
0
 (c = 0.080, EtOAc). 
Analytical data matched previously reported data.
45 
 
Ethyl 2-(4-fluorophenyl)-2-formylpent-4-enoate (13e) 
 
Racemic: General procedure for racemic Pd-catalyzed allylic alkylation reaction 
(Method 4) using hydroxyarylacrylate 10e (50.0 mg, 0.2379 mmol, 1.0 eq), Pd(PPh3)4 
(27.4 mg, 0.0238 mmol, 0.1 eq), and allyl acetate (30.8 µL, 0.2855 mmol, 1.2 eq) in 
dichloromethane (5 mL) at rt for 2h to provide the above mentioned compound as a 
yellow oil (59.0 mg, >99% yield).  
Chiral: General procedure for Pd-AAA reaction (Method 3) using hydroxyarylacrylate 
10e (50.0 mg, 0.2379 mmol, 1.0 eq, 1.0 eq), Pd2(dba)3CHCl3 (6.1 mg, 0.0059 mmol, 
0.025 eq), (R,R)-L3 (11.3 mg, 0.0143 mmol, 0.06 eq), allyl acetate (30.8 µL, 0.2855 
mmol, 1.2 eq) and DIPEA (82.7 µL, 0.4758 mmol, 2.0 eq) at -20
0
C to provide the above 
mentioned compound as a yellow oil (59.0 mg, >99% yield). 
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1
H NMR (300 MHz, CDCl3): δ 9.89 (s, 1H), 7.22–7.10 (m, 4H), 5.73 (m, 1H), 5.11 (m, 
2H), 4.30 (q, J = 7.2 Hz, 2H), 3.08 (dd, J = 6.6, 14.1 Hz, 1H), 2.88 (dd, J = 7.8, 13.8 Hz, 
1H), 1.30 (t, J = 7.1 Hz, 3H).  
Chiral HPLC: 82% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 98:02 hexane/ethanol, 0.5 mL/min, 220 nm, 13.57 min (minor), 14.36 min 
(major). 
[α]D
27
: = + 40.6
0
 (c = 0.072, EtOAc). 
Analytical data matched previously reported data.
45
 
 
Ethyl 2-(4-bromophenyl)-2-formylpent-4-enoate (13f) 
 
Racemic: General procedure for racemic Pd-catalyzed allylic alkylation reaction 
(Method 4) using hydroxyarylacrylate 10f (50.0 mg, 0.1844 mmol, 1.0 eq), Pd(PPh3)4 
(21.3 mg, 0.0184 mmol, 0.1 eq), and allyl acetate (23.9 µL, 0.2213 mmol, 1.2 eq) in 
dichloromethane (5 mL) at rt for 2h to provide the above mentioned compound as a 
yellow oil (57.0 mg, >99% yield).  
Chiral: General procedure for Pd-AAA reaction (Method 3) using hydroxyarylacrylate 
10f (50.0 mg, 0.1844 mmol, 1.0 eq), Pd2(dba)3CHCl3 (4.8 mg, 0.0046 mmol, 0.025 eq), 
(R,R)-L3 (8.7 mg, 0.0111 mmol, 0.06 eq), allyl acetate (23.9 µL, 0.2213 mmol, 1.2 eq) 
and DIPEA (64.2 µL, 0.3688 mmol, 2.0 eq) at -20
0
C to provide the above mentioned 
compound as a yellow oil (57.0 mg, >99% yield). 
126 
 
 
 
1
H NMR (300 MHz, CDCl3): δ 9.88 (s, 1H), 7.54 (d, j = 8.7, 2H), 7.13 (d, j = 8.7, 2H), 
5.73 (m, 1H), 5.11 (m, 2H), 4.28 (q, J = 7.2 Hz, 2H), 3.10 (dd, J = 6.3, 13.8 Hz, 1H), 2.86 
(dd, J = 7.8, 13.8 Hz, 1H), 1.29 (t, J = 7.1 Hz, 3H).  
13
C NMR (75 MHz, CDCl3): δ 195.9, 170.3, 134.1, 132.2, 129.1, 128.7, 128.535, 128.4, 
122.5, 119.7, 65.2, 61.9, 36.7, 14.1. 
 Chiral HPLC: 85% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 98:02 hexane/ethanol, 0.5 mL/min, 220 nm, 14.89 min (minor), 15.96 min 
(major). 
[α]D
27
: = + 78.3
0
 (c = 0.058, EtOAc). 
HRMS (ESI): Calculated (m/z) for C14H16O3Br (M+H)
+
 : 311.0283, Found 311.0274. 
 
Ethyl 2-formyl-2-(4-nitrophenyl)pent-4-enoate (13g) 
 
Racemic: General procedure for racemic Pd-catalyzed allylic alkylation reaction 
(Method 4) using hydroxyarylacrylate 10g (50.0 mg, 0.2108 mmol, 1.0 eq), Pd(PPh3)4 
(24.3 mg, 0.0211 mmol, 0.1 eq), and allyl acetate (27.3 µL, 0.2530 mmol, 1.2 eq) in 
dichloromethane (5 mL) at rt for 2h to provide the above mentioned compound as a 
yellow oil (58.0 mg, >99% yield).  
Chiral: General procedure for Pd-AAA reaction (Method 3) using hydroxyarylacrylate 
10g (50.0 mg, 0.2108 mmol , 1.0 eq), Pd2(dba)3CHCl3 (5.4 mg, 0.0053 mmol, 0.025 eq), 
(R,R)-L3 (10.0 mg, 0.0126 mmol, 0.06 eq), and allyl acetate (27.3 µL, 0.2530 mmol, 1.2 
eq) at -20
0
C to provide the above mentioned compound as a yellow oil (58.0 mg, >99% 
yield). 
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1
H NMR (300 MHz, CDCl3): δ 9.93 (s, 1H), 8.26 (d, j = 8.7, 2H), 7.45 (d, j = 8.7, 2H), 
5.72 (m, 1H), 5.14 (m, 2H), 4.32 (q, J = 7.2 Hz, 2H), 3.10 (dd, J = 6.3, 13.8 Hz, 1H), 2.97 
(dd, J = 8.1, 13.8 Hz, 1H), 1.30 (t, J = 7.2 Hz, 3H).  
13
C NMR (75 MHz, CDCl3): δ 195.4, 169.7, 147.5, 142.1, 131.5, 128.7, 124.0, 120.3, 
65.6, 62.4, 37.2, 14.0. 
Chiral HPLC: 90% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 1.24:0.01 hexane/ethanol, 1.25 mL/min, 220 nm, 22.85 min (minor), 24.01 min 
(major). 
[α]D
27
: = + 72.5
0
 (c = 0.072, EtOAc). 
HRMS (ESI): Calculated (m/z) for C13H14NO4 (M-H)
+
 : 248.0923, Found 248.0922.  
 
Ethyl 2-formyl-2-(naphthalen-2-yl)pent-4-enoate (13h) 
 
Racemic: General procedure for racemic Pd-catalyzed allylic alkylation reaction 
(Method 4) using hydroxyarylacrylate 3h (50.0 mg, 0.2064 mmol, 1.0 eq), Pd(PPh3)4 
(23.8 mg, 0.0206 mmol, 0.1 eq), and allyl acetate (26.7 µL, 0.3121 mmol, 1.2 eq) in 
dichloromethane (5 mL) at rt for 5h to provide the above mentioned compound as a 
yellow solid (57.8 mg, >99% yield).  
Chiral: General procedure for Pd-AAA reaction (Method 3) using hydroxyarylacrylate 
3h (50.0 mg, 0.2064 mmol, 1.0 eq), Pd2(dba)3CHCl3 (5.3 mg, 0.0052 mmol, 0.025 eq), 
(R,R)-L3 (9.8 mg, 0.0124 mmol, 0.06 eq), allyl acetate (26.7 µL, 0.3121 mmol, 1.2 eq) 
and DIPEA (71.9 µL, 0.4128 mmol, 2.0 eq) at -20
0
C to provide the above mentioned 
compound as a yellow solid (57.8 mg, >99% yield). 
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1
H NMR (300 MHz, CDCl3): δ 10.02 (s, 1H), 7.91–7.34 (m, 7H), 5.82 (m, 1H), 5.19 (d, 
J = 18 Hz, 1H), 5.13 (d, J = 9.9 Hz, 1H), 4.35 (q, J = 7.1 Hz, 2H), 3.25 (dd, J = 6.3, 13.8 
Hz, 1H), 3.01 (dd, J = 8.1, 13.8 Hz, 1H), 1.31 (t, J = 7.1 Hz, 3H).  
13
C NMR (75 MHz, CDCl3): δ 196.4, 170.8, 133.3, 132.7, 132.4, 128.9, 128.4, 128.2, 
127.6, 126.8, 126.7, 126.6, 124.7, 119.3, 65.8, 61.8, 36.8, 14.1. 
Chiral HPLC: 83% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 98:02 hexane/ethanol, 0.5 mL/min, 220 nm, 28.06 min (minor), 32.98 min 
(major). 
[α]D
27
: = + 48.5
0
 (c = 0.067, EtOAc). 
HRMS (ESI): Calculated (m/z) for C18H19O3 (M+H)
+
 : 283.1328, Found 283.1360.  
 
Ethyl 2-formyl-2-(furan-2-yl)pent-4-enoate (13i) 
 
Racemic: General procedure for racemic Pd-catalyzed allylic alkylation reaction 
(Method 4) using hydroxyarylacrylate 10i (50.0 mg, 0.2745 mmol, 1.0 eq), Pd(PPh3)4 
(31.7 mg, 0.0275 mmol, 0.1 eq), and allyl acetate (35.6 µL, 0.3294 mmol, 1.2 eq) in 
dichloromethane (5 mL) at rt for 2h to provide the above mentioned compound as a 
brownish yellow oil (60.5 mg, >99% yield).  
Chiral: General procedure for Pd-AAA reaction (Method 3) using hydroxyarylacrylate 
10i (50.0 mg, 0.2745 mmol, 1.0 eq), Pd2(dba)3CHCl3 (7.1 mg, 0.0069 mmol, 0.025 eq), 
(R,R)-L3 (13.0 mg, 0.0165 mmol, 0.06 eq), and allyl acetate (35.6 µL, 0.3294 mmol, 1.2 
eq) at -20
0
C to provide the above mentioned compound as a brownish yellow oil (60.5 
mg, >99% yield). 
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1
H NMR (300 MHz, CDCl3): δ 9.81 (s, 1H), 7.44 (s, 1H), 6.40 (d, j = 4.8, 2H), 5.72 (m, 
1H), 5.17 (d, J = 1.2 Hz, 1H), 5.08 (d, J = 10.8 Hz, 1H), 4.27 (q, J = 7.2 Hz, 2H), 3.03 
(dd, J = 7.2, 14.1 Hz, 1H), 2.93 (dd, J = 7.5, 14.1 Hz, 1H), 1.28 (t, J = 7.1 Hz, 3H).  
13
C NMR (75 MHz, CDCl3): δ 193.8, 168.4, 148.3, 143.2, 132.0, 119.4, 110.7, 109.3, 
62.5, 62.0, 35.6, 14.1. 
 [α]D
27
: = + 56.0
0
 (c = 0.089, EtOAc). 
HRMS (ESI): Calculated (m/z) for C12H15O4 (M+H)
+
 : 223.0970, Found 223.0943.  
 
Procedure for the reduction of ethyl 2-formyl-2-(furan-2-yl)pent-4-enoate (13i) to ethyl 
2-(furan-2-yl)-2-(hydroxymethyl)pent-4-enoate (13′i) 
 
 
 
To a 50 mL round bottom flask with 13i (150.0 mg, 0.6750 mmol, 1.0 eq) was charged 
with MeOH (25 mL) and cooled to 0°C. Next, NaBH4 (127.0 mg, 3.3750 mmol, 5.0 eq) 
were added as a solid and let the mixture stir for 2h.  The reaction was quenched with 
H2O (15 mL) at 0°C and then was extracted three times with dichloromethane. The 
organic layer was washed with brine, then dried over anhydrous Na2SO4, and 
concentrated in vacuo. Column chromatography on silica gel with 9:1 hexane: EtOAc 
provided 122 mg (82% yield) of the reduced quaternary alcohol product 13′i as a yellow 
oil. 
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1
H NMR (300 MHz, CDCl3): δ (ppm) 7.39 (s, 1H), 6.36(m, 1H), 6.31 (d, j = 3.3 Hz, 
1H), 5.71 (m, 1H), 5.16 (d, J = 19.5 Hz, 1H), 5.12 (d, J = 11.1 Hz, 1H), 4.24 (q, j = 7.2 
Hz,  2H), 4.04 (q, j = 11.4 Hz, 2H), 2.83 (d, j = 7.2 Hz, 2H), 2.07 (s, 1H), 1.27 (t, j = 7.2 
Hz, 3H).  
13
C NMR (75 MHz, CDCl3): δ 172.5, 152.7, 141.9, 132.8, 118.9, 110.2, 107.6, 64.9, 
61.4, 53.2, 37.1, 14.1. 
Chiral HPLC: 75% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 99:01 hexane/ethanol, 1.0 mL/min, 210 nm, 14.51 min (minor), 15.97 min 
(major). 
[α]D
27
: = - 5.0
0
 (c = 0.036, EtOAc). 
HRMS (ESI): Calculated (m/z) for C12H17O4 (M+H)
+
 : 225.1127, Found 225.1110. 
 
Ethyl 2-acetyl-2-phenylpent-4-enoate (20) 
 
Racemic: General procedure for racemic Pd-catalyzed allylic alkylation reaction 
(Method 4) using hydroxyarylacrylate 19 (50.0 mg, 0.2424 mmol, 1.0 eq), Pd(PPh3)4 
(28.0 mg, 0.0242 mmol, 0.1 eq), allyl acetate (31.4 µL, 0.2909 mmol, 1.2 eq) and KOtBu 
(32.6 mg, 0.2909 mmol, 1.2 eq) in dichloromethane (5 mL) at rt for 5h to provide the 
above mentioned compound as a yellow oil (58.0 mg, 97% yield).  
Chiral: General procedure for Pd-AAA (Method 2) reaction using hydroxyarylacrylate 
19 (25.0 mg, 0.1212 mmol, 1.0 equivalent), Pd2(dba)3CHCl3 (3.1 mg, 0.0030 mmol, 
0.025 equivalent), (R,R)-L3 (5.7 mg, 0.0073 mmol, 0.06 equivalent), allyl acetate (15.7 
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µL, 0.1454 mmol, 1.2 equivalent) and KOtBu (16.3 mg, 0.1454 mmol, 1.2 eq) at -10
0
C to 
provide the above mentioned compound as a yellow oil (29.0 mg, 97% Yield). 
1
H NMR (300 MHz, CDCl3): δ 7.35–7.28 (m, 5H), 5.75 (m, 1H), 5.01 (m, 2H), 4.27 (q, 
J = 6.0 Hz, 2H), 3.10 (dd, J = 6.3, 13.8 Hz, 1H), 2.86 (dd, J = 7.8, 13.8 Hz, 1H), 2.07 (s, 
3H), 1.27 (t, J = 9.0 Hz, 3H).  
13
C NMR (75 MHz, CDCl3): δ 203.0, 170.5, 136.9, 133.5, 129.3, 128.8, 128.4, 127.9, 
127.7, 118.4, 68.8, 61.4, 39.8, 28.7, 14.1. 
 Chiral HPLC: 52% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 99:01 hexane/iPA, 1.0 mL/min, 210 nm, 9.70 min (major), 11.07 min (minor). 
HRMS (ESI): Calculated (m/z) for C15H18O3 (M+H)
+
 : 247.1329, Found 247.1333. 
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CHAPTER 3: APPLICATION TO THE SYNTHESIS OF 3,3′-DISUBSTITUTED 
OXINDOLE AND α-DISUBSTITUTED QUATERNARY β-LACTONE 
FRAMEWORKS 
 
3.1. 3,3′-disubstituted oxindole frameworks in medicinal chemistry 
 
3,3′-disubstituted oxindole framework is one of the most classic and privileged 
heterocyclic motif that is present in a large family of bioactive natural products and 
pharmaceutically active compounds (Figure 17).
112
 Horsfiline is an oxindole alkaloid 
found in the plant Horsfieldia superba and was first isolated in 1991 by Bodo and co-
workers.
106c
 It has analgesic effects. It is also active against human breast cancer cells. 
Coerulescine, an analog of horsfiline, has a moderate local anesthetic effect. Elacomine is 
naturally occurring hemiterpene spirooxindole alkaloids isolated from the root of a shrub 
Elaeagnus commutata.
113
 It showed cell cycle inhibition activities and is known as tumor 
suppressor. Rychnophyllin is another antineoplastic agent. Rhynchophylline is found in 
Uncaria rhynchophylla, native to Thailand.  It is a non-competitive NMDA antagonist 
and calcium channel blocker.
114
 Sprotryprostatins are indole alkaloids from 
diketopiperazine class of natural products. It is found in a fungus, Aspergillus fumigatus. 
They are microtubule inhibitor and prevent cell division by mytosis. Recently, they have 
attracted a lot of attention as anti-cancer drug.
115
 Maremycin A and B are first sulfur-
containing diketopiperazine oxindole alkaloids isolated from the culture broth of marine 
bacteria, Streptomyces.
116
 Donaxaridine was isolated from the giant reed plant Arundo 
donax, is a secondary metabolites used by the plant in response to microorganism.
117
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Dioxibrassinine is another sulfur-containing oxindole alkaloid. In addition, the 3,3′-
disubstituted oxindole scaffold is part of pharmaceutically active compounds, such as 
AG-041R, which is a potent gastrin/CCK-B receptor antagonist.
118
 
 
Figure 17. Representative natural products and bioactive compounds with the 3,3′-
disubstituted oxindole framework. 
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3.1.1. General considerations on the asymmetric synthesis of 3,3′-disubstituted oxindole 
 
The frequent presence of 3,3′-disubstituted oxindole in natural products, drugs, and 
related analogs has initiated investigantions into its formation by asymmetric synthesis. 
The goal has been to synthesize enough material of the desired natural products and 
related analogs to enable biological evaluation, studies on structure-activity relationships, 
and eventual development of new therapeutic agents. 
 
As we know, it is very challenging to asymmetrically synthesize compounds containing 
tetrasubstituted carbon stereocenters. It’s even more difficult to synthesize 3,3′-
disubstituted oxindoles due to the presence of multiple tetrasubstituted carbon 
stereocenters, including all-carbon or heteroatom-containing ones. These challenges 
provided an ideal testing ground for organic chemists to develop new catalytic synthetic 
methodologies. 
 
A number of catalytic enantioselective methods have been developed to synthesize the 
tetrasubstituted carbon at the C-3 position of the oxindole framework, which could be 
classified into the following categories by the substrates employed: (a) nucleophilic 
additions to isatins; (b) direct functionalization of 3-substituted oxindoles; (c) 
intramolecular coupling reactions; (d) reactions based on O-substituted oxindoles; (e) 
methyleneindolinones as substrates; and (f) oxindoles as electrophiles (Scheme 68).
119
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Scheme 68. Synthetic strategies for the catalytic asymmetric synthesis of 3,3′-
disubstituted oxindoles. 
 
Using 3-prochiral oxindoles as nucleophile to react with a variety of electrophiles and 
thereby constructing tetrasubstituted carbon stereocenter at the C-3 position is one of the 
most versatile methodology. This allows the synthesis of the desired tetrasubstituted 
carbon stereocenter with all carbon substituents as well as with a heteroatom substituent.  
 
The pKa value is one of essential charcateristics of a pseudo-prochiral oxindole that is 
crucial for the functionalization at C-3 position. The pKa of unsubstituted oxindole is 
18.2. However, it changes substantially depending on the substituents. The higher the pKa 
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value, the stronger the bases is needed to activate the prochiral oxindole by 
deprotonation. While alkyl substituents in C-3 position and N-protecting groups increase 
the pKa substantially to as much as 18.5, acetyl protecting groups for nitrogen in 
oxindoles decreases it significantly from 18.2 to 13 (Figure 18). Considering this, a 
number of current methods employ N-Boc-3-substituted oxindoles as starting material, 
due to (1) suitable pKa value for efficient activation by deprotonation; (2) bidentate 
coordination of the substrate to a chiral metal complex as well as the necessity of bulkier 
group for better enantioselectivity (Figure 18). Moreover, it is still very challenging to 
construct the desired quaternary carbon stereocenter at C-3 position from N-unprotected 
oxindole. 
 
Figure 18. pKa values of protected and unprotected oxindoles. 
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3.1.2. Recent advances in asymmetric synthesis of 3,3′-disubstituted oxindole 
 
Isatin or 1H-indole-2,3-dione has been widely used as an intermediate for the synthesis of 
various oxindole compounds. It is an indole derivative, which was first synthesized by 
Erdmann
120
 and Laurent
121
 in 1840 as a product of the oxidation of indigo dye. It has 
been isolated from many plants as well, such as Isatis tinctoria, Calanthe 
discolor and Couroupita guianensis.
112e
  
 
In 2009, Shibasaki and co-workers
122
 reported the alkenylation and arylation of isatins 
using silicon-based nucleophiles to produce biologically relevant 3-aryl-3-hydroxy-2-
oxindoles. The reaction was performed with copper catalyst. The group found that the use 
of bulkier protecting group influence the enantioselectivity greatly and finally, di(p-
methoxyphenyl)phenylmethyl (DMTr) as protecting group afforded the desired product 
with as much as 97% ee. The addition of ZnF2 was used to accelerate the reaction and 
eventually, 3 equivalents relative to the copper catalyst was found to be optimal (Scheme 
69). 
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Scheme 69. Synthesis of 3,3′-disubstituted oxindole by arylation and alkenylation of 
isatins. 
 
Direct cross-aldol reaction of donor carbonyl compounds with highly reactive isatins in 
the presence of chiral enamine catalyst has become another facile method for the 
construction of 3,3′-disubstituted oxindole ring. Toru and co-workers123 published an 
excellent research that described a L-proline based bifunctional catalyst promoting the 
reaction between acetone and isatins affording the desired product with high yield and ee. 
Soon this method was applied to the total synthesis of (R)-convolutamydine A using 4.6-
dibromoisatin as starting material by the same group with 98% yield and 97% ee 
(Scheme 70). 
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Scheme 70. Aldolization of acetone to isatins and synthesis of (R)-convolutamydine A. 
 
Later in 2009, Wang and co-workers
124
 reported the cross-aldol reaction of isatins with α-
branched aldehydes to synthesize two vicinal quaternary centered 3-substituted 2-
hydroxyindol-2-ones with high enantioselectivity. This time, (S)-Pyrrolidine-tetrazole 
was used as a catalyst (Scheme 71).  
 
 
 
Scheme 71. The aldolization of α-substituted aldehydes and isatins. 
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3-substituted-3-amino-2-oxindoles, which is also a privileged core structure of a variety 
of natural products and biologically active compounds,
125
 have also been producted from 
isatin imines. Isatine imines are one of the most effective precursors to the synthesis of 3-
substituted-3-amino-2-oxindoles due to its ability to accept addition of nucleophile 
enantioselectively by various nucleophilic addition reactions.
126
 
 
Recently in 2015, Feng and co-workers
127
 reported the reaction of silyl ketene imines 
with isatin imines by Mannich reaction using N,N′-dioxide/Zn(II) as organocatalyst. The 
reaction produced a variety of β-amino nitriles containing vicinal tetrasubstituted 
stereocenters in excellent yield (upto 98%) with dr upto >19:1 and with excellent 
enantioselectivity ranging from 91 – 99% ee (Scheme 72). Then the desired product was 
efficiently transformed to 1,3-diamine and β-amino amide, which is similar to the potent 
gastrin/CCK-B receptor antagonist AG-041R (see Figure 16). 
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Scheme 72. Enantioselective Mannich reaction of silyl ketene imines with isatin imine. 
 
In 2014, Arai and co-workers
128
 reported the exciting reaction of nitroalkanes with isatin 
imine using chiral Ni (II) as catalyst. Bis(imidazoline)pyridine was used as chiral ligand. 
The desired product, 3-amino-2-oxindole was isolated with excellent yield and 
enantioselectivity. To demonstrate the synthetic ability of the method, they showed the 
reduction of nitro group as well as the deprotection of Boc group yielding desired product 
without loss of ee. They also went on to propose transition state where pyridine-NiCl2 
complex acts as Lewis acid and activates the ketimines through nickel coordination by 
lone pair on nitrogen in isatin imine. Then this activated isatin imine is attacked by 
nitronate carbanion (Scheme 73). 
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Scheme 73. Bis(imidazoline)pyridine-NiCl2 catalyzed asymmetric reaction of 
nitroalkanes with isatin imine. 
 
Wong and co-workers
129
 reported the first enantioselective catalytic alkylation of 3-
prochiral oxindole to produce the C-3 quaternary stereocenter in 1991. They have used 
phase-transfer catalytic (PTC) conditions employing chinchona based PTC catalyst 
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(Scheme 74). Employing this methodology, they have demonstrated the synthesis of (−)-
esermethole which is a known intermediate in the synthesis of (+)-physostigmine. 
 
 
Scheme 74. PTC-catalyzed alkylation of oxindole. 
 
Then in 2005, Trost and co-workers
130
 reported asymmetric allylic alkylation reaction of 
3-aryl oxindoles using Pd as catalyst (Pd-AAA). The reaction afforded very high ee 
(Scheme 75). 
 
 
Scheme 75. Pd-AAA of 3-aryloxindoles. 
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As a continuation, in 2006, the same group reported the use of aldehyde and ester 
substituents in the C-3 position of oxindole as nucleophiles for Pd-AAA reaction.
131
 
While the product from the AAA reaction of 3-aldehyde substituted oxindole with allyl 
acetate was unstable to purification and providing deformylated product in the end 
(Scheme 76), the reaction with ester-substituted oxindole yielding desired product with 
high yield and ee (Scheme 77).  They went on to synthesize natural product Horsfiline to 
show the application of this methodology. 
 
 
 
Scheme 76. Deformylation of the initial Pd-AAA aldehyde adduct. 
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Scheme 77. Pd-AAA reaction of 3-esteroxindole and its application. 
 
Soon, the same group reported that molybdenum provided better enantioselectivity 
compare to palladium as a catalyst in asymmetric allylic alkylation reaction of 3-alkyl 
substituted oxindoles. They argued that molybdenum goes through inner-sphere 
mechanism of coordination unlike palladium that undergoes predominantly outer-sphere 
mechanism. It was the first time molybdenum was used as a catalyst in AAA reaction 
which produced a number of 3-allyl-3-alkyloxindoles with good to excellent yield and 
enantioselectivity (Scheme 78).
106g
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Scheme 78. Mo-AAA of 3-alkyloxindole. 
 
Later in 2011, the same research group demonstrated this Mo-AAA reaction of 3-
alkyloxindoles to synthesize biologically active (−)-physostigmine and (−)-phenserine, as 
well as ent-(−)-debromoflustramine B.106n 
 
This Mo-AAA reaction is not limited to the 3-alkyl substituted oxindoles, as the reaction 
has been successfully employed with 3-aryloxindoles as substrate as well. A series of 3-
allyl-3-aryloxindoles containing vicinal quaternary and tertiary stereogenic centers have 
been synthesized by Mo-AAA reaction using substituted allyl electrophiles. The reaction 
provided branched product as the major product with excellent dr and ee (Scheme 79).
132
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Scheme 79. The catalytic asymmetric construction of vicinal quaternary and tertiary 
chiral centers via Mo-AAA of 3-aryloxindoles. 
 
Trost et al also used Pd-AAA reaction with 3-aryl substituted oxindole.
133
 This time they 
have used allylidene dipivalate as allyl source to construct a useful allyl enol pivalate 
product with high yield and enantioselectivity. The reaction favored linear over branched 
product. Later, in order to show the utility of this enantiorich enol pivalate product, 
desired aldehyde has been produced by treating it with methanolic KOH. The reaction 
showed very clean aldehyde product without the formation of competitive aldol or retro-
Michael products.  In addition, the catalytic hydrogenation of the product ally enol 
pivalate has been carried out which provided functionalized protected alcohol in good 
yield (Scheme 80). 
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Scheme 80. Pd-AAA of 3-aryloxindoles with allylidene dipivalate. 
 
Recently in 2015, Kesavan and co-workers
134
 synthesized enantiorich 3-allyl-3-
hydroxyoxindoles from 3-OBoc oxindole using tartrate drived bis(oxazoline) as a ligand. 
The reaction produced the desired product with high enantio- and diastereoselectivity. 
Using the methodology, they demonstrated the application by synthesizing a 
spirooxindole comprising a 3,2′-tetrahydrofuran moiety which is an important anticancer 
drug candidate (Scheme 81).
135
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Scheme 81. Synthesis of 3-allyl-3-hydroxyoxindoles from 3-OBoc oxindole and the 
application of the reaction. 
 
Intramolecular Heck reaction has been brilliantly applied by Overman and co-workers
136, 
61b
 to synthesize 3,3′-disubstituted oxindole framework. The reaction employed (Z)-2-
butenanilide as starting material and Pd (0) as catalyst. After investigating the reaction for 
optimum conditions, they found that 20 mol% of a BINAP derived chiral palladium 
catalyst, in addition to PMP as an additive, yielded the desired product with good yield 
and up to 95% ee. This methodology was then applied to synthesize biologically active 
natural product, (−)-physostigmine (Scheme 82). However, as is always the case, the 
limitation of this intramolecular coupling reaction is that it requires highly specialized 
substrate to produce quaternary stereocenter at C-3 position of oxindole. 
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Scheme 82. Synthesis of 3,3′-disubstituted oxindole via intramolecular Heck cyclization 
and total synthesis of (−)-physostigmine. 
 
3.1.3. Palladium vs. Molybdenum in AAA 
 
Molybdenum is claimed to be better in some cases for inducing enantiodiscrimination 
compared to palladium in AAA reaction.
106n
 Trost argues that it is because of the ability 
of molybdenum to go through inner-sphere mechanism of coordination of nucleophile to 
the metal instead of palladium where outer-sphere mechanism is more prominent 
(Scheme 83). The catalytic cycle for the transition-metal-catalyzed AAA reaction of 
prochiral nucleophiles is as follows: coplexation of the olefin to the metal, ionization of 
the metal to generate π-allylmetal complex, alkylation of the nucleophilic substrate, and 
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finally decomplexation to regenerate the catalyst by dissociation of the olefinic double 
bond of the allylic product from the metal. The chiral induction at the nucleophile 
depends on the step where the nucleophile attacks the π-allylmetal complex. There are 
two possible mechanisms for this step: outer-sphere mechanism and inner-sphere 
mechanism. An outer sphere mechanism is where an SN2 attack of the nucleophile to one 
of the terminal carbons of the allyl group of the π-allylmetal complex takes place. 
Palladium is assumed to go through AAA reaction by this mechanism. In this 
mechanism, the alkylation steps occurs outside of the coordination sphere of the metal 
since the nucleophile is not inside the chiral environment created by the chiral ligand but 
it’s approaching towards it from outside. Hence, high enantioselectivity is difficult to 
achieve with palladium as catalyst under standard reaction conditions. On the other hand, 
molybdenum, by being electron deficient compare to palladium, it sees nucleophile as an 
electron source or in other words, ligand. As a consequence, the nucleophile pre-
coordinates to the metal first and subsequent reductive elimination provides the product. 
Due to this pre-coordination, the nucleophile in under the total influence of the chiral 
ligand before performing the reductive elimination step, which is enantioselectivity 
determining in the inner-sphere process. The inner-sphere process places the nucleophile 
and the chiral ligand in close proximity, and thereby, should provide more opportunity 
for enantiodiscrimination. 
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Scheme 83. Outer-sphere and inner-sphere mechanism of transition-metal-catalyzed 
AAA.  
 
3.1.4. Catalytic enantioselective total synthesis of Coerulescine and Horsfiline 
 
Coerulescine and Horsfiline are spirooxindole alkaloids. Horsfiline was first isolated by 
Bodo and co-workers
106c
 in 1991 from Horsfieldia superba and Coerulescine was by 
Willing and co-workers
137
 in 1998 from the blue canary grass Phalaris coerulescens 
(Figure 19). The spirocyclic oxindoles have showed a variety of biological activities; for 
instance, anticancer activities,
138
 contraceptive activities,
139
 and antimigraine activity.
140
 
Due to such diverse activities, spirooxindole alkaloids have become attractive targets in 
medicinal chemistry and drug discovery.
112a
 Coerulescine and Horsfiline, the simplest 
molecules of this alkaloid family, have also garnered attentions to synthetic chemists. 
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Even though several reports
141
 have been publish to synthesize racemic Coerulescine and 
Horsfiline, the asymmetric version of the synthesis of both of these compounds is very 
rare. There is only one report,
142
 to the best of my knowledge, for the synthesis of 
enantiorich Coerulescine and six reports
133, 142, 143
 for enantioselective synthesis of 
Horsfiline have been published to date. 
 
Figure 19. Coerulescine and Horsfiline 
 
 
 
Recently, in 2014, Hayashi and co-workers
142
 reported the three one-pot enantioselective 
synthesis of both (−)-coerulescine 21 and (−)-horsfiline 22 (Scheme 84). A one-pot 
method is effective and economical because it avoids several purification processes and 
thereby, minimizes the use of chemicals and decreases the total production time as well 
as cost. The two key reactions in this total synthesis was (1) the synthesis of a 2-
oxoindoline-3-ylidene acetaldehyde from acetaldehyde and an isatin derivative by aldol 
reaction, (2) the organocatalytic asymmetric Michael addition of nitromethane to the 2-
oxoindoline-3-ylidene acetaldehyde to construct all-carbon quaternary stereogentic 
center. 
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The first step of the synthesis was to employ an aldol reaction of acetaldehyde with the 
isatin derivatives, followed by dehydration yielding 2-oxoindoline-3-ylidene 
acetaldehydes as E/Z isomeric mixtures in excellent yields. The catalytic enantioselective 
conjugate addition of these aldehydes with nitromethane provided desired quaternary 
stereocenters with excellent ee. Very simple chiral diarylprolinol silyl ether has been 
employed as a catalyst to induce enantioselectivity. Next, Zn/AcOH, and water were 
introducted to the same reaction vessel to reduce the nitro group into an amine. This 
amine, at the same time, provided an intramolecular reductive amination to afford the 
pyrolidino spirocycles. Then the reaction mixture was introduced with formaldehyde to 
install methyl group on nitrogen by an intermolecular reductive amination. These four 
steps starting from the formation of quaternary centers have been performed in the same 
vessel. Deprotection of the benzyl group performed under Birch condition provided 
desired (R)-coerulescine 21 and (R)-horsfiline 22 with overall 46% and 33% yield; and 
94% and 95% ee respectively. 
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Scheme 84. Three one-pot sequential syntheses of (R)-coerulescine 21 and (R)-horsfiline 
22. 
 
In another research in 2005, Trost and co-workers
133
 synthesized (+)-horsfiline 22 with 
moderate yield and enantioselectivity (Scheme 85). They have used both O- and N-
protected and 3-ester substituted prochiral oxindole as substrate. This unique substrate 
has been prepared by four steps. In the first step, p-anisidine was refluxed with 2,4-
dimethoxybenzaldehyde in toluene followed by reduction of the intermediate imine 
adduct with sodium borohydride in methanol resulted quantitative yield of the desired 
amine. Then acylation was carried out in the presence of triethylamine with the acid 
chloride derivative of ethyl diazoacetate afforded amide with 90% yield. The subsequent 
C−H insertion of amide using Rh2(CF3CONH2)4 as catalyst provided desired oxindole 
product. The protection of oxindole was performed with TIPSOTf which yielded 3-ester 
substituted and both O- and N-protected prochiral oxindole in 79-86% yield. With the 
desired substrate in hand, next step was to perform Pd-AAA reaction to introduce allyl 
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group on C-3 position of the oxindole. After thorough optimization studies, 1 mol% 
[Pd(C2H5Cl)]2 with 3% chiral DACH pheny Trost ligand, L2 in the presence of 15% 
TBAT as an additive was found to be the best which provided as much as 84% ee and 
96% yield of the desired 3,3′-disubstituted oxindole product. Then, oxidative cleavage of 
the allyl group was performed by catalytic osmium tetraoxide and N-methylmorpholine 
N-oxide (NMO) followed by cleavage of the diol by lead tetraacetate in dichloromethane 
yielded the aldehyde in 97% yield. The subsequent reductive amination of this aldehyde 
ensued the β-lactam product in 65% yield. Then deprotection of the benzyl group from 
oxindol nitrogen was performed with 60% yield by refluxing with DDQ. Once 
deprotected β-lactam was formed, only step remained was chemoselective reduction 
which proved to be a difficult challenge. A suitable reducing agent was needed which 
would have the ability to successfully differentiate the two amides in lactam. After 
rigorous optimization studies, it was found that the addition of enough amount of 
trityllithium just to completely deprotonate the secondary amide followed by the addition 
of 2 hydride equivalent of the LAH solution at 0 ˚C provided the best result in terms of 
yield (45%) of (+)-horsfiline 22. This catalytic enantioselective total synthesis of 
horsfiline required eight steps and the overall yield was 11.1%.  
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Scheme 85. Catalytic enantioselective synthesis of horsfiline 22. 
 
3.2. α-disubstituted β-lactone frameworks in medicinal chemistry 
 
β-lactones have shown great potential as an important synthetic target due to their 
frequent presence in variety of bioactive natural products (Figure 20),
144
 their all-around 
usefulness as synthetic intermediate to more complex structure,
145
 and their utility as 
monomer in the synthesis of biodegradable polymers.
146
 Tetrahydrolypstatin inhibits 
pancreatic lipase enzyme. It is a water-soluble enzyme secreted by the pancreas. One of 
the primary tasks of pancreatic lipase is to break down lipids and dietary fats via 
hydrolysis by breaking hydrogen bonds. This is critical since lipids and fats cannot be 
absorbed through the intestinal lining without undergoing hydrolysis first. 
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Tetrahydrolypstatin is an FDA approved drug for treating obesity, a new global health 
problem. Vittatalactone is a pheromone released by striped cucumber beetle. It is a 
serious pest of curcurbit crops in North America. These beetles aggregate in numbers and 
feed on young crops during springs, causing serious damage. A field study suggested that 
these beetles generate a hormone that contains vittatalactone to direct them to aggregate 
in great numbers. Ebelactones and belactosin C are human fatty acid synthase (FAS) 
inhibitor. FAS is attracting huge attention in carcer drug reseach due to the fact that it is 
up-regulated in most solid tumors, including breast,
147
 prostate,
148
 and ovary.
149
 
Moreover, studies indicated the pharmacologic blockade of this enzyme can be cytostatic 
and cytotoxic to cancer cells.
150
 Marizomib is a phase one clinical candidate for cancer. 
Lactacystin-β-lactone which is an analog of marizomib showed great potential as well. 
Compound 23 and 24 inhibit caseinolytic protein protease (ClpP) enzyme. ClpP, a 
phylogenetically highly conserved serine protease, was found to be instrumental in 
producing virulence by many bacterial pathogens. Recent study showed the inhibition of 
this enzyme by 23 and 24 in Staphylococcus aureus significantly attenuated their 
capability to produce virulence factors such as life threating toxins.
151
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Figure 20. Representative natural products and bioactive compounds containg β-lactone 
moiety. 
 
 
 
3.2.1. Recent advances in the asymmetric synthesis of β-lactones 
 
 The first enantioselective synthesis of β-lactones was reported by Wynberg and co-
workers
152
 in 1985. Quinine and quinidine has been studied as chiral inducing catalyst. 
Quinidine provided better ee compared to quinine. In the reaction, chlorinated aldehydes 
and ketones are employed in the presence of quinidine as catalyst which yielded chiral β-
lactones with as much as 98% ee (Scheme 86). 
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Scheme 86. First example of the synthesis of asymmetric β-lactone. 
 
Since then, a large number of researches have been published to synthesize β-lactones 
asymmetrically employing ketene as starting material along with aldehydes for [2+2] 
cycloaddition reaction.
153
 Various kinds of catalysts has been used, among which chiral 
Lewis acids,
154
 Lewis acids in combination with nucleophilic catalysis,
155
 and chiral 
Lewis bases, such as, cinchona alkaloids,
156
 planar chiral ferrocenylamine catalysts,
157
 
chiral N-heterocyclic carbines,
158
 and chiral phosphines
159
 are notable. 
 
161 
 
 
 
Recently in 2014, Feng and co-workers
160
 reported the highly diastereo- and 
enantioselective [2+2] cycloadditions of disubstituted ketenes employing modular chiral 
Lewis acid N,N′-dioxide-metal complex as catalyst (Scheme 87). A series of 
arylalkylketenes reacted with isatins yielding optically active β-lactones with vicinal 
chiral centers in excellent yields (up to 99%) and enantioselectivities (up to 99%). To 
demonstrate the synthetic values of the reactions, one of the β-lactones has been 
transformed to highly substituted 3-hydroxyindolinone containing two quaternary centers 
through ring-opening by introducing benzylamine. 
 
 
Scheme 87. Asymmetric synthesis of β-lactones by chiral Lewis acid catalyst. 
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Nucleophilic quinidine catalyst has employed along with innovative use of Mukaiyama 
reagent by Romo and co-workers
161
 in the following nucleophile-catalyzed aldol 
lactonization (NCAL) reaction to synthesize enantioselective bicylic-β-lactones (Scheme 
88). Mukaiyama reagent is widely used for the activation of carboxylic acids to provide 
esters, amides, or lactones.
162
 The introduction of this reagent in the reaction led to 
increased conversion and efficiency (70-82% yield) with shorter reaction time. The 
reaction provided desired products with excellent enantioselectivity (91-98%). The 
proposed mechanism of this process consists the activation of carboxylic acids, 
acylammonium formation, ammonium enolate generation by deprotonation, 
intramolecular aldol reaction, rate-determining oxetane formation, and finally, 
regeneration of the nucleophilic catalyst. 
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Scheme 88. Asymmetric synthesis of bicyclic β-lactones via intramolecular, nucleophile-
catalyzed aldol lactonization. 
 
Remarkably, planar chiral DMAP and PPY derivative has also been employed as 
nucleophilic catalyst by Fu and co-workers
157
 for the asymmetric synthesis of highly 
substituted β-lactones (Scheme 89). It was the first example of the [2+2] cycloaddition of 
disubstituted ketenes. The reaction didn’t yield to β-lactones at high temperature. 
Interestingly, however, at low temperature it provided the desired product with high yield 
and ee. It has been found that this planar-chiral catalyst prefers cis-diastereomer of the β-
lactones (ca. 4.5:1 selectivity) with very good enantioselectivity (up to 91%). In order to 
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show the synthetic ability of the methodology, they went on to synthesize β-hydroxy 
carboxylic acid and β-azido carboxylic acid with high yield and ee. 
 
 
 
Scheme 89. Asymmetric synthesis of highly substituted β-lactones by Greg Fu’s catalyst. 
 
Recently, Smith and co-workers
158d
 published NHC-catalyzed asymmetric β-lactone 
formation from arylalkylketenes and electron-deficient substituted benzaldehydes as well 
as pyridinecarboxaldehydes (Scheme 90). The reaction provided highly substituted β-
lactones with vicinal tertiary or quaternary stereocenters. In respect to benzaldehydes, 2-
nitrobenzaldehyde provided best result in terms of diastereo- and enantioselectivity (up to 
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93:7 dr and 93% ee) (Scheme 90, eq. 1). Substituted 2- and 4-pyridinecarboxaldehydes 
were tested as well in this methodology instead of benzaldehydes, yielded the desired β-
lactones in good yield and ee (Scheme 90, eq. 2). However, it has been found that the 
diastereocontrol is highly dependent on the aldehyde substituent when employing 
pyridinecarboxaldehydes. 
 
 
 
Scheme 90. NHC-promoted asymmetric β-lactone formation from arylalkylketenes and 
substituted benzaldehydes or pyridinecarboxaldehydes. 
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In 2010, Kerrigan and co-workers
159
 reported the use of chiral phosphine as catalyst to 
synthesize asymmetric all-carbon quaternary β-lactones employing arylketoketenes and 
aromatic aldehydes as starting material (Scheme 91). This [2+2] cycloaddition reaction 
provided the desired highly substituted β-lactones with high enantio- (seven examples 
with ee ≥ 90%) and diastereoselectivity (nine examples with dr ≥ 9:1). (R)-BINAPHANE 
has been employed as catalyst. This time, they showed the ability of this cycloaddition 
reaction with less reactive aromatic aldehydes which were not tolerated as substrates by 
earlier NHC catalyst system. They went on to show the synthetic utility of this reaction 
by converting the highly substituted β-lactones to synthons such as β-hydroxy carboxylic 
acids and β-azido carboxylic acids. 
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Scheme 91. Phosphene-catalyzed asymmetric synthesis of β-lactones from 
arylketoketenes and aromatic aldehydes. 
 
Transition-metals have also been employed as a catalyst for the asymmetric synthesis of 
β-lactones.163 As an example, Davies and co-workers164 recently synthesized β-lactones 
in high yield and with high levels of diastereo- and enantioselectivity using rhodium as 
catalyst (Scheme 92, 93, and 94). This reaction goes through intramolecular C-H 
insertion of aryldiazoacetate. Ortho substitution on the aryl group of aryldiazoacetate was 
found to play a crucial role on this C-H insertion reaction. The reaction was not even 
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observed when unsubstituted phenyldiazoacetate was employed. Unexpectedly, the 
reaction provided desired β-lactones with the activation of methylene C-H bonds 
(Scheme 93) as well as relatively unreactive methyl (Scheme 92) and methine (Scheme 
94) C-H bonds on ester groups. 
 
 
 
Scheme 92. Methyl C-H insertion for the formation of β-lactones by rhodium catalyst. 
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Scheme 93. Methylene C-H insertion for the formation of β-lactones by rhodium catalyst. 
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Scheme 94. Methine C-H insertion for the formation of β-lactones by rhodium catalyst. 
 
3.3. Results and discussions 
 
3.3.1. Asymmetric synthesis of 3,3′-disubstituted oxindole from 3-hydroxy-2-nitro aryl 
acrylates 
 
Now that we have got our developed methodology in hand, we wanted to show the utility 
of this Pd-AAA reaction by synthesizing 3,3′-disubstituted oxindole framework, one of 
the most previledged and classical building blocks present in a large family of bioactive 
natural products and pharmaceutical agents.   
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As shown in the retrosynthetic analysis (Scheme 95), 3,3′-disubstituted oxindole 25 and 
26 can be obtained by selective reduction of nitro group of all-carbon quaternary 
stereocenters 13j and 13k, which, in turns, are easy accessible from our Pd-AAA 
methodology employing 3-hydroxy-2-nitro aryl acrylates 10j and 10k as starting 
material. However, literature search suggested that compound 25 and 26 might not be 
easy to isolate since aldehydes on the C-3 position of oxindoles have a tendency to 
defomylate.
132
 If that is the case, we can also make the desired oxindole 29 and 30 by 
first reducing the aldehyde on 13j and 13k by NaBH4 reduction followed by reduction of 
nitro group which should close the ring. 
 
 
 
Scheme 95. Retrosynthetic analysis of 3,3′-disubstituted oxindole using our newly 
developed Pd-AAA methodology. 
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First, we wanted to subject 3-hydroxy-2-nitro-phenyl acrylate 10j to our developed Pd-
AAA methodology which should give us desired all-carbon α-aryl quaternary stereocents 
13j. We expected high yield and ee, however, only found out very poor stereoselectivity 
(6%). The yield was low as well. We also used 5-methoxy-2-nitro analog 10k with a 
hope that it might give better ee and wanted to carry on with our planned total synthesis. 
However, it too provided the desired product 13k with only slightly better 
enantioselectivity (29%), which was unsatisfactory (Scheme 96). 
 
 
Scheme 96. Pd-AAA of 10j and 10k using previously optimized conditions. 
 
Disappointed by the results, we wanted to find out whether the low enantioselectivity is 
due to the electronic or steric effect (Scheme 97). To find out if it’s electronic, we applied 
the same conditions to methoxy-substituted analog 10l at the same C-2 position on 
benzene ring, since its electron donating whereas nitro is electron withdrawing. It 
provided 13l with similar ee (10%). So, we concluded that it’s not electronic. In order to 
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prove the steric effect behind this unexpected result, we hypothesized that 2-fluoro 
analog 10m would be the best candidate since fluorine is almost similar in size compared 
to hydrogen atom and it should provide similar enantiodiscriminative selectivity 
compared to 10a (94%) if steric congestion is the reason. Thus we subjected 10m to the 
optimized condition, only to find out it too ensued similar result (7% ee). Unsatisfied by 
these results, we subjected the same reaction conditions to different analogs, namely, 2,4-
dichloro 10n, and 5-bromo-2-methoxy 10o. While 10n provided similar disappointing 
results, 10o yielded 13o with slightly better ee (21%). 
 
 
Scheme 97. Steric vs electronic effects in Pd-AAA of 10l-o. 
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Even though the results were dissatisfactory, the slight increase in ee for 13k and 13o 
provided a clue that it might be only because of the optimized condition, which is not 
good enough for ortho-substituted analogs. We just have to optimize the reaction again 
and find out a different condition for this class of analogs. 
 
First we decided to keep our previously optimized ligand fixed but vary solvent, 
temperature, and bases (Table 9). We have studied variable polarity solvents of both 
protic and aprotic classes, namely DCM, DME, ether, toluene, MeOH, EtOH, iPA, 
tBuOH, Acetonitrile, DMSO, DMF, Nitromethane, HMPA, and THF. Surprisingly we 
didn’t observe any O-allylation with any of these solvents. Conversion is always good at 
room temperature (entry 1, 2, 7, 9, 16, 17, 18, 20, and 21) and even at low temperature in 
some cases (entry 12, 13, 14, 15, and 28) without employing bases. However, for some 
cases at low temperature, base was needed to increase the conversion (entry 4 vs 3 and 5; 
22 vs 23-27). We didn’t find a patterened correlation of enantioselectivity with the 
change in polarity of solvents. For example, toluene provided 38% ee at rt (entry 9) and 
increasing the polarity seemed like decreasing ee at the beginning as with DCM and ether 
provided ony 5 and 7 %ee respectively (entry 2 and 7). Polar protic solvents did not 
provide enough ee to study further (entry 12, 13, 14, and 15). However, polar aprotic 
solvent proved to be another better class of solvents besides non-polar toluene, as among 
acetonitrile, DMSO, DMF, nitromethane, HMPA and THF (entry 16-21), HMPA 
provided 31% (entry 20) and THF provided maxiumum 41% ee at rt (entry 21). On the 
other hand, temperature does have an effect on ee in some cases (entry 2 vs 3-5; 21 vs 23-
28). We found best conditions (ee 57%) with THF at −10 ˚C (entry 27 and 28).  It seems 
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like the reaction goes to completion without any base in THF at as low as −10 ˚C without 
affecting %conversion or %ee (entry 28) because no reaction was observed at −20 ˚C in 
THF without bases (entry 22). 
 
Table 9. Optimization studies for the Pd-AAA of 3-hydroxy-2-nitro phenyl acrylate 10j. 
 
Entry Solvent Base Temp. 
[
0
C] 
Conv. 
[%] 
ee 
[%] 
1 DCM DIPEA rt 100 0 
2 DCM - rt 100 5 
3 DCM DIPEA -20 100 10 
4 DCM - -20 30 14 
5 DCM CsF -20 100 20 
6 DME - -20 55 20 
7 Ether - rt 100 7 
8 Toluene CsF -20 75 35 
9 Toluene CsF rt 100 38 
10 Toluene DIPEA -20 70 34 
11 Toluene DIPEA -10 81 36 
12 MeOH - -10 100 10 
13 EtOH - -10 100 0 
14 iPA - -10 100 24 
15 tBuOHa - -10 100 42 
16 Acetonitrile - rt 85 20 
17 DMSO - rt 100 9 
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18 DMF - rt 82 20 
19 Nitromethane - rt 100 12 
20 HMPA - rt 100 31 
21 THF - rt 100 41 
22 THF - -20 No Rxn. - 
23 THF DIPEA -20 100 53 
24 THF CsF -20 100 55 
25 THF Quinine -20 100 50 
26 THF KOtBu -20 100 45 
27 THF CsF -10 100 57 
28 THF -  -10 100 57 
a
Reaction run at room temperature. 
 
Next, we kept the solvent and temperature constant to THF and −10 ˚C that provided 
maximum 57% ee (Table 9, entry 24) and studied ligands. This time, we have employed 
four new ligands (L5-L8) along with four others (L1-L5) which have been used 
previously (Scheme 98, Table 10). Unfortunately, none of these ligands proved better 
than L3 in terms of enantioselectivity. L2 provided 46% ee (entry 2), which was the 
closest one compared to L3. L4 also provided a decent ee (38%), however, with poor 
conversion (35%) to the desired product 13j along with undesired O-allylated product 
(entry 3). Interestingly, L5, another Trost ligand that contains pydine ring instead of 
pheyl or naphthyl ring, did not give any reaction at all (entry 4). Two different ferrocenyl 
ligands L6 and L7 have also been employed, which ensued racemic product with very 
poor yield (entry 5 and 6). One BOX ligand L8 has been tried as well without much 
success (entry 7). 
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Scheme 98. Optimization of ligands for Pd-AAA of 10j. 
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Table 10. Optimization of ligands for Pd-AAA of 10j. 
Entry Ligand Conv. 
[%] 
ee 
[%] 
1 L1 80
a
 34 
2 L2 100 46 
3 L4 35
a
 38 
4 L5 - - 
5 L6 29
a
 0 
6 L7 45
a
 0 
7 L8 100 10 
a
Rest are O-allylated product. 
 
In 2008, our group
165
 published an interesting work that showed a novel RO-BH2 
intermediate with 3-hydroxy aryl acrylates 10 and BH3 at −78 ˚C by the innovative use of 
1
H{
11
B} and 
1
H{
13
C, 
11
B} NMR spectroscopy (Scheme 99). 
 
 
 
Scheme 99. Locking the Z isomer of 10 by BH3. 
 
Thus, we envisioned that the introduction of BH3 or even chiral borane (Scheme 100) can 
overcome the problem associtated with the interconversion of E and Z stereoisomers of 
10 and thereby locking one isomer over other which might be beneficial. So, we were 
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hopeful that the combined effect of chiral borane on one hand, which could lock the 
nucleophile 10 by bonding with carbony- and enolate-oxygen atoms as well as block one 
side of the enolate double bond by chiral ligand for boron (Scheme 100, Table 11) and on 
the other hand, chiral ligand for palladium to creat chiral environment around electrophile 
might be helpful in our cause. Chiral BINOL has been used as a chiral inducing agent for 
nucleophile. Both THF and toluene were tested as solvents (entry 1, 2, and 3). None was 
proved better than using L3 alone (57% ee). Without using chiral ligand L3, racemic 
product was ensued, which proved that the chiral borane was probably not binding at all 
(entry 1). 
 
 
Scheme 100. Pd-AAA reactions employing both chiral electrophile and chiral 
nucleophile. 
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Table 11. Pd-AAA reactions employing both chiral electrophile and chiral nucleophile. 
Entry Solvent Conv. 
[%] 
ee 
[%] 
1a THF 100 0 
2 THF 100 56 
3 Tol 100 45 
a
Without L3. 
 
We also employed chiral phosphoric acid as an additional chiral inducing agent along 
with/without chiral ligand L3 and L8 for palladium due to the reason explained earlier 
(see Section 2.3, Scheme 30 and 31). Allyl alcohol was used as electrophile instead of 
ally acetate. We used chiral phosphoric acid of both (R)- or (S)-Trip (Table 12). This time 
too, without any ligand, the reaction yielded racemic product (entry 1 and 2). 
Surprisingly, the reaction did not occur with the use of L8 along with (R)-Trip (entry 4). 
L3 provided 40% ee which is little lower than earlier (57%), probably due to the 
temperature (rt) of the reaction which is higher that earlier temperature (entry 3). 
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Table 12. Pd-AAA employing chiral phosphoric acid along with chiral ligand.  
 
 
Entry Ligand Solvent TRIP 
(R/S) 
Conv. 
[%] 
ee  
[%] 
1 - THF R >99 Racemic 
2 - THF S >99 Racemic 
3 L3 THF R >99 40 
4 L8 THF R 0 - 
 
Since none of these investigantions provided enantioselectivity satisfactory to us, we then 
kept L3 fixed and went on to study the effect of various additives in the reactions (Table 
13). The use of exogenous additives is a fairly common practice in asymmetric synthesis. 
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Table 13. Optimization of additives for Pd-AAA of 10j. 
 
Entry Additive
a
 Conv. 
[%] 
ee 
[%] 
1 HMPA 100 50 
2 nBu4NI
a,b
 100 0 
3 nBu4NF
a,b
 100 44 
4 1,3-Diphenylguanidine
a
 100 48 
5 Ph3SiCl
a
 - - 
6 KCl
a
 100 44 
7 B(OMe)3
a
 100 35 
8 BSA
a,b
 100 60 
9 R-Trip
c
 100 40 
10 R-Binol
c
 100 30 
11 MeOH
d
 100 66 
12 EtOH
d
 100 40 
13 iPA
d
 100 67 
14 tBuOH
d
 100 82 
15 H2O
d
 100 23 
16 NaHSO3
d
 100 77 
17 1,10-Diaza-18-crown-6
e 85 63 
a
1.2 equivalent of additives, unless otherwise mentioned. 
b
30 mol%. 
c
10 mol%. 
d
2-3 equivalent. 
e
The reaction was run at rt and enantiomeric reversal was observed. 
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Most of these additives were selected from the literature, besides NaHSO3 which has 
never been used as additive in an asymmetric reaction, to the best of our knowledge. 
Some of these additives which provided mentionable enantiselectivity in our case are 
HMPA, BSA, most of the alcohols including MeOH, iPA, and tBuOH, NaHSO3, and one 
of the diaza crown ether derivatives (entry 1, 8, 11, 13, 14, 16, and 17 respectively). 
tBuOH as additives has been employed before by Trost and co-workers
166
 with 
significant improvement in ee, which proved to be true for our case as well. It 
participated in the enantiodiscriminative process most satisfactorily so far with 82% ee 
(entry 14). NaHSO3 is another interesting additive we have found that provided us as 
much as 77% ee (entry 16). Suprisingly, 1,10-diaza-18-crown-6 has provided a decent 
63% ee of the desired product 13j at rt with reversal of enantiomers (entry 17). 
 
Since alcohols as a general class of compounds provided better overall results as 
additives and from earlier optimization studies (see Table 9, entry 8-11) we found that 
toluene is another better solvent for this Pd-AAA of 10j along with THF, we wanted to 
employ these alcohols as additives using toluene as reaction solvent. However, none of 
these additives in toluene provided better result than that in THF (Table 14). Maximum 
60% ee was observed with tBuOH (entry 4). Moreover, undesired O-allylated product 
was also observed for all of these reactions. 
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Table 14. Further optimization of additives employing toluene as reaction solvent. 
 
Entry Additivesa Conv.
b 
[%] 
ee 
[%] 
1 MeOH 75 0 
2 EtOH 70 44 
3 iPA 45 35 
4 tBuOH 45 60 
a
2-3 equivalent of additives. 
b
Rest are O-allylated product. 
 
 
We have also tried molybdenum (Mo) instead of palladium (Pd) as catalyst due to the 
reason explained in details in section 3.1.3 (Scheme 101). Essentially, molybdenum goes 
through inner-sphere mechanism of co-ordination and is thought to be more effective in 
enantiodiscrimination compared to outer-sphere mechanism which is operational with 
palladium. Both allyl acetate and allyl methyl carbonate have been employed as 
electrophile for these study. We have examined L3 and L5 as ligands for molybdenum 
together with hexane: toluene (1:1), toluene, and THF as solvents; DIPEA, KOtBu, and 
LiHMDS as bases; tBuOH, iPA, BSA, and NaHSO3 as additives; and all of these 
reactions have been tested at rt as well as at 50 ˚C. Surprisingly, no product was obtained 
for most of the reactions. Only starting material was isolated. For a very few reactions, 
maximum 10% of the desired 13j was found by 
1
H NMR in the crude mixture. 
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Scheme 101. Attempted Mo-AAA reaction with 10j. 
 
Due to the importance of 5-methoxy-2-nitro analog of the acrylate 10k which can be used 
for the asymmetric synthesis of Horsfiline, we have also explored the Pd-AAA reaction 
with this compound. Earlier, we have employed the previously optimized condition to 
this analog, however, without much success (see Scheme 96). This time, we optimized 
the condition again by the systemetic variations of ligands, solvents, and additives, while 
the temperature of the reaction was kept fixed at −10 ˚C (Scheme 102, Table 15). L2 - L5 
has been used for the investigation. L3 again proved to be the best ligand in terms of 
enantiomeric excess which provided 5%, 50%, 29%, and again 29% ee respectively in 
DCM, THF, toluene, and hexane: toluene (1:1) mixture (entry 2, 7, 11, and 13 
respectively). Since THF and toluene provided better ee compared to other solvents, we 
decided to explore the effect of additives in these solvents with L3 as the ligand of choice 
(entry 14-18). While toluene did not show any further improvement with either BSA or 
(R)-BA as additives (entry 14, and 15), THF provided as much as 70% ee when BSA was 
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employed (entry 17). Unlike with 10j, tBuOH was not found to be that much effective 
with 10k, which provided 13k with only 55% ee (entry 16). 
 
 
 
Scheme 102. Ligands for Pd-AAA of 10k. 
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Table 15. Optimization studies of Pd-AAA of 10K. 
Entry Ligand Solvent Additive Conv. 
[%] 
ee  
[%] 
1 (R,R)-L2 DCM - > 99 Racemic 
2 (R,R)-L3 DCM - > 99 5 
3 (R,R)-L4 DCM - 73 Racemic 
4 (R,R)-L5 DCM - 0 - 
5 (R,R)-L6 DCM - 0 - 
6 (R,R)-L2 THF - > 99 45 
7 (R,R)-L3 THF - > 99 50 
8 (R,R)-L4 THF - 79 44 
9 (R,R)-L5 THF - 0 - 
10 (R,R)-L6 THF - 0 - 
11 (R,R)-L3 Toluene - > 99 29 
12 (R,R)-L6 Toluene - 0 - 
13 (R,R)-L3 Hex:Tol - >99 29 
14 (R,R)-L3 Tol BSA >99 35 
15 (R,R)-L3 Tol R-BA 20 24 
16 (R,R)-L3 THF tBuOH > 99 55 
17 (R,R)-L3 THF BSA > 99 70 
18 (R,R)-L3 THF R-BA 0 - 
 
Since we have achieved 82% ee of 13j from the Pd-AAA reaction of 10j (see Table 12, 
entry 14), we went on to synthesize 3,3′-disubstituted oxindole framework 29 in order to 
show the application of this methodology in the synthesis of natural building blocks 
(Scheme 103). Reduction of aldehyde of 13j to 27 provided quantitative yield. Then 
selective reduction of nitro group of 27 with Zn/NH4Cl in ethanol-water (4:1) mixture 
provided the desired 3,3′-disubstituted oxindole 29 with 80% yield. 
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Scheme 103. Asymmetric synthesis of 3,3′-disubstituted oxindole 29. 
 
Currently, the work is in progress to synthesize Coerulescine 21 and Horsfiline 22 using 
this methodology (Scheme 104). 31 or 32 can be achieved from 29 or 30 respectively by 
oxidative cleavage of the allyl group. Then reductive amination followed by ring closing 
should provide Coerulescine 21 or Horsfiline 22. 
 
 
Scheme 104. Proposed synthesis of Coerulescine 21 and Horsfiline 22. 
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3.3.2. Asymmetric synthesis of α-disubstituted β-lactones from 3-hydroxy  aryl acrylate 
10a 
 
Asymmetric α-disubstituted all-carbon quaternary β-lactone 37 has also been synthesized 
applying our methodology from parent quaternary aldehyde analog 13a by three simple 
steps with high overall yield (87%) and enantioselectivity (94% ee). NaBH4 reduction of 
13a provided quaternary alcohol 35 with >99% yield. The diacid compound 36 was 
prepared quantitatively from 35 by stirring in NaOH solution, followed by ring closing 
yielded desired α-disubstituted all-carbon quaternary β-lactone 37 with 87% yield 
(Scheme 105). 
 
 
 
Scheme 105. Asymmetric synthesis of quaternary β-lactone 37 from 13a. 
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3.4. General methods and experimental 
 
3.4.1. Preparation of 3-hydroxy aryl acrylates 10j-10o for Palladium-Catalyzed 
Asymmetric Allylic Alkylation (Pd-AAA) 
 
Hydroxyarylacrylates 10j,
33
 10k,
33
 10n,
45
 and 10o
45
 were prepared according to 
previously existing procedures. Work-up procedure described in sections 1.2.1 and 1.5.1 
was followed. 
 
Hydroxyarylacrylates 10l and 10m prepared folloing the procedure for 10h described in 
section 2.7.1. 
 
(Z)-ethyl 3-hydroxy-2-(2-methoxyphenyl)acrylate (10l) 
 
2-methoxybenzaldehyde (1.36 g, 10.0 mmol),  Ethyl diazoacetate (1.45 mL, 12.0 mmol),  
HBF4.OEt2 (0.14 mL, 1.0 mmol) in dichloromethane (100 mL) at -78
0
C to rt for 5h to 
provide the above mentioned compound as a clear oil (1.46g, 65% yield).  
1
H NMR (CDCl3, 300 MHz): δ 11.99 (d, j = 12.6 Hz, 1H), 7.41 – 6.75 (5H), 4.35 (q, j = 
9.0 Hz, 2H), 3.78 (s, 3H), 1.24 (t, j = 7.2 Hz, 3H). 
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(Z)-ethyl 2-(2-fluorophenyl)-3-hydroxyacrylate (10m) 
 
2-fluorobenzaldehyde (1.24 g, 10.0 mmol),  Ethyl diazoacetate (1.45 mL, 12.0 mmol),  
HBF4.OEt2 (0.14 mL, 1.0 mmol) in dichloromethane (100 mL) at -78 
0
C to rt for 5h to 
provide the above mentioned compound as a clear oil (1.49g, 71% yield).  
 
3.4.2. General procedures for palladium-catalyzed allylic alkylation reactions 
 
All-carbon quaternary aldehydes 13j-13o were prepared following the procedure 
described in section 2.7.2. 
 
Ethyl 2-formyl-2-(2-nitrophenyl)pent-4-enoate (13j) 
 
Racemic: General procedure for racemic Pd-catalyzed allylic alkylation reaction 
(Method 4) using hydroxyarylacrylate 10j (50.0 mg, 0.1803 mmol, 1.0 eq), Pd(PPh3)4 
(20.8 mg, 0.0180 mmol, 0.1 eq), and allyl acetate (23.4 µL, 0.2164 mmol, 1.2 eq) in 
dichloromethane (5 mL) at rt for 2h to provide the above mentioned compound as a off-
white solid (55.7 mg, >99% yield).  
Chiral: General procedure for Pd-AAA reaction (Method 3) using hydroxyarylacrylate 
10j (50.0 mg, 0.1803 mmol, 1.0 eq), Pd2(dba)3CHCl3 (4.7 mg, 0.0045 mmol, 0.025 eq), 
(R,R)-L3 (8.5 mg, 0.0108 mmol, 0.06 eq), allyl acetate (23.4 µL, 0.2164 mmol, 1.2 eq), 
tBuOH (43.1 µL, 0.4508 mmol, 2.5 eq) in THF (5 mL) at -10
0
C to provide the above 
mentioned compound as a off-white solid (55.7 mg, >99% yield). 
192 
 
 
 
1
H NMR (300 MHz, CDCl3): δ 10.16 (s, 1H), 8.16 (d, j = 9 Hz, 1H), 7.74 (m, 1H), 7.63 
(m, 1H), 7.57 (m, 1H), 5.72 (m, 1H), 5.24 (m, 2H), 4.22 (q, j = 8.0 Hz, 2H), 3.06 (d, j = 
6.0 Hz, 2H), 1.25 (t, J = 7.1 Hz, 3H).  
13
C NMR (75 MHz, CDCl3): δ 196.9, 169.4, 148.4, 133.7, 131.1, 130.7, 130.5, 129.0, 
125.9, 120.4, 63.9, 62.0, 37.8, 14.0. 
 Chiral HPLC: 82% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 95:05 hexane/ethanol, 1.0 mL/min, 220 nm, 12.16 min (major), 14.26 min 
(minor). 
HRMS (ESI): Calculated (m/z) for C14H16NO5 (M+H)
+
 : 278.1023, Found 278.1033. 
 
Ethyl 2-formyl-2-(5-methoxy-2-nitrophenyl)pent-4-enoate (13k) 
 
Racemic: General procedure for racemic Pd-catalyzed allylic alkylation reaction 
(Method 4) using hydroxyarylacrylate 10k (50.0 mg, 0.1627 mmol, 1.0 eq), Pd(PPh3)4 
(18.8 mg, 0.0163 mmol, 0.1 eq), and allyl acetate (21.1 µL, 0.1952 mmol, 1.2 eq) in 
dichloromethane (5 mL) at rt for 2h to provide the above mentioned compound as a 
brown solid (50.3 mg, 100% conversion).  
Chiral: General procedure for Pd-AAA reaction (Method 3) using hydroxyarylacrylate 
10k (25.0 mg, 0.0814 mmol, 1.0 eq), Pd2(dba)3CHCl3 (2.1 mg, 0.0020 mmol, 0.025 eq), 
(R,R)-L3 (3.9 mg, 0.0049 mmol, 0.06 eq), allyl acetate (10.6 µL, 0.0976 mmol, 1.2 eq), 
BSA (23.9 µL, 0.0976 mmol, 1.2 eq) in THF (3 mL) at -10
0
C to provide the above 
mentioned compound as a brown solid (24.13 mg, 100% conversion). 
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1
H NMR (300 MHz, CDCl3): δ 10.16 (s, 1H), 8.28 (d, j = 9 Hz, 1H), 7.45-6.93 (2H), 5.9 
(m, 1H), 5.26 (m, 2H), 4.22 (q, j = 8.0 Hz, 2H), 3.94 (s, 3H), 3.00 (d, j = 6.0 Hz, 2H), 
1.25 (t, J = 7.1 Hz, 3H).  
Chiral HPLC: 70% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 90:10 hexane/ethanol, 0.5 mL/min, 220 nm, 27.40 min (major), 29.63 min 
(minor). 
 
Ethyl 2-formyl-2-(2-methoxyphenyl)pent-4-enoate (13l) 
 
Racemic: General procedure for racemic Pd-catalyzed allylic alkylation reaction 
(Method 4) using hydroxyarylacrylate 10l (50.0 mg, 0.1908 mmol, 1.0 eq), Pd(PPh3)4 
(21.2 mg, 0.0191 mmol, 0.1 eq), and allyl acetate (24.8 µL, 0.2290 mmol, 1.2 eq) in 
dichloromethane (5 mL) at rt for 2h to provide the above mentioned compound as a 
yellow oil (59.2 mg, >99% yield).  
Chiral: General procedure for Pd-AAA reaction (Method 3) using hydroxyarylacrylate 
10l (50.0 mg, 0.1908 mmol, 1.0 eq), Pd2(dba)3CHCl3 (5.0 mg, 0.0048 mmol, 0.025 eq), 
(R,R)-L3 (9.0 mg, 0.0114 mmol, 0.06 eq), allyl acetate (24.8 µL, 0.2290 mmol, 1.2 eq), 
in hexane: toluene (1:1) at -20
0
C to provide the above mentioned compound as a yellow 
oil (59.2 mg, >99% yield). 
1
H NMR (300 MHz, CDCl3): δ 10.06 (s, 1H), 7.34-6.90 (m, 4H), 5.95 (m, 1H), 5.10 (m, 
2H), 4.22 (q, j = 8.0 Hz, 2H), 3.79 (s, 3H), ), 3.10 (dd, J = 6.3, 13.8 Hz, 1H), 2.87 (dd, J = 
7.8, 13.8 Hz, 1H), 1.24 (t, J = 7.2 Hz, 3H).  
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Chiral HPLC: 10% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 96:04 hexane/ethanol, 0.5 mL/min, 220 nm, 18.36 min (major), 20.28 min 
(minor). 
 
Ethyl 2-(2-fluorophenyl)-2-formylpent-4-enoate (13m) 
 
Racemic: General procedure for racemic Pd-catalyzed allylic alkylation reaction 
(Method 4) using hydroxyarylacrylate 10m (50.0 mg, 0.1998 mmol, 1.0 eq), Pd(PPh3)4 
(23.0 mg, 0.0200 mmol, 0.1 eq), and allyl acetate (25.9 µL, 0.2398 mmol, 1.2 eq) in 
dichloromethane (5 mL) at rt for 2h to provide the above mentioned compound as a clear 
oil(61.7 mg, >99% yield).  
Chiral: General procedure for Pd-AAA reaction (Method 3) using hydroxyarylacrylate 
10m (50.0 mg, 0.1998 mmol, 1.0 eq), Pd2(dba)3CHCl3 (5.2 mg, 0.0050 mmol, 0.025 eq), 
(R,R)-L3 (9.4 mg, 0.0120 mmol, 0.06 eq), allyl acetate (25.9 µL, 0.2398 mmol, 1.2 eq), 
in hexane: toluene (1:1) at -20
0
C to provide the above mentioned compound as a clear oil 
(61.7 mg, >99% yield). 
1
H NMR (300 MHz, CDCl3): δ 9.98 (s, 1H), 7.37-7.08 (m, 4H), 5.80 (m, 1H), 5.11 (m, 
2H), 4.28 (q, j = 7.5 Hz, 2H), 3.16 (dd, J = 6.3, 13.8 Hz, 1H), 2.91 (dd, J = 7.8, 13.8 Hz, 
1H),1.27 (t, J = 7.5 Hz, 3H).  
13
C NMR (75 MHz, CDCl3): δ 195.6, 170.0, 162.2, 134.1, 132.1, 130.2, 129.7, 124.7, 
119.4, 116.1, 62.7, 61.9, 36.0, 14.0. 
 Chiral HPLC: 10% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 99:01 hexane/ethanol, 1.0 mL/min, 220 nm, 8.61 min (major), 9.19 min (minor). 
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Ethyl 2-(2,4-dichlorophenyl)-2-formylpent-4-enoate (13n) 
 
Racemic: General procedure for racemic Pd-catalyzed allylic alkylation reaction 
(Method 4) using hydroxyarylacrylate 10n (50.0 mg, 0.1660 mmol, 1.0 eq), Pd(PPh3)4 
(19.1 mg, 0.0166 mmol, 0.1 eq), and allyl acetate (21.5 µL, 0.1992 mmol, 1.2 eq) in 
dichloromethane (5 mL) at rt for 2h to provide the above mentioned compound as an 
yellow oil (51.3 mg, >99% yield).  
Chiral: General procedure for Pd-AAA reaction (Method 3) using hydroxyarylacrylate 
10n (50.0 mg, 0.1660 mmol, 1.0 eq), Pd2(dba)3CHCl3 (4.3 mg, 0.0042 mmol, 0.025 eq), 
(R,R)-L3 (8.1 mg, 0.0100 mmol, 0.06 eq), allyl acetate (21.5 µL, 0.1992 mmol, 1.2 eq), 
in hexane: toluene (1:1) at -20
0
C to provide the above mentioned compound as an yellow 
oil (48.2 mg, 93% yield). 
1
H NMR (300 MHz, CDCl3): δ 10.32 (s, 1H), 7.72 (s, 1H), 7.44–7.28 (m, 2H), 5.75 (m, 
1H), 5.2-5.1 (m, 2H), 4.25 (q, J = 7.1, 2H), 3.10 (dd, J = 6.3, 13.8 Hz, 1H), 2.94 (dd, J = 
7.2, 14.1 Hz, 1H), 1.26 (t, J = 7.1 Hz, 3H).  
Chiral HPLC: 6% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 96:04 hexane/ethanol, 0.5 mL/min, 220 nm, 13.46 min (major), 14.66 min 
(minor). 
Analytical data matched previously reported data.
45
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Ethyl 2-(5-bromo-2-methoxyphenyl)-2-formylpent-4-enoate (13o) 
 
Racemic: General procedure for racemic Pd-catalyzed allylic alkylation reaction 
(Method 4) using hydroxyarylacrylate 10o (50.0 mg, 0.1465 mmol, 1.0 eq), Pd(PPh3)4 
(16.9 mg, 0.0147 mmol, 0.1 eq), and allyl acetate (19.0 µL, 0.1758 mmol, 1.2 eq) in 
dichloromethane (5 mL) at rt for 2h to provide the above mentioned compound as an 
yellow oil (45.3 mg, >99% yield).  
Chiral: General procedure for Pd-AAA reaction (Method 3) using hydroxyarylacrylate 
10o (50.0 mg, 0.1465 mmol, 1.0 eq), Pd2(dba)3CHCl3 (3.8 mg, 0.0037 mmol, 0.025 eq), 
(R,R)-L3 (7.1 mg, 0.0088 mmol, 0.06 eq), allyl acetate (19.0 µL, 0.1758 mmol, 1.2 eq), 
in hexane: toluene (1:1) at -20
0
C to provide the above mentioned compound as an yellow 
oil (44.4 mg, 97% yield). 
1
H NMR (300 MHz, CDCl3): δ 10.1 (s, 1H), 7.42–7.31 (m, 2H), 6.75 (d, J = 8.7 Hz, 
1H), 5.77 (m, 1H), 5.15-5.05 (m, 2H), 4.20 (q, J = 7.1 Hz, 2H), 3.73 (s, 3H), 3.00 (dd, J = 
6.6, 13.8 Hz, 1H), 2.80 (dd, J = 7.8, 13.8 Hz, 1H), 1.26 (t, J = 7.1 Hz, 3H) . 
Chiral HPLC: 21% ee, Regis Technologies Pirkle Covalent chiral stationary phase 
column, 96:04 hexane/ethanol, 0.5 mL/min, 220 nm, 18.83 min (minor), 19.80 min 
(major). 
Analytical data matched previously reported data.
45
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3.4.3. Synthesis of 3,3′-disubstituted oxindole 29 
 
 
 
Ethyl 2-(hydroxymethyl)-2-(2-nitrophenyl)pent-4-enoate (27)  
 
Ethyl 2-formyl-2-(2-nitrophenyl)pent-4-enoate 13j (430.0 mg, 1.44 mmol, 1.0 eq) was 
added to a 100 mL round bottomed flask and placed in an argon atmosphere. 30mL dry 
methanol was then added via syringe and the mixture was allowed to stir until all starting 
material was dissolved. The reaction flask was then brought down to 0 
o
C and NaBH4 
(294.0 mg, 7.76 mmol, 5.0 eq) was added to the stirring mixture. Subsequently, the 
mixture was removed from the ice bath and allowed to stir for 5 minutes and then 
returned to ice and monitored by TLC until completion. After no starting material 
remained, 10 mL of water was added to quench the reaction mixture. The mixture was 
then extracted three times with 15 mL portion of DCM, dried, and concentrated in vacuo. 
The resultant crude was purified by column chromatography on silica gel eluted with 5% 
EtOAc in Hexane to afford the above mentioned product 27 as brownish viscous liquid 
(430.0 mg, > 99% conv.). 
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1
H NMR (300 MHz, CDCl3): δ 7.88 (d, j = 9 Hz, 1H), 7.59 (m, 2H), 7.44 (m, 1H), 5.59 
(m, 1H), 5.12 (m, 2H), 4.31 (d, j = 12 Hz, 1H), 4.10 (m, 2H), 3.98 (d, j = 12 Hz, 1H), 
3.00 (dd, j = 6.0, 12.0 Hz, 2H), 2.70 (s, 1H), 1.19 (t, J = 7.5 Hz, 3H).  
13
C NMR (75 MHz, CDCl3): δ 172.7, 150.1, 133.1, 132.1, 129.9, 128.0, 126.1, 125.2, 
119.5, 67.1, 61.2, 55.1, 39.2, 14.0. 
HRMS: Calculated (m/z) for C14H17NO5 (M+H)
+
 : Predicted 280.1179, Found 
280.1180. 
 
3-allyl-3-(hydroxymethyl)indolin-2-one (29) 
 
Ethyl 2-(hydroxymethyl)-2-(2-nitrophenyl)pent-4-enoate 27 (200.0 mg, 0.72mmol, 1 eq), 
zinc powder (400.0 mg, 6.12 mmol, 8.5eq), 370.0 mg of solid NH4Cl (6.92 mmol, 9.6eq) 
were taken in a flask and placed in an argon atmosphere. A dry and degassed 10.0 mL of 
the ethanol: water (4:1) mixture was added to the flask via syringe followed by vigorous 
stirring. Then heat was applied to bring the mixture to reflux. The mixture was allowed to 
react for 2 hours and monitored by TLC before being cooled down to room temperature. 
The zinc dust was then removed by filtering through a cotton plug and ethanol was 
removed in the rotary evaporator before extraction with ethyl acetate. The organic layer 
was washed with water and brine, dried over anhydrous Na2SO4 and concentrated in 
vacuo. The crude was purified via column chromatography using basic or neutral Al2O3 
as a stationary phase with 100% ethyl acetate, which yielded the desired oxindole 29 as 
white solid (0.12 g, 80% yield).  
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1
H NMR (300 MHz, (CDCl3): δ 8.12 (s, 1H), 7.26-6.91 (m, 4H), 5.51 (m, 1H), 5.10 (m, 
2H), 3.89 (dd, J =12.0, 36.0 Hz, 2H), 2.70 (m, 2H), 2.04 (s, 1H). 
13
C NMR (75 MHz, (CDCl3): δ 180.8, 141.1, 131.6, 129.9, 128.5, 123.7, 122.7, 119.2, 
109.9, 66.5, 54.7, 37.3. 
HRMS: Calculated (m/z) for C12H13NO2 (M+H)
+
 : Predicted 204.1009, Found 
204.1019. 
 
3.4.4. Synthesis of α-disubstituted all-carbon quaternary β-lactone 37 
 
 
 
Ethyl 2-(hydroxymethyl)-2-phenylpent-4-enoate (35) 
 
To a 10 mL round bottom flask with 13a (50.0 mg, 0.2153 mmol, 1.0 eq) was charged 
with MeOH (5 mL) and cooled to 0°C. Next, NaBH4 (40.5 mg, 1.0765 mmol, 5.0 eq) 
were added portion wise and let the mixture stir for 3h.  The reaction was quenched with 
H2O (3 mL) at 0°C and then was extracted three times with dichloromethane. The organic 
layer was washed with brine, then dried over anhydrous Na2SO4, and concentrated in 
vacuo. Column chromatography on silica gel with eluted with hexane and EtOAc 
provided 50.3 mg (>99% yield) of the reduced quaternary alcohol product 35 as a clear 
oil.  
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1
H NMR (300 MHz, CDCl3): δ (ppm) 7.39-7.28 (m, 5H), 5.75 (m, 1H), 5.21-5.09 (m, 
2H), 4.26-4.18 (m, 2H), 4.05 (q, j = 12.0 Hz, 2H), 2.8 (d, j = 9.0 Hz, 2H), 2.48 (s, 1H), 
1.25 (t, j = 7.5 Hz, 3H).  
13
C NMR (75 MHz, CDCl3): δ 174.7, 140.1, 133.7, 129.0, 128.8, 127.2, 126.8, 126.3, 
118.7, 66.5, 61.1, 55.7, 38.3, 14.1. 
 HRMS (ESI): Calculated (m/z) for C14H18O3 (M+H)
+
 : 235.1329, Found 235.1334. 
 
2-(hydroxymethyl)-2-phenylpent-4-enoic acid (36) 
 
Aq. NaOH (4 M, 0.32 mL) was added to a solution of ester 35 (50.0 mg, 0.2134 mmol, 
1.0 equiv) in methanol (not dried, 3.0 mL) under air at 0 °C. The cold bath was removed 
and the mixture stirred at room temperature until all starting material was consumed (5 
h). The solution was diluted with water and the aqueous layer washed three times with 
diethyl ether before it was carefully acidified using concentrated aq. HCl. The aqueous 
phase was extracted three times with diethyl ether, the combined extracts were dried over 
Na2SO4, filtered and evaporated to yield the crude hydroxyacid 36 as white solid (44.0 
mg, >99% yield), which was used in the next step without further purification.  
1
H NMR (300 MHz, CDCl3): δ (ppm) 7.34-7.28 (m, 5H), 6.57 (br., 2H), 5.68-5.63 (m, 
1H), 5.18 (d, j = 15.0 Hz, 1H), 5.11(d, j = 12.0 Hz, 1H), 4.25 (m, 1H), 4.15 (m, 1H), 2.87 
(d, j = 6.0 Hz, 2H).  
13
C NMR (75 MHz, CDCl3): δ 179.5, 138.9, 133.3, 128.7, 128.0, 127.5, 126.8, 126.7, 
119.0, 65.3, 55.7, 38.5. 
 HRMS (ESI): Calculated (m/z) for C12H14O3 (M-H)
-
 : 205.0870, Found 205.0869. 
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3-allyl-3-phenyloxetan-2-one (37) 
 
A dry 10 mL flask was charged with acid 36 (50 mg, 0.2424 mmol, 1.0 equiv) from the 
previous step, a stir bar, and dichloromethane (3.0 mL) under argon. The resulting 
solution was then cooled to 0 °C. Triethylamine (100 µL, 0.7272 mmol, 3.0 equiv) and 
tosyl chloride (50.8 mg, 0.2666 mmol, 1.1 equiv) were subsequently added and the 
mixture was stirred for 2 h. It was then warmed to rt and stirred for another 30 minutes. 
TLC showed the consumption of starting material. Water (4.0 mL) and CH2Cl2 (4.0 mL) 
were added and the organic phase was separated. The aqueous layer was then further 
extracted with CH2Cl2 (3 X 10 mL). The combined organic layers were washed with 
brine, dried over sodium sulfate, filtered and concentrated in vacuo. The crude was 
purified by preparative TLC (elutes at 10:90 EtOAc/hexanes) to afford β- lactone 37 as a 
white solid (39.7 mg, 87%). 
1
H NMR (500 MHz, CDCl3): δ (ppm) 7.43-7.28 (m, 5H), 5.81-5.73 (m, 1H), 5.24-5.20 
(m, 2H), 4.55 (dd, j = 5.0, 15.0 Hz, 2H), 2.85 (dd, j = 10.0, 15.0 Hz, 1H), 2.75 (dd, j = 
5.0, 15.0 Hz, 1H).  
13
C NMR (125 MHz, CDCl3): δ 171.8, 137.3, 131.4, 128.9, 127.9, 126.1, 120.5, 69.7, 
65.1, 44.0. 
MS: Compound decomposed during HRMS. 
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